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ABSTRACT
Metabolic flux and population heterogeneity analysis were used to develop relations
between mammalian cell physiology and specific culture environments and to formulate
strategies for increasing cell culture performance. Mitochondrial characteristics associated with
respiration, membrane potential, and apoptosis along with physiological state multiplicity
involving both metabolism and apoptotic death played a key role in this research.
Research involving the accurate calculation of metabolic flux and the analysis of cellular
behavior occurring in continuous cultures set the stage for subsequent research on physiological
state multiplicity. This phenomena was observed in continuous cultures when at the same
dilution rate, two physiologically different cultures were obtained which exhibited similar
growth rates and viabilities but drastically different cell concentrations. Metabolic flux analysis
conducted using metabolite and gas exchange rate measurements revealed a more efficient
culture for the steady state with the higher cell concentration, as measured by the fraction of
pyruvate carbon flux shuttled into the tri-carboxylic (TCA) cycle for energy generation. This
metabolic adaptation was unlikely due to favorable genetic mutations and was implemented in
subsequent research aimed at improving cell culture performance.
A hypothesis stating that mitochondrial physiology and cellular physiology are correlated
was tested and confirmed. A mammalian cell population was separated using FACS into
subpopulations based on their mean mitochondrial membrane potential (MMP) as measured
using the common mitochondrial stain, Rhodamine 123. The MMP sorted subpopulations were
subjected to apoptosis inducers, and the apoptotic death was characterized both morphologically
through the determination of apoptosis related chromatin condensation and also biochemically
through the measurement of caspase-3 enzymatic activity. The results showed dramatic
differences in apoptotic death kinetics with the higher MMP subpopulations demonstrating a
higher resistance to apoptotic death.
These results were applied in the development of novel fed-batch feeding and operating
strategies. The first strategy showed that overfeeding cells later in culture leads to an increase in
culture viable cell concentration, viability, and productivity. The second strategy showed that
cell populations with a higher mean MMP are able to resist apoptosis during fed-batch culture.
These results indicate that mammalian cell populations have considerable flexibility in their
ability to redistribute metabolic flux in central carbon metabolism. Furthermore, these cell
populations contain subpopulations that vary in their resistance to apoptotic death. The analysis
of mitochondrial physiology and metabolic flux led to these discoveries, and these areas will
play a key role in future mammalian cell culture research.
Thesis Supervisor: Daniel I. C. Wang
Title: Institute Professor
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1. INTRODUCTION
1.1 Historical Review
Jacob Bronowski cites the biological revolution as "the change from which civilization
took off."
It is usually called the 'agricultural revolution'. But I think of it as something
much wider, the biological revolution. There was intertwined in it the cultivation
of plants and the domestication of animals in a kind of leap-frog. And under this
ran the crucial realization that man dominates his environment in its most
important aspect, not physically but at the level of living things - plants and
animals (Bronowski, 1976).
This realization of mans' dominance over living things led to thousands of years of conscious
manipulation of biological systems though the domestication and selection of animals and crops.
However, man also unknowingly used unseen biological systems for his benefit as well as
demonstrated in the use of microorganisms in fermentation processes producing beer, wine, and
other products. Leeuwenhoek's observation of microscopic "animalcules" in 1676 and Pasteur's
discovery that "wine is a sea of organisms" in 1857 led the way for the scientific analysis of
these unseen biological systems through modem biology (Prescott et al., 1993).
Although fermentation is an ancient industry, when restricted to the production of
chemically defined biological substances, modem biotechnology is considered to be about 100
years old. Biotechnology's early efforts to produce organic chemicals such as acetone and citric
acid before and during the First World War led the way for antibiotic and secondary metabolite
production during and after the Second World War. The microorganisms used in these
production processes were obtained through "what G. Pontecorvo described as a 'prehistoric'
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technique: mutation and screening (selection) from the available gene pool" (Prescott et al.,
1993). Although these techniques are still used today, they are oftentimes complemented with
recombinant DNA technology. Developed in the 1970s, this technology gave scientists the
techniques to cut, join, and replicate DNA and reverse transcribe RNA giving them the
unprecedented ability to deliver and express foreign DNA in a host cell. In 1980, the first
recombinant DNA company, Genentech, announced an initial public offering on Wall Street that
resulted in a multimillion dollar market valuation. Soon after, the first recombinant therapeutic
protein, insulin, was marketed in 1982, and this opened the way for the modern biotechnology
industry.
Many therapeutic proteins are now produced in mammalian cell culture due to the ability
of these cells to properly perform post-translational modifications, such as glycosylation, on the
protein products. Interferon, tissue plasminogen activator, erythropoietin, and factor VIII are just
a few of the products that have helped propel mammalian cell culture derived therapeutic
production into becoming a multi-billion dollar industry.
1.2 Motivation
Biological systems in general, and their interaction with their environment,
abound with an overwhelming complexity of detail through which general
concepl 3 and relationships cannot readily be perceived. Because of this
complexity, many biologists are concerned with details, and have tended to
neglect problems associated with integrated systems. On the other hand,
engineers who have not yet encountered such complexity in manufacturing
facilities are concerned with integrated systems which are just beginning to
approach the complexity of biological systems (Tsuchiya et al., 1966).
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These comments are still relevant to biochemical engineering today as shown through the
differences in how scientific research is conducted in biology and engineering. Molecular
biology is still criticized for being too qualitative, detail oriented, and in need of a more
quantitative framework for analyzing biological systems (Bailey, 1999; Maddox, 1992).
Conversely, engineering is oftentimes not detailed enough for a proper analysis of the
complexity involved in biological systems. The current problems in biochemical engineering
concerning the minimization of cell death and the maximization of culture cell concentration and
productivity illustrate the need for quantitative methodologies designed for the analysis of
complex biological systems such as cellular metabolic pathways and regulatory networks and
their relations with cellular behavior.
These methodologies have been developed to describe a variety of biological phenomena
such as cell cycle control, cell migration, and receptor trafficking (Lauffenburger and
Linderman, 1993). In addition, metabolic flux analysis provides another such framework, and
cell culture performance can be further improved by analyzing carbon flux in central carbon
metabolism to determine key nutrient requirements, potential rate controlling biochemical
reactions, and mechanisms that regulate the control of metabolic flux flowing through metabolic
reaction networks. This thesis applies metabolic flux analysis to elucidate the physiological state
of mammalian cells at different continuous culture environmental conditions with the ultimate
goals of identifying environments and operating conditions that result in optimal culture
performance and factors that contribute to the regulation of metabolic flux distribution.
One significant source of complexity in biological systems is the tremendous amount of
physiological multiplicity and population heterogeneity that occurs even under constant
environmental conditions. In biochemical engineering, the observed variance in survival ability
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and metabolic adaptation in culture demonstrates the need to provide a methodology to analyze
this population heterogeneity. In this thesis, the technique of directed evolution through FACS
separation was utilized in order to characterize subpopulations that demonstrate variances in their
survival ability, and these findings were then applied in the creation of novel cell culture
processes.
1.3 Thesis Objectives
This research was conducted in an effort to quantitate and understand cultured
mammalian cell behavior with respect to metabolic flux distribution, population survival
heterogeneity, and cell death. In addition to studying the experimental data needed to calculate
accurate metabolic fluxes, the physiology and metabolic adaptation of cultured mammalian cells
at various growth rates was investigated. Of particular interest was the observed steady state
multiplicity, whereby drastically different cell concentrations were observed at the same growth
rate and viability. The observed variations in the efficiency of pyruvate utilization in the tri-
carboxylic (TCA) cycle for the multiple steady states led to the hypothesis that TCA cycle
efficiency variations could be used as a basis for developing strategies for feeding fed-batch
cultures and for selecting high mitochondrial activity (high TCA cycle activity) subpopulations
for culture inoculums. The presence of steady state multiplicity led to an investigation of culture
population heterogeneity, mitochondria, and apoptotic cell death, and subsequent experimental
work involved the use of FACS analysis of mitochondrial parameters as a basis for determining
the influence of mitochondrial properties on cell death. Since apoptosis accounts for a
significant amount of death in mammalian cell cultures, the link between mitochondrial
parameters and apoptosis was investigated under both short term conditions involving specific
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apoptosis inducing conditions and under the more general long-term apoptosis inducing
conditions found in fed-batch cultures.
Specifically, this thesis addresses these objectives:
*What experimental techniques and data are required for accurate metabolic flux
calculations?
*How does cellular metabolic flux distribution vary at different cellular growth rates?
-Can variance in metabolic flux distribution result in culture cell concentration and
viability variance?
*Does culture population heterogeneity exist with respect to apoptotic death?
*Are mitochondrial properties related to cellular physiology and susceptibility to
apoptotic death?
*Can metabolic adaptation and mitochondrial heterogeneity be used in the design of
novel fed-batch operational strategies?
1.4 Thesis Organization
This thesis consists of nine chapters. The first three chapters cover a brief discussion of
the motivation and objectives for this research, a detailed review of the literature (metabolism,
metabolic flux analysis, population heterogeneity, apoptosis, and mitochondria), and a
description of the materials and methods used in the research. The next five chapters describe
and discuss the experimental results. Specifically, the fourth chapter describes in detail the
methodology used in metabolic flux calculations including the formulation of the biomass
equation and the methods required for accurate flux calculations. In addition, the methodology
required to obtain accurate pentose phosphate pathway metabolic flux data is included in order to
demonstrate the additional effort required for accurate metabolic flux analysis tracer
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experiments. The fifth and sixth chapters cover the continuous culture experiments performed
using the Chinese hamster ovary and hybridoma cell lines. In particular, the fifth chapter
emphasizes the metabolic flux distribution around the pyruvate branchpoint at varying growth
and death rates, and the sixth chapter describes variances in flux distribution around the pyruvate
branchpoint and their relation to steady state multiplicity. The seventh chapter describes the
research conducted on the mitochondrial membrane potential sorted cell subpopulations that
were characterized for both their morphological and biochemical responses to apoptosis
inducers. The eighth chapter applies the results from the previous chapters in the design of novel
strategies for fed-batch culture operation. The ninth chapter reviews the main conclusions of this
research and gives recommendations for future work. The remaining two sections list the
nomenclature and references used in this thesis.
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2. LITERATURE REVIEW
2.1 Mammalian Cell Culture
Mammalian cells have been used extensively in the production of therapeutic protein
products due to their ability to produce properly folded and glycosylated versions of these
proteins which have been correlated with specific activity and circulatory half life (Goochee et
al., 1991; Kaufman, 1989; Kaufman et al., 1988). Although yeast, insect, plant, and mammalian
cells are capable of glycosylating proteins, only mammalian cells produce glycoforms similar to
those required for human therapeutics (Goochee et al., 1991; Kaufman, 1989; Kaufman et al.,
1988). Therefore, mammalian cells will undoubtedly serve as the preferred cell type for complex
therapeutic protein production.
However, mammalian cell cultures exhibit several complex problems not found in
microbial fermentations such as difficulty in achieving high cell concentrations and viabilities
and therefore high protein product concentrations. Some of these problems stem from the
sensitivity of fragile mammalian cells to their environment resulting in slow growth, poor
productivity, low cell concentrations, and necrotic cell death. Cell damage due to hydrodynamic
effects in the bioreactor has been shown to contribute to cell death (Hu and Peshwa, 1991). In
addition, sparging for bioreactor oxygenation has proven to be another problem resulting in cell
death (Jobses et al., 1991; Meier et al., 1999). Osmolarity, pH, and temperature can also
significantly affect the performance of a culture process (Borys et al., 1993; Miller et al., 1988;
Ozturk and Palsson, 1991; Xie, 1997). A variety of methods have been proposed to address
these problems such as altering the reactor system and reactor operating conditions (Avgerinos et
al., 1990; Batt et al., 1990; Hu and Peshwa, 1991).
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In addition, the cellular nutrient environment is critical in mammalian cell culture.
Mammalian cells need a complex mixture of glucose, amino acids, vitamins, trace metals, and
salts (Butler and Jenkins, 1989). In addition, they oftentimes require growth factors and other
serum components which activate cell proliferation and provide protection from apoptotic death
(Barnes and Sato, 1980; Chung et al., 1997; Glassy et al., 1988). These requirements are rather
specific and deviations can cause cell death. In addition, the metabolism of cultured mammalian
cells is atypical and can have high rates of aerobic glycolysis, glutaminolysis, and byproduct
production (Glacken et al., 1986; Lanks and Li, 1988; Xie, 1997). High glucose and glutamine
concentrations result in the production of high levels of waste metabolites such as lactate,
ammonia, and alanine illustrating the inefficient utilization of these substrates (Glacken et al.,
1986; Hansen and Emborg, 1994; Hassell et al., 1991; Xie, 1997). These factors all contribute to
the need to develop novel feeding strategies in order to improve culture viable cell
concentrations and to maintain cell viability.
Several hypotheses on the proper way to design and feed medium have been proposed to
satisfy mammalian cell culture requirements. Several researchers have suggested that cultures
should be controlled at low glutamine and glucose concentrations in order to reduce toxic lactate
and ammonium build-up. This strategy resulted in a lower lactate and ammonium production
and a subsequent increase in cell concentration (Glacken et al., 1986; Ljunggren and HaiggstrOm,
1994). Another strategy involved fortifying the medium with a balanced amount of nutrients in
order to achieve high cell concentrations in batch culture. This strategy resulted in an increase in
cell density to 1.0*107 viable cells/ml and a five- to eight-fold increase in product concentration
even though the lactate and ammonia concentrations were higher than those found in typical
cultures (Jo et al., 1990). Medium concentrates and on-line nutrient feeding have also been
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utilized in fed-batch processes to improve cell culture performance (Bibila et al., 1994; Zhou et
al., 1995). Xie and Wang formulated a strategy that employed a stoichiometric approach toward
medium design. Characteristics of the cell line composition were used to formulate a medium in
a fed-batch culture. This culture was also controlled at low glucose and glutamine
concentrations to reduce byproduct production, and the nutrient feeding was based on the cell
growth in the culture. This strategy resulted in viable cell concentrations of up to 1.7* 107 viable
cells/ml, a twenty-fold increase in product concentration, and a substantial decrease in byproduct
concentrations (Xie and Wang, 1994c). These approaches all resulted in higher viable cell
concentrations. On the other hand, substantial cell death still occurred at the end of the cultures
indicating that these strategies have not completely solved the problem of cell death. In addition,
these complex feed medium and feeding strategies as well as the reduction in specific growth
rate contribute to the increased culture development and operation time.
The genetic background of the cell line has proven to be another critical parameter for
mammalian cell culture, and research has demonstrated the utility of enhancing the cellular
genetic controls of the cell cycle and apoptosis (programmed cell death). The expression of
recombinant cyclin E in CHO cells stimulated cell progression through the cell cycle and
resulted in enhanced proliferation that required no exogenous growth factors (Renner et al.,
1995). Furthermore, the addition of a cell cycle arresting agent, rapamycin, to a hybridoma cell
line with a deregulated cell cycle resulted in an increase in culture cell concentration, viability,
and productivity (Balcarcel, 1999). This strategy was similar to one proposed by Mosser and
Massie (Mosser and Massie, 1994) in which the proto-oncogene, c-myc, was downregulated to
prevent unregulated cell cycle entry. In addition, the overexpression of anti-apoptotic proteins
such as Bcl-2 in mammalian cell lines has also increased the culture viability by protecting cells
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from apoptotic death triggered by nutrient and growth factor limitations as well as other
proapoptotic signals (Adams and Cory, 1998; Chung et ai., 1998; Garland and Halestrap, 1997;
Goswami et al., 1999; Mosser and Massie, 1994; Simpson et al., 1999; Simpson et al., 1998).
2.2 Modeling Metabolism in Mammalian Cell Culture
2.2.1 Mammalian Cell Culture Modeling
Numerous efforts have been made to increase the efficiency of cell culture processes
through model-based culture design and control. The most common strategy involves utilizing
unstructured and structured models to optimize bioreactor operations. The unstructured or
empirical models have been used most often due to their simplicity, but they can only be used for
a limited range of operating conditions. Structured models are based on a detailed description of
cellular metabolism and can e employed for a wider range of process conditions. However,
these models are oftentimes both complicated and incomplete, and they do not describe the
complex and oftentimes unknown regulatory mechanisms that govern growth behavior (Portner
and Schifer, 1996; Tsuchiya et al., 1966). A few models, such as E-CELL, have attempted to
describe entire cells by including not only metabolic reactions but protein-DNA interactions and
gene expression, but these models are still too simplified to fully account for the regulation of
significant cellular processes (Tomita et al., 1999).
An example of unstructured cell culture model development was presented by Glacken et
al. (Glacken et al., 1988; Glacken et al., 1989a; Glacken et al., 1989b). This model was
formulated and optimized by combining an unstructured initial growth rate model with transient
data obtained through additional experiments. Fractional factorial experiments were used to
reduce the number of significant culture variables in the model. The chosen independent
variables: glucose, glutamine, serum, ammonium, lactate, and basal DMEM concentration, were
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reduced to two major factors: serum and ammonium. The initial growth rate was then expressed
as a function of these two major factors along with the glutamine concentration due to the
contribution of glutamine to ammonium levels through degradation. Ammonium was
determined to be a strong, noncompetitive inhibitor whereas lactate was observed to be a weak
inhibitor of the initial growth rate (Glacken et al., 1988). The model was then expanded to
include serum degradation which was attributed to thiol chemistry and the culture redox state
(Glacken et al., 1989a). Finally, this model was applied in the simulation of fed-batch reactor
runs. For these simulations, the unstructured model was modified with additional equations to
account for the time lag associated with medium composition changes. This model successfully
described the transient behavior of a fed-batch process, but was unable to predict productivity
(Glacken et al., 1989b).
Numerous other unstructured models have been formulated to describe cell culture
processes. Monod-type equations form the basis of these models with glucose and glutamine
serving as limiting substrates and lactate and ammonium serving as inhibiting compounds.
However, these models are generally criticized for their significant error and unpredictable
nature attributed to a lack of understanding about fundamental aspects of cellular metabolism
(Portner and Schlifer, 1996). In fact, this variability is most likely due to the unpredictability
associated with the general lack of understanding of metabolic regulation and its relations with
cellular physiology. Furthermore, this variability can be associated with physiological state
multiplicity, and this point is discussed in more detail in chapters six, seven, and eight.
Several structured models have been proposed in order to incorporate a more detailed
description of cellular metabolism. Batt and Kompala (Batt and Kompala, 1989) presented one
excellent example of such models. Their compartment-type structured model was based on
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cellular metabolic reactions and lumped intracellular constituents into metabolic pools expressed
as fractions of the biomass. This enabled them to calculate the instantaneous specific growth
rate. The pools consisted of cellular amino acids, nucleotides, proteins, and lipids, secreted
lactate, ammonium, and product, and substrate glucose, glutamine, and medium amino acids.
The system of dynamic equations was used to simulate mammalian cell culture growth
dynamics. Under both steady state and transient conditions, the researchers obtained good
agreement with experimental data although the accuracy could clearly be improved by adding
more metabolic regulatory information (Batt and Kompala, 1989).
Another structured modeling technique involves modeling cell growth as an optimum
process. This model assumes that organisms are optimal strategists that choose substrates that
will maximize their growth. The metabolic regulatory control is deduced as being the "optimal
solution to a problem of resource allocation for achieving maximal growth" (Bailey and Ollis,
1986). This "cybernetic model" has been applied successfully in describing and matching
experimental data for diauxic and triauxic microbial growth (Kompala et al., 1986).
The structured and unstructured models typically used to describe and rationalize culture
data and cell growth are oftentimes not clear due to the large number of parameters and are not
informative since they rely on assumptions concerning cellular behavior (Portner and Schifer,
1996; Zeng et al., 1998). In fact, the unpredictable nature of mammalian cell culture is
extremely difficult to model through current methodologies due to the lack of understanding of
actual in-vivo metabolism and metabolic regulation (Pbrtner and Schafer, 1996). In addition,
these models oftentimes make no attempts to incorporate or even recognize features of metabolic
regulation (Bailey and Ollis, 1986). Furthermore, cell death and its relations with metabolism
are still not addressed, particularly in the case of programmed cell death or apoptosis. Much of
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this understanding of actual in-vivo metabolism and metabolic regulation under culture
conditions can be obtained through a methodology that integrates metabolite exchange rates and
shows their relations to cellular physiology and behavior. The information obtained though this
framework could then be incorporated into more accurate metabolic models that would allow for
more realistic models designed for bioreactor operation optimization.
2.2.2 Metabolic Flux Analysis
Metabolic flux analysis provides such a framework, and cell culture performance can be
further improved by analyzing carbon flux in central carbon metabolism to determine key
nutrient requirements and potential rate controlling biochemical reactions. Prior metabolic
research has elucidated metabolic reactions in the framework of biochemical networks.
Metabolic flux analysis provides the methodology for analyzing these metabolic networks and
has been applied in the quantitation of physiological states and the interpretation of experimental
data in addition to metabolic engineering, optimal medium development, process design, and
process optimization (Varma and Palsson, 1994). In short, flux analysis provides researchers
with a useful tool to extract additional information from cell culture data that can be utilized in
cell culture modeling and design.
However, metabolic flux control is still poorly understood due to the complexity of
biological systems and the limited availability of in-vivo flux data. Previous research has
demonstrated that large variations in metabolic flux and flux distribution can result even when
in-vitro measured enzyme activities exhibit little change (Vriezen and van Dijken, 1998). This
shows a strong dependence of metabolic flux on the in-vivo regulation of enzyme activity and
not the in-vitro assayed activity. Dynamic models of in-vivo metabolism have been attempted,
but they require extensive enzyme kinetic and regulatory data (Joshi and Palsson, 1989a; Joshi
33
and Palsson, 1989b; Joshi and Palsson, 1990a; Joshi and Palsson, 1990b). Furthermore, the
application of in-vitro enzyme kinetics to in-vivo kinetics ignores numerous in-vivo aspects of
enzyme regulation. Enzymatic specific activity can be regulated through allosteric effects,
activators, inhibitors, and covalent modification. The enzyme concentration can be controlled
through transcription and translation regulatory mechanisms. Finally, cellular
microenvironments involving multi-enzyme complexes and membrane associated enzymes and
enzyme complexes all contribute to the in-vivo regulation of metabolic flux (Liao and Delgado,
1993). Modeling and simulation environments for biochemical and genetic processes have been
developed, but these models describe only simplified, hypothetical cells (Tomita et al., 1999).
These observations caste doubt on the usefulness of strictly analytical approaches toward the
analysis of real biological systems.
Numerous attempts have been made to model in-vivo metabolic reaction dynamics
through empirical measurements to determine metabolic flux control. Recently, emphasis has
been placed not on the flux control exercised by individual enzymes but rather on metabolic
pathway flux control, and this systems approach has been termed metabolic control analysis
(Heinrich and Rapoport, 1974; Kacser and Bums, 1973). This method states that the key to
understanding metabolic network regulation is through the quantitation of a network's response
to a parameter perturbation (Liao and Delgado, 1993). Elasticity, response, and control
coefficients are all used to quantify these responses. Furthermore, these coefficients are related
to one another through various theorems. This methodology has been applied to obtain
metabolic network control data through genetic perturbations (gene dosage and expression level)
and environmental perturbations (chemical control of enzyme levels and inhibition titration).
These techniques were applied in the analysis of microorganism metabolism and mitochondria
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respiration (Liao and Delgado, 1993). This framework was extended through a top-down
approach in which groups of reactions are analyzed for their control on metabolic reaction
networks (Stephanopoulos and Simpson, 1997). These techniques provide a useful framework to
analyze metabolic regulation in real biological systems. However, a complete analysis requires a
considerable amount of experimental work to obtain network perturbations, and obtaining this
data has proven to be rather difficult (Liao and Delgado, 1993; Varma and Palsson, 1994).
Furthermore, these results are valid for a narrow range of operating conditions. Finally, large
flux control coefficient values do not imply that the specific enzyme controls regulation through
feedback control loops (Stephanopoulos and Vallino, 1991).
Metabolic flux analysis involving mass balances or metabolite balancing is particularly
useful in the investigation of regulated cellular metabolism under varying environmental
conditions when specific enzyme regulation is not known and one does not have the resources
for network perturbations to conduct metabolic control analysis. This framework involves the
steady state or pseudo steady state analysis of metabolic pathways where mass balances are
applied to a stoichiometric network model of major metabolic reactions. Measured extracellular
production and consumption rates are combined with this reaction network, a least squares
analysis is performed, and then the metabolic fluxes are calculated (Stephanopoulos et al., 1998).
This technique can yield a significant amount of information on metabolic fluxes, and enables
one to conduct principle node and flux distribution analysis. This technique has been applied in
a number of situations, and nutrient, waste metabolite, dissolved oxygen, and peptide hydrolysate
concentrations have all been shown to cause metabolic responses that can be quantitated using
flux analysis resulting in information concerning potential feeding strategies, medium
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formulations, and genetic manipulations necessary to improve cell culture performance
(Bonarius et al., 1996; Bonarius et al., 1998a; Nyberg et al., 1999a; Zupke et al., 1995b).
One significant problem encountered in metabolite balancing techniques involves the
analysis of cyclic metabolic pathways which result in linearly dependent or singular networks
(Bonarius et al., 1996; Bonarius et al., 1998b; Vallino, 1991). One method that solves this
problem is to measure co-metabolites produced in cyclic pathways. The pentose phosphate
pathway and the TCA cycle still pose a problem due to the fact that they both produce CO2, and
this requires the addition of constraints such as assuming a pentose phosphate pathway activity
or maximizing ATP or NAD(P)H production in the solution (Bonarius et al., 1998b).
One of the principle applications of metabolic flux analysis has been to not just obtain
metabolic fluxes but also to analyze branchpoint flux control through the calculation of flux split
ratios (Stephanopoulos and Vallino, 1991). A comparison of metabolic flux distribution for
various environments enables one to classify key network junctions as being either flexible,
weakly rigid, or rigid nodes (Stephanopoulos et al., 1998). Furthermore, alternative pathways
and maximum theoretical yields can be determined through flux analysis (Stephanopoulos et al.,
1998).
Metabolite balancing combined with isotopic tracers has also been devised for the
analysis of intracellular flux in-vivo (Mancuso et al., 1998; Mancuso et al., 1994; Portais et al.,
1993; Sharfstein et al., 1994; Wiechert and de Graaf, 1996; Zupke and Stephanopoulos, 1995a).
Isotopic tracers detectable either through radioactivity measurements or NMR are incorporated
into metabolites depending upon the fluxes of the corresponding biochemical reactions.
Therefore, the latter can be, in principle, determined from measurements of isotope enrichment
of selected metabolites.
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Isotope enrichment has been applied in the analysis of a number of metabolic networks.
For example, 3C enrichment of extracellular lactate was used to validate flux estimates obtained
through metabolite balancing (Zupke and Stephanopoulos, 1995a). Another set of experiments
utilized [1-' 3C]glucose to quantitate the effect of the medium glutamine concentration. This
work indicated that glutamine levels have a significant effect on energy metabolism only when
abruptly changed; the fact that no changes in energy metabolism occurred for gradual glutamine
level perturbations led to the hypothesis that futile cycles exist in metabolic networks (Mancuso
et al., 1998). In another series of experiments, researchers directly determined that lactate carbon
comes predominantly from glucose and that the pentose phosphate pathway flux is much lower
than the glycolytic flux when cells are cultured under low growth rate conditions. Additional
findings were that the malate shunt flux is high and that pyruvate carbon flows through the
pyrllvate dehydrogenase complex and not through pyruvate carboxylase. Other isotope
experiments yielded data on glycolysis, biosynthesis, and metabolite exchange with TCA cycle
intermediates (Mancuso et al., 1994; Sharfstein et al., 1994).
The data from '3C enrichment can be further analyzed for NMR spectrum fine structure
to determine isotopomer levels. This method can be extremely powerful due to the additional
information obtained by determining the actual position of a tracer molecule within a metabolite
(Christensen and Nielsen, 1999; Klapa et al., 1999; Park et al., 1999; Wiechert and de Graaf,
1996; Wittmann and Heinzle, 1999). These isotopomers can be distinguished from one another
through NMR spectrum fine structure analysis. A metabolite with n carbons can result in 2n
isotopomers resulting in a significant amount of data. Although more isotopomer fractions can
be analyzed through NMR, mass spectroscopy has become increasingly popular in the analysis
of these isotopomers (Christensen and Nielsen, 1999; Wittmann and Heinzle, 1999).
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Figure 2-1 summarizes the various experimental methods one can use to obtain metabolic
flux data through the use of a simple example metabolic network described in Wiechert and de
Graaf (Wiechert and de Graaf, 1996). In the first illustration, the production and consumption
rates of the metabolites A, F, G, H, and I can be used to obtain the network metabolic fluxes
through metabolite balancing techniques. The second illustration shows the fate of each carbon
in the reaction network as well as the fate of a substrate isotope tracer (A) when placed in the
network. The shading of the carbon atom represents the relative carbon enrichment and shows
how the various distribution of isotope enrichment can be used to determine metabolic flux.
Finally, the third illustration shows the various isotopomers that result from the addition of an
isotope tracer. These isotopomers can yield more detailed data due to the ability to determine the
exact fate of each isotope tracer carbon atom in the metabolic reaction network.
Although techniques that utilize isotope tracers are powerful in determining metabolic
flux, the low sensitivity of NMR as well as the difficulties posed by the analysis of radioactive
isotope incorporation into metabolites inhibit the general use of these methods for cell culture
flux analysis. High cell densities are required for isotope label analysis resulting in the need to
use hollow-fiber bioreactor systems (Mancuso et al., 1998; Mancuso et al., 1994; Sharfstein et
al., 1994). Additionally, the cellular growth rate in these reactors is extremely low which may
present metabolic flux information that is not relevant for cells growing under normal culture
conditions. Furthermore, reaction reversibility has been shown to complicate flux determination
in certain pathways due to label redistribution although this reversibility could be used to obtain
useful information concerning metabolic phenomena such as futile cycles (Follstad and
Stephanopoulos, 1998; Wiechert and de Graaf, 1997a; Wiechert et al., 1997b). This indicates
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Figure 2-1. Techniques for metabolic flux analysis. A simple example metabolic network
described in Weichert and de Graaf (1996) illustrates the three main techniques used for
metabolic network analysis: metabolite balancing, carbon isotope labeling, and isotopomer
analysis.
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that a complete and thorough analysis must be conducted whenever one uses isotope labeled
substrates in order to obtain valid data.
In general, for established metabolic networks, metabolite material balancing has proven
to be a quick and effective way to determine metabolic fluxes and flux distribution patterns while
requiring no kinetic or regulatory information. The use of redundant measurements enhances the
usefulness of metabolite balancing by enabling one to determine the consistency of a data set and
locate the source of gross inconsistencies among measurements or network bioreactions. This
technique verifies and improves the accuracy of metabolite balancing through the use of extra
constraints or measurements for a metabolic network. Statistical tests are utilized to not only
detect errors but also to diagnose the source of these errors (Nyberg et al., 1999a; van der
Heijden et al., 1994a; van der Heijden et al., 1994b; Wang and Stephanopoulos, 1983; Zupke and
Stephanopoulos, 1995a).
2.3 Mammalian Cell Continuous Culture
Although flux analysis can be carried out using data obtained during transients (Zupke et
al., 1995b; Zupke and Stephanopoulos, 1995a), continuous culture systems are preferable as they
allow one to study cultured cells in controlled, well-defined environments where they can reach a
metabolic steady state (Stephanopoulos et al., 1998; Wiechert and de Graaf, 1996). This
contrasts sharply with batch and fed-batch culture where the conditions are constantly changing
resulting in confusing data sets that can lead to incorrect conclusions concerning relations
between cellular physiology, metabolism, and other culture parameters. In continuous culture,
the various reactor residence times approximate the different environments that cells encounter
both in the early and late portions of batch and fed-batch culture runs which allow a more precise
determination of environmental influences on cellular physiology. Previous continuous culture
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work involving mammalian cells has covered a wide variety of conditions including nutrient
concentrations, dissolved oxygen levels, pH, dilution rate, and other variable reactor parameters
(Hayter et al., 1992a; Hayter et al., 1993; Hayter et al., 1992b; Jan et al., 1997; Martens et al.,
1993; Meijer and van Dijken, 1995; Miller et al., 1988). In addition, continuous culture has been
utilized in the formulation and testing of Monod unstructured models in order to obtain empirical
data describing cultured cell kinetic behavior (Frame and Hu, 1991a). Such work has yielded
considerable information on metabolite production and consumption rates, cellular growth, and
productivity at various reactor residence times and environmental conditions.
Perturbations involving the analysis of transients in continuous cultures were also
conducted in an effort to determine the regulatory architecture of cultured cell metabolism. In
theory, metabolic control analysis can be used with this transient data to determine this metabolic
regulation (Delgado and Liao, 1992b; Delgado and Liao, 1992a). Oftentimes, no metabolic
control analysis or flux analysis is performed in continuous culture research, but the effects of
transients in input glucose, glutamine, amino acids, and vitamins concentrations have all been
analyzed for mammalian cell continuous cultures (Hiller et al., 1994; Miller et al., 1989a; Miller
et al., 1989b). Metabolic flux analysis has been performed on some mammalian cell continuous
culture data that involved the analysis of peptide hydrolysates as well as the influence of
ammonia levels on cellular metabolism (Bonarius et al., 1996; Bonarius et al., 1998a; Nyberg et
al., 1999a).
Continuous culture reactor systems have also been utilized to examine cellular
productivity for various environments and residence times. Although several researchers have
indicated that specific productivity increases or remains constant with the specific growth, most
researchers have data that support the hypothesis that an increase in specific productivity results
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from a decrease in growth rate (Linardos et al., 1991; Miller et al., 1988). In addition, specific
productivity has been observed to decline over the course of a continuous culture, and this
decline was attributed to the formation of a nonproducing subpopulation of cells (Frame and Hu,
1991a; Frame and Hu, 1991b; Frame and Hu, 1990). Although the formation of nonproducing
cell lines is oftentimes attributed to chromosome deletions, other experimental data have
supported the hypothesis that mRNA translation is the source of the problem (Kohler et al.,
1976).
2.4 Physiological Multiplicity and Population Heterogeneity in Biological Systems
The loss of antibody productivity due to the rise of a subpopulation of non-producing
cells in continuous culture illustrates how selection dynamics can occur in a continuous culture
resulting in a potentially evolving biological system. Modeling the behavior of cells in
continuous culture has been performed since the 1960's, but only recently have studies presented
thorough theories that demonstrate the potential for sustained oscillations and multiple steady
states (Xiu et al., 1998). These modifications to the older theories involved the realization that
models based on Monod kinetics are not acceptable for all situations and that metabolic pathway
regulation must be taken into account. One recent theoretical analysis of continuous culture
demonstrated how multiplicity can exist in a continuous culture system where product inhibition
along with enhanced productivity under high substrate levels cause multiple steady states. In
addition, product formation and inhibition can lead to oscillatory behavior (Xiu et al., 1998).
This oscillatory behavior was also predicted using stability analysis performed on models that
contain more structure than the Monod models (Bailey and Ollis, 1986).
Competition for a limiting substrate, changes in clumping characteristics, and production
of an inhibitor are just a few of the ways subpopulations may compete with one another in
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continuous cultures. "Specific selection" refers to a known mutation in a cell line, whereas
"non-specific selection" or "periodic selection" refers to a situation in which the genes
responsible for the selection are unknown and its occurrence is partly unpredictable (Dykhuizen
and Hartl, 1983). Mutational changes in Escherichia coli and Saccharomyces cerevisiae are
reproducible in several cases in which the selected mutants obtained from replicate glucose
substrate continuous culture experiments have predictable changes with a defined genetic and
physiological basis (Appenzeller, 1999; Dykhuizen and Hartl, 1983). Furthermore, other
researchers discovered high temperature adaptation is reproducible even at the DNA sequence
level. However, other evolutionary forces such as maltose substrate feeding and bacteriophage
infection led to unpredictable phenotypes and genotypes suggesting that numerous complexities
are involved in this issue (Appenzeller, 1999; Dykhuizen and Hartl, 1983).
These observations point to one of the most important questions in research on evolution:
how much of the results of evolution are the consequence of either chance or adaptation? In
other words: is evolution reproducible? Oftentimes, at the level of adaptive performance and
phenotype, evolution appears to be reproducible with similar cellular physiologies resulting from
similar environmental stresses (Dykhuizen and Hartl, 1983). However, on the genetic scale,
evolution is less reproducible as demonstrated when the adapted subpopulations are exposed to a
new environment that results in variability in the survival for each subpopulation. However, in
some cases genetic changes that are a result of evolution and selection are predictable, even at
the DNA sequence level (Appenzeller, 1999).
Population heterogeneity can result from a number of mechanisms. Development or
differentiation can play a role in heterogeneity in which sister cells are not identical in
morphological and / or biochemical characteristics. This phenomenon, termed "asymmetric cell
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division," has been studied in a wide number of cell types such as Bacillus subtillis,
Saccharomyces cerevisiae, Caenorhabditis elegans, and Caulobacter crescentus. The
mechanism behind this developmental heterogeneity can involve intrinsic properties such as the
partitioning of molecules (membrane proteins or RNA) in specific cellular regions before cellular
division causing the sister cells to have different physiologies. In addition, asymmetry in the cell
division plane involving the orientation of the mitotic spindle can contribute to asymmetric cell
division as well. Cell signaling can also play a role in which cells differentiate after they have
divided (Horvitz and Herskowitz, 1992). However, determining the exact mechanism of
asymmetric cell division can be extremely difficult due to the complexity involved in keeping
track of individual cells (Jan and Jan, 1998).
Population heterogeneity can also result through non-developmental mechanisms.
Recessive mutants can form and survive although they are not as robust as the wild-type cell
line. Single nucleotide substitutions, DNA frameshifts, genetic "hotspots", and jumping genes
can all contribute to the formation of new mutant subpopulations (Crow, 1983). Subpopulation
selection can occur within the context of sexual reproduction according to the Hardy-Weinberg
rules of heredity with the resulting heterogeneous population forming as a result of the
equilibrium between the forces of selection and mutation (Crow, 1983). Additionally, a number
of biological phenomena have been attributed to threshold mechanisms in which a sensitive
biological switch converts a cell from one physiological state to another (Chung and
Stephanopoulos, 1996). Although theoretical deterministic models can explain population
heterogeneity, the non-uniqueness of the model solutions suggests that chance plays a role in the
appearance of heterogeneity in which slight changes in the levels of certain factors results in
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macroscopic physiological changes (Chung and Stephanopoulos, 1996; Spudich and Koshland,
1976).
Cell populations that are genetically homogeneous and contained in a homogeneous
environment still exhibit population heterogeneity which is not a function of variances in the
extracellular environment or cell cycle (Spudich and Koshland, 1976). Non-genetic population
heterogeneity is believed to be caused by differences in transcriptional state controlled by
threshold mechanisms resulting in the induction or repression of genes (Dykhuizen and Hartl,
1983). This hypothesis is supported by the recent finding that many genetic regulatory
compounds operate at low concentrations, and this results in large fluctuations in genetic
regulation and translation (McAdams and Arkin, 1999; McAdams and Arkin, 1998). Also, cells
characterized by specific morphological features still vary in functionality. For example,
pancreatic -cells demonstrate heterogeneity in glucose responsiveness in-vitro (Pipeleers,
1992). All of these observations indicate that the assumption that a cell culture contains a
homogeneous population lacks both experimental (Horvitz and Herskowitz, 1992; Jan and Jan,
1998; Pipeleers, 1992; Spudich and Koshland, 1976) and theoretical (Chung and
Stephanopoulos, 1996) support.
2.5 Mitochondria and Oxidative Phosphorylation
Virtually all eukaryotic cells contain mitochondria which are organelles that contain a
number of critical cellular components such as the respiratory chain and other enzymes required
for the TCA cycle and fatty acid oxidation. An endosymbiotic partnership involving the
combination of an oxygen-respiring ancestor of modem purple bacteria with mastigotes resulted
in the creation of a protoeukaryotic cell with the endosymbiotic bacteria eventually evolving into
mitochondria (Margulis, 1996; Margulis, 1998). These semi-autonomous organelles are
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responsible for a large number of important cellular functions such as the regulation of
metabolism and energetics as well as the regulation of apoptosis (programmed cell death). The
mitochondrial matrix contains the enzymes involved in the citric acid or tricarboxylic (TCA)
cycle, and mitochondria are responsible for the generation of the majority of cellular ATP
through oxidative phosphorylation carried out in the respiratory assemblies situated in the inner
mitochondrial membrane (Mitchell, 1979; Stryer, 1988).
Mitochondria contain both an inner and outer membrane. Inside the inner membrane is
the mitochondrial matrix which contains the enzymes required for pyruvate and fatty acid
oxidation. The inner membrane is folded into numerous ridges called cristae which allow for a
significant increase in membrane surface area which in turn allows for a high respiratory chain
activity. In fact, the total cellular inner mitochondrial membrane surface area can be over
seventeen times larger than the total plasma membrane area (Lodish et al., 1995). The outer
membrane is permeable to small molecules and ions whereas the inner membrane is virtually
impermeable to all ions and other polar molecules. Molecules and proteins can be transported
across the inner membrane through specific protein carriers (Stryer, 1988).
Mitochondria electron transport (oxidative phosphorylation) involves three main
complexes and is illustrated in figure 2-2. The first complex, NADH-Q reductase, accepts
electrons from NADH and transfers them to a second complex, cytochrome reductase, through
ubiquinone. Ubiquinone also accepts electrons from FADH2. Cytochrome reductase transfers
the electrons to cytochrome c which then transfers them to cytochrome oxidase. There, the
electrons are transferred four at a time to molecular oxygen resulting in the production of two
water molecules. The electrons are transferred though each complex and carried through iron-
sulfur and heme complexes. Electron transfer can be inhibited at each of the complexes through
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Figure 2-2. Mitochondria electron transport. In the inner mitochondrial membrane, electrons
are transferred through a series of protein complexes resulting in the pumping of protons out of
the matrix. ATPase uses the proton gradient to generate ATP. Various compounds can
specifically inhibit each protein complex.
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the use of the specific compounds shown in figure 2-2. The electron transfer occurring through
each complex causes the pumping of protons out of the mitochondrial matrix. These protons
flow back into the mitochondrial matrix through ATPase resulting in ATP generation (Mitchell,
1979; Stryer, 1988). Protons may also leak across the inner mitochondrial membrane resulting in
a lower effective ATP production efficiency (Brand et al., 1994).
Mitochondrial membrane potential (MMP) can not be measured using microelectrodes
due to their small size, but it can be measured using membrane permeable lipophilic cationic
dyes such as Rhodamine 123 (Rh123), 3,3'-dihexyloxacarbocyanine iodide (DiOC6), 5,5',6,6'-
tetrachloro-1,1',3,3'-tetraethylbenzimidazolylcarbocyanine iodide (JC-1), (Benel et al., 1989;
Juan et al., 1994; Salvioli et al., 1997). These dyes incorporate according to the Nemst equation
(equation 2.1).
RT
Ap = APm + ApH (2.1)
nF
The proton motive force (Ap) consists of both an electric (ATm) and chemical activity (ApH)
potential. The values for each potential are approximately 160 - 180 mV for the mitochondrial
membrane potential (AWm) and 60 mV for the pH gradient component (Kamo et al., 1979;
Lodish et al., 1995; Mitchell, 1979). Researchers have experimentally verified a direct
correlation between to the electric potential component of the proton motive force (mitochondrial
membrane potential) and Rh123 cellular uptake (Chen, 1988; Emaus et al., 1986). Electron
transport inhibitors, such as azide, antimycin A, or rotenone acting as shown in figure 2-2,
drastically reduce Rh123 uptake. In addition, azide and oligomycin together completely
eliminate Rh123 uptake unlike other mitochondrial membrane potential stains which can still
incorporate to some small degree into mitochondrial membranes without the presence of a
membrane potential (Chen, 1988). Rh123 is frequently used in experiments due to its low
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toxicity, and it has been utilized to develop relations between mitochondrial membrane potential
and cell growth, cell differentiation, cell motility, and concentrations of agents that influence
membrane potential (Chen, 1988; Ferlini et al., 1995).
Most eukaryotic cells have a mitochondrial volume of 15 - 25% (Bereiter-Hahn and
Voth, 1994; Lodish et al., 1995; Stryer, 1988). Mitochondria have been observed to associate
with energy consuming cellular structures such as the nucleus, rough endoplasmic reticulum, and
plasma membrane. This heterogeneity in cellular location indicates that adenine nucleotide
diffusion may be limiting resulting in cytoplasmic ATP gradients. This hypothesis is supported
by the fact that cells contain intracellular pH and 02 gradients and that mitochondrial activity can
vary for those mitochondria situated centrally in a cell versus those located peripherally. These
gradients may be beneficial in situations such as local hypoxia around the nucleus in order to
reduce the number of free radicals that can attack nucleic acids (Bereiter-Hahn and Voth, 1994).
In addition, this heterogeneity can vary as a function of cell-cell contact and intracellular acidic
vesicle location (Diaz et al., 1999). Mitochondria have also been observed to change shape and
location and can move at a speed of 2 - 30 ,gm/min (maximum speed of 100 m/min).
Mitochondria can respond to local changes in ATP levels induced through microinjection, and
this response varies depending on the cellular metabolic state (Bereiter-Hahn and Voth, 1994).
These observations illustrate the dynamic behavior mitochondria have which enables them to
respond to cellular needs.
Over the course of the cell cycle, mitochondrial mass and volume doubles.
Mitochondrial biogenesis occurs mostly in the G1 phase of the cell cycle but can occur in the late
S phase. Imbalances between mitochondrial proliferation and cell growth have been observed
indicating that the mitochondrial growth rate differs from the cellular growth rate. This
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mitochondrial growth rate can also vary with the cell cycle and cellular metabolic state (ames
and Bohman, 1981).
As mentioned previously, functional heterogeneity for mitochondria within a single cell
has been observed. This means that experimental data collected using one mitochondrial
subpopulation isolated from cells may not represent the actual intracellular distribution of the
mitochondrial properties being studied. For example, within the same mitochondrial population,
various subpopulations of mitochondria that were isolated through density gradient
centrifugation had different mitochondrial membrane potentials (MMP) and other morphological
and biochemical features that varied as a function of the metabolic state of the cell (Cossarizza et
al., 1996). At the single organelle level under membrane depolarization conditions, a small class
of mitochondria that still maintain a high membrane potential have been observed (Diaz et al.,
1999). Also, the physiological environment contributes to the appearance of various classes of
mitochondria that differ in membrane potential even when size and density changes are taken
into account (Cossarizza et al., 1996; Petit et al., 1990).
2.6 Apoptosis
Recently, cell death has received significant attention due to the discovery that apoptosis
or programmed cell death is accomplished through specialized and highly regulated cellular
mechanisms. This complex series of events involves the active participation of cell surface
receptors, proteases, organelles, and other cellular components. This active process contrasts
with the conventional view of cell death, termed necrosis, in which violent environmental
conditions cause plasma membrane rupture and disintegration. A typical pattern of necrosis,
coagulation necrosis, involves the denaturation and coagulation of cellular protein as a result of
ischemia, hypoxia, chemical toxins, infection, and trauma, whereas a different type of necrosis,
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colliquative necrosis, occurs when tissue becomes rapidly liquefied due to violent damage (Buja
et al., 1993). Apoptosis, on the other hand, causes distinct morphological changes in which
chromosomal DNA condenses and fragments, the cell membrane blebs, and finally apoptotic
vesicles begin to form causing the cell to fragment into numerous apoptotic bodies. Cellular
DNA is also cleaved at linker regions producing 180 base pair fragments which show up as a
DNA ladder on gels of extracts taken from apoptotic cells (Hale et al., 1996). Apoptosis can also
be characterized by additional, less obvious cellular changes. The mitochondrial membrane
potential drops early on in the apoptotic death pathway. In addition, the plasma membrane
asymmetry breaks down, causing phosphatidylserine to translocate to the outer cell surface.
Caspases, or intracellular proteases, are also activated which cleave specific sites on specific
proteins which cause apoptosis related morphological changes. Cytochrome c, apoptosis
inducing factor (AIF), and other proteins that are either activated in the cytosol or released from
mitochondria also contribute to the activation of caspases (Bedner et al., 1999).
Apoptosis can be triggered through a variety of cellular genetic or chemical perturbations
that affect the cell surface, cytosol, cytoskeleton, nucleus, and intracellular signaling pathways
(Wertz and Hanley, 1996). Tumor necrosis factor, reactive oxygen species, cytotoxic agents,
mitogenic oncogenes, and insulin and IGF-1 withdrawal are just a few of the vast number of
apoptosis inducing stimuli (Alnemri, 1999; Ashkenazi and Dixit, 1998; Wertz and Hanley, 1996;
Yang et al., 1996). In mammalian cell culture, nutrient deprivation as well as growth factor
deprivation contribute to apoptosis (Chung et al., 1998; Simpson et al., 1998). Mitochondrial
electron transport chain inhibitors also induce apoptosis (Wolvetang et al., 1994). The diversity
of apoptosis inducing stimuli and the prevalence of apoptosis occurring in a variety of cell types
have caused a dramatic rise in the study of this mode of cell death. Furthermore, research is
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conducted not only on the prevention of apoptosis occurring in mammalian cell culture but also
in the induction of apoptosis in cancerous cell lines.
Several genes have been implicated in the mediation and modulation of apoptosis. The
initial research in this area that was aimed at determining the genetic players of apoptosis was
performed on the nematode Caenorhabditis elegans. The C. elegans genes, ced-3 and ced-4,
promote apoptosis and ced-9 prevents apoptosis, and a number of mammalian genes homologues
have been discovered (Hale et al., 1996; Steller, 1995). One of the first oncogenes that was
discovered to have proapoptotic activity was c-myc. Deregulated c-myc is associated with
cancer, cellular proliferation, and the loss of cell cycle control (Evan and Littlewood, 1998;
Williams and Smith, 1993). Experimental evidence indicates that cell renewal and cell death are
linked demonstrating that cell proliferative and apoptotic pathways are coupled. The p53 tumor
suppressor gene encodes for a DNA transcription factor that is inactive in numerous cancers
indicating that this gene is oftentimes required to prevent the proliferation of somatic cells. p53
activation causes one of two responses: growth arrest and apoptosis. This response depends
upon the cell type, cellular environment, and other factors (Evan and Littlewood, 1998). The
bcl-2 gene family is homologous to ced-9 in C. elegans and is linked to apoptosis. This gene
family contains both pro and antiapoptotic genes, and bcl-2 has been used extensively to enhance
cell resistance to apoptosis (Adams and Cory, 1998; Chung et al., 1998; Garland and Halestrap,
1997; Goswami et al., 1999; Hockenbery, 1995; Mosser and Massie, 1994; Simpson et al., 1999;
Simpson et al., 1998; Steller, 1995; Vaux et al., 1988; Williams, 1991).
The general mechanism of apoptosis is presented in figure 2-3. This figure illustrates the
basic outline of two apoptotic pathways that have been elucidated in the literature. The first
pathway involves death receptors, such as Fas, TNFR1, or DR3, in which a ligand binds to the
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Figure 2-3. General mechanism of apoptosis. Death receptor complexes and other cell death
triggers activate the caspase cascade. The effector caspases carry out the apoptotic death signal
by cleaving specific cellular protein targets resulting in the morphological and biochemical
changes associated with apoptosis.
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receptor causing receptor oligomerization and activation of apical caspases (caspase-2, -8, or -
10). These caspases then activate the effector caspases (caspase-3, -6, or -7) whose activity
results in the morphological features associated with apoptotic cells (Alnemri, 1999; Ashkenazi
and Dixit, 1998). The second apoptotic pathway involves the changes that occur in mitochondria
(Green and Reed, 1998; Kroemer et al., 1995; Petit et al., 1996; Petit et al., 1997; Susin et al.,
1998; Zamzami et al., 1996). A variety of cell death triggers result in the release of apoptosis
inducing proteins such as cytochrome c, Apaf-1, apoptosis inducing factor (AIF), and
procaspases from mitochondria which result in the activation of effector caspases (Alnemri,
1999). These two pathways are not independent, but rather they are interrelated through receptor
activated caspases that induce apoptotic changes in mitochondria (Bossy-Wetzel and Green,
1999).
The main component of the apoptosis pathway consists of a proteolytic cascade of
proteins termed caspases. This family of cysteine proteases cleaves specific proteins, activating
or deactivating them, resulting in the morphological and biochemical changes associated with
apoptosis (Cohen, 1997; Salvesen and Dixit, 1997; Thornberry and Lazebnik, 1998). Caspases
are originally expressed in inactive forms (procaspases) that are activated by apoptosis inducing
signals. The procaspase contains three domains: an -NH2 terminal region, a large subunit
(approximately 20 kD), and a small subunit (approximately 10 kD). The -NH 2 is highly variable
among the various caspases and is involved in the regulation of caspase activation (Cohen, 1997;
Thornberry and Lazebnik, 1998). Caspases are activated through the proteolytic cleavage of the
three domains followed by the association of the large and small subunits resulting in an active
heterodimeric enzyme (Thornberry and Lazebnik, 1998). The crystal structures of a couple of
caspases have also shown that these heterodimers associate to form a tetramer. The active
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caspase has a primary recognition pocket that specifically accepts the aspartic acid side chain
(SI). Additional amino acids surrounding the pocket are specific for a variety of other amino
acid residues (S2 - S4), and this specificity for a specific tetrapeptide sequence helps to
differentiate the various caspase enzymes from one another. The specificity of these caspases
enables them to cleave specific proteins resulting in aoptosis inhibitor deactivation, cell
structure cleavage, and specific protein deregulation (Cohen, 1997; Salvesen and Dixit, 1997).
Caspase cleavage is extremely efficient with a kat/Km constant value greater than 106 M s-'
(Thornberry and Lazebnik, 1998).
The apoptotic proteolytic caspase cascade can be divided into two main groups, one
consisting of initiator or apical caspases and one consisting of executioner or effector caspases.
Caspase-8, -9, -10, and -2 are in the apical caspase group and serve as regulators of the caspase
cascade. These caspases are activated through the binding of a specific cofactor such as the
FADD and DED domains of a death receptor complex as in the case of caspase-8 or through the
binding of Apaf-1, cytochrome c, and dATP as in the case of caspase-9 (Li et al., 1997;
Thornberry and Lazebnik, 1998). These activated apical caspases activate the effector caspases
through proteolytic cleavage. Caspase-3, -6, and -7 are in the effector caspase group, and they
carry out the execution of cell death through cell disassembly. This cascade model of effector
caspase activation is supported by a significant amount of experimental evidence obtained from a
variety of cell types which suggests that this mechanism exists in most cell types that undergo
apoptosis (Muzio et al., 1998; Salvesen and Dixit, 1997; Thornberry and Lazebnik, 1998).
The effector caspase, caspase-3, has been identified as one of the key caspases involved
in apoptosis. This particular caspase has been linked to the proteolytic cleavage of a number of
protein substrates including PARP (DNA repair), Acinus (chromatin condensation), DNA-PKcs
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(DNA double-strand break repair), lamins (nuclear structure), U1-70 kDa (RNA splicing), Fodrin
(cytosol structure), Protein kinase C, SREBP (sterol-regulatory element-binding protein), and
Gelsolin (actin modulating protein) in addition to the activation of CAD (DNase) and DNA
fragmentation factor (Cohen, 1997; Enari et al., 1998; Kothakota et al., 1997; Liu et al., 1997;
Sahara et al., 1999). Caspase-3 is specific for a DXXD-like substrate (Cohen, 1997). In
addition, procaspase-3 has been identified as having a cytosolic and mitochondrial distribution in
nonapoptotic cells and can be activated through either the receptor mediated apoptotic pathway
through caspase-8 or through the mitochondria mediated pathway involving the apoptosome
(procaspase-9, Apaf-1, and cytochrome c) or AIF (Li et al., 1997; Mancini et al., 1998; Stennicke
et al., 1998; Zou et al., 1997).
A number of inhibitors of caspases have been characterized. Several viral inhibitors,
including CrmA, p35, and a family of IAPs (inhibitors of apoptosis proteins), have been
discovered (Cohen, 1997; Deveraux et al., 1998). In addition, the peptide z-VAD-fmk
(benzyloxcarbonyl-Va!-Ala-Asp[OMe] fluormethyl ketone) irreversibly binds to the caspase
active site causing permanent loss of caspase activity (Cohen, 1997; Thornberry and Lazebnik,
1998). Researchers have applied inhibitors in an effort to prevent apoptosis in cultured cells with
varying degrees of success (Cohen, 1997; Goswami et al., 1999).
As mentioned previously, the caspase proteolytic cascade can be initiated through two
different mechanisms, and the first mechanism involves death receptor activation. Two well
characterized death receptors are CD95 (Fas or Apol) and TNFR1 (p55 or CD120a) with their
corresponding ligands termed CD95L and TNF respectively. Other death receptors are DR3
(Apo3 or TRAMP), DR4 (TWEAK) and DR5 (Apo2, TRAIL-R2, or KILLER). All of these
death receptors belong to the tumor necrosis factor (TNF) receptor superfamily (Ashkenazi and
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Dixit, 1998). These receptors contain an intracellular region termed the "death domain" through
which the receptor activates the cellular apoptotic pathway. This death domain (DD) has been
identified in both the TNFR1 and CD95 death receptors as a region of approximately 70 to 80
amino acids that is critical for the initiation of the apoptotic death signal (Tartaglia et al., 1993).
The ligand binding results in receptor-receptor coupling which results in a receptor trimer
complex. The death domains (DD) cluster and bind which in turn causes a series of additional
proteins to bind to the complex such as FADD, TRADD, and RIP (Fraser and Evan, 1996;
Wallach, 1997). This binding then activates the apical caspase, caspase-8, which in turn
activates the effector caspases that cause apoptotic morphology changes (Ashkenazi and Dixit,
1998).
Receptor activation has been linked to the loss of mitochondrial function. The
mitochondrial function of cells undergoing Fas-mediated apoptosis was examined through 
measurement of the oxygen consumption of mitochiondria isolated from the apoptotic cells.
These mitochondria were subjected to a series of substrates and inhibitors specific for various
parts of the electron transport chain. The results indicated that cytochrome c becomes either
inhibited or inactivated during apoptosis resulting a loss of electron transport chain function. In
addition, the caspase inhibitor, z-VAD-fmk, was shown to inhibit this cytochrome c inactivation,
indicating that a caspase proteolytic event must occur in order to explain this loss of cytochrome
c activity (Krippner et al., 1996). In addition, oxidative phosphorylation uncouplers were found
to enhance Fas receptor death signaling, and the maintenance of mitochondrial membrane
integrity was found to prevent TNF induced apoptosis (Linsinger et al., 1999; Pastorino et al.,
1996). The caspase proteolytic link to mitochondrial events was investigated in other work.
Caspase-8 was observed to induce the rapid release of cytochrome c from mitochondria although
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this reaction required the presence of unknown cytosolic factors indicating the indirect nature of
the caspase-8 interaction. Caspase-8 and -3 were observed to cleave Bid, a proapoptotic
member of the Bcl-2 family, which induced cytochrome c release. In addition, caspase-6 and -7
also induced cytochrome c release through the action of an unknown, bid-independent
mechanism (Bossy-Wetzel and Green, 1999).
The events associated with apoptosis all tend to focus on one key cellular organelle,
mitochondria, and a significant amount of experimental evidence supports the key role this
organelle plays in apoptosis (Earnshaw, 1999; Green and Reed, 1998; Kroemer et al., 1995; Petit
et al., 1996; Petit et al., 1997; Susin et al., 1998; Zamzami et al., 996). For several decades,
scientists hypothesized that endonuclease and caspase activation were the key players in the
apoptotic death pathway. The idea that mitochondria were not involved in apoptosis stemmed
from the observation that no significant morphological changes occur in mitochondria during
apoptosis and that cells with no mitochondrial DNA (po cells) can still undergo apoptosis.
However, this view has changed dramatically in the last several years as a consequence of a
significant amount of reproducible experimental observations that point to mitochondria as one
of the key players in apoptosis. These observations include events that occur during apoptosis
such as changes in mitochondria membrane potential (APm) and electron transport function and
the release of apoptosis stimulating compounds from mitochondria as well as the fact that
compounds that stabilize mitochondrial membranes inhibit apoptosis (Bedner et al., 1999; Petit
et al., 1997; Susin et al., 1998). Furthermore, the mitochondrial release of caspase activating
factors such as cytochrome c, AIF, and procaspases all support the central role mitochondria play
in apoptosis (Bossy-Wetzel et al., 1998; Earnshaw, 1999; Susin et al., 1999b; Susin et al.,
1999a). Additionally, the Bcl-2 family of proteins is predominantly located in mitochondria
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(Kluck et al., 1997; Mancini et al., 1998; Susin et al., 1999a; Susin et al., 1998; Wolter et al.,
1997; Yang et al., 1997). Finally, death signals from death receptors and caspases act on
mitochondria which indicates that apoptotic death pathways appear to all converge on the
mitochondria (Bossy-Wetzel and Green, 1999; Green and Reed, 1998).
Mitochondria are ideally situated for life and death signaling pathways due to the
importance of mitochondria in cellular energetics and their sensitivity to the cellular
physiological state. Mitochondria can trigger cell death through a variety of mechanisms.
Numerous kinetic studies have demonstrated that mitochondria lose their membrane integrity
early on in the apoptotic death pathway. Lipophilic cationic dyes that accumulate in the
mitochondrial matrix such as DiOC 6, Rhodamine 123, and JC-1 have been utilized to determine
the mitochondrial membrane potential (A'm) of cells undergoing apoptosis. In a majority of
cases, a decrease in the Atm precedes any biochemical and morphological changes associated
with apoptosis (Bedner et al., 1999; Susin et al., 1998). The disruption of the electron transport
chain and the generation of reactive oxygen species (ROS) and superoxide radicals accompany
this loss of (ATm) during the later stages of apoptosis. The formation of ROS has been linked to
necrosis type death morphology although a number of researchers have implicated ROS as a
signaling molecule for apoptosis (Goossens et al., 1996; Mignotte and Vayssire, 1998).
Antioxidant enzyme expression has been linked to the maintenance of mitochondrial membrane
integrity suggesting a link between ROS and apoptosis (Kowaltowski et al., 1998). The loss of
cytochrome c function has been observed to occur early on in apoptotic cell death resulting in the
loss of mitochondrial function (Heiskanen et al., 1999; Krippner et al., 1996). This evidence all
supports the hypothesis that mitochondrial membranes and electron transport function are
compromised during apoptosis (Susin et al., 1998).
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Cell-free systems also support the key role mitochondria play in apoptosis. The induction
of nuclear apoptosis characterized by DNA fragmentation and chromatin condensation requires
the presence of mitochondria or mitochondria products (Juin et al., 1998; Susin et al., 1998). In
addition, cytosolic extracts from cells dying from apoptosis can induce mitochondria extracted
from healthy cells to release proapoptotic factors such as cytochrome c. Furthermore, the
addition of mitochondria to apoptotic cytosol increases caspase-3-like activity (Juin et al., 1998).
Mitochondria release a variety of proteins that are linked to caspase activation and the
caspase cascade. Cytochrome c is released from mitochondria and forms part of the apoptosome
consisting of cytochrome c, Apaf--1, and procapase-9 (Li et al., 1997). This results in the
activation of capsase-9 which in turn activates caspase-3 and the caspase cascade. In addition,
mitochondria have been observed to release procaspases suggesting the presence of an inner-
mitochondrial pool of procaspases that are released upon receiving an apoptotic death signal
(Green and Reed, 1998; Mancini et al., 1998; Susin et al., 1999b). Furthermore, the release of an
apoptosis inducing factor (AIF) from mitochondria has been identified and linked to chromatin
condensation, DNA fragmentation, and cytochrome c release (Susin et al., 1999a).
The mitochondrial megachannel has also been linked to apoptotic events. The
permeability transition (PT) is associated with the opening of the mitochondrial megachannel
(PT pore) that is situated at the contact site between the inner and outer mitochondrial
membranes. The exact structure of the mitochondrial membrane megachannel is unknown but it
contains the inner membrane protein, adenine nucleotide translocator (ANT), and outer
membrane proteins such as porin (voltage dependent anion channel; VDAC). These proteins
work together and create a channel large enough for molecules less than 1.5 kD to pass through.
This PT pore helps to regulate mitochondrial matrix Ca++, pH, AYm, and volume. Inhibitors of
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the PT pore, such as bongkrekic acid and cyclosporins, prevent the loss of ATm and other
indicators of apoptosis (Fulda et al., 1998; Green and Reed, 1998; Pastorino et al., 1996; Susin et
al., 1998). Conversely, stimuli that disrupt the PT pore cause ATPm loss and the release of
cytochrome c and other proapoptotic factors (Green and Reed, 1998; Susin et al., 1998).
An additional link between mitochondria and apoptosis is formed through the relations
between the Bcl-2 family of proteins and mitochondria. The Bcl-2 family consists of three
subfamilies: a prosurvival Bcl-2 subfamily (Bcl-2, Bcl-XL, Bcl-w, etc.), a proapoptosis Bax
subfamily (Bax, Bak, and Bok), and another proapoptosis BH3 subfamily (Bid, Bad, etc.). The
Bcl-2 homology consists of four domains (BH1 to BH4), and all Bcl-2 family proteins contain at
least part of one of these domains. The prosurvival Bcl-2 proteins contain several of the domains
whereas the proapoptosis Bcl-2 proteins contain only part of the BH3 domain. The fact that pro
and antiapoptosis family members can heterodimerize indicates that their relative concentrations
may play a role in the regulation of apoptosis (Adams and Cory, 1998). Bcl-2, Bcl-XL, and Bax
all form channels in lipid bilayers in-vitro and are believed to be involved with pore formation in
mitochondria (Reed, 1997). Several Bcl-2 proteins contain membrane anchor regions that enable
them to be anchored in the outer mitochondrial membrane with the protein oriented toward the
cytosol (Green and Reed, 1998). Bcl-2 and its homologs have been linked to a number of
mitochondrial events associated with apoptosis, and can prevent the release of cytochrome c into
the cytosol and therefore inhibit caspase activation (Green and Reed, 1998; Kluck et al., 1997;
Reed, 1997; Yang et al., 1997). Bcl-2 was also found to inhibit Bax-induced apoptosis even after
cytochrome c was released revealing additional complexity concerning the role of Bcl-2 in the
inhibition of apoptosis (Ross6 et al., 1998). Bcl-XL binds with caspase-9 and Apaf-1 resulting in
the inhibition of apoptosis (Pan et al., 1998). Bcl-XL was also shown to regulate the
61
mitochondrial membrane potential and volume homeostasis as well as prevent mitochondrial loss
of cytochrome c during apoptosis (Kim et al., 1997; Vander Heiden et al., 1997). The
proapoptosis Bcl-2 protein, Bax, moves from the cytosol to mitochondria during apopt'sis
resulting in an acceleration of death which can be inhibited by Bcl-XL and Bcl-2 (Antonsson et
al., 1997; Finucane et al., 1999; Wolter et al., 1997). Bcl-2 can also be converted into a Bax-like
death factor through caspase-3 cleavage under in-vitro conditions which can result in the
promotion of cytochrome c release from mitochondria (Cheng et al., 1997; Kirsch et al., 1999).
These observations all support the hypothesis concerning the key role mitochondria related
proteins play in apoptosis.
The overall apoptosis death pathway can be divided into three main phases. The first
phase is the premitochondrial phase during which signal transduction pathways are initiated. For
this phase, the PT pore is hypothesized to serve as the central site which allows mitochondria to
integrate a variety of proapoptosis signals. The second phase is termed the mitochondrial phase
that involves the apoptosis signal amplification process through the release of cytochrome c and
other factors. In addition, mitochondrial membrane integrity and function are lost during this
phase. The final phase is called the postmitochondrial phase during which caspases are
activated. This model summarizes the basic mechanism of apoptosis and emphasizes the central
role mitochondria play in programmed cell death (Susin et al., 1998).
2.7 Summary
Biochemical engineering has focused on developing techniques for increasing and
maintaining high viable cell concentrations in culture in order to produce higher concentrations
of therapeutic protein products. A number of beneficial bioreactor operation strategies have been
developed along with additional techniques for enhancing the robustness of cultured cell lines.
62
However, cell death has proven to still be a significant problem for mammalian cell culture, and
the primary goal of this thesis was to development methods for reducing death in mammalian
cell culture.
The modeling techniques used to develop operating strategies for cell culture have not
addressed the extensive amount of regulation governing the flow and distribution of metabolic
flux in central carbon metabolism. Metabolic flux analysis coupled with continuous culture
experiments can provide a more rigorous platform not only for the analysis of cultured cells
subjected to various culture environments but also as a means of determining the true flexibility
and adaptability of cellular behavior in culture. Although these results would not necessarily be
directly relevant to industry, they could be utilized in the formulation of novel hypotheses that
could then be applied in the optimization of industrial culture operations.
Population heterogeneity has proven to be a significant but largely neglected section of
biochemical engineering. Cell selection dynamics, development, differentiation, and stability are
all involved in population heterogeneity. Furthermore, heterogeneous events occur not only at
the cellular level but also at the intracellular organelle and genetic regulation levels, resulting in
variability in intracellular rnicroenvironments and genetic expression. One goal of this thesis
was to address population heterogeneity within the context of biochemical engineering in order
to develop analysis methods and applications for the formulation of novel bioreactor operating
strategies.
Additionally, mitochondria play a fundamental role in this thesis. The TCA cycle,
respiration, and apoptosis are topics that all revolve around mitochondria. The research
presented in this thesis demonstrating physiological multiplicity involved the analysis of
mitochondrial respiration and TCA cycle activity. Furthermore, mitochondrial properties were
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used as the basis for analyzing population heterogeneity in mammalian cell culture with the
ultimate goal of utilizing these mitochondrial parameters for the optimization of cell cultures.
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3. MATERIALS AND METHODS
3.1 Cell Culture
3.1.1 Cell Lines and Media
The initial continuous culture experiments were performed using a Chinese hamster
ovary (CHO) cell line that produced recombinant human gamma-interferon (Devos et al., 1982;
Scahill et al., 1983). This y-CHO cell line was originally anchorage dependent and grown in
serum containing medium. For the continuous culture experiments, the cells were grown in a
serum-free medium that contained an animal tissue hydrolysate (Primatone RL; Quest
International, Norwich, NY). The final serum-free medium contained RPMI-1640 (Sigma
Chemical Co.) supplemented with 2.5 g/L Primatone RL, 0.4 g/L 2-hydroxypropyl--
cyclodextrin (Sigma), 1 g/L (0.1%) Pluronic F-68, 5 mg/L insulin (USB), 5 mg/L transferrin
(USB), 1 mM sodium pyruvate, 1 M putrescine, 11 mg/L choline chloride, 100 gAM
ethanolamine, 1.5 gM linoleic acid, 0.25 AuM methotrexate, 10,000 units/L penicillin - 10 mg/L
streptomycin (Sigma), 6.3 mg/L EDTA, and trace minerals (10 nM sodium selenite, 1 nM
manganese sulfate, 10 nM molybdic acid, 10 nM ammonium metavanadate, 10 nM cupric
sulfate, 3 gtM zinc sulfate, and 5 pgM ferric citrate).
The subsequent continuous culture, mitochondrial membrane potential FACS sorted cell
subpopulation, and fed-batch experiments were conducted using a murine hybridoma cell line
(ATCC CRL-1606) producing IgG against human fibronectin (Schoen et al., 1982). The
hybridoma cell line was grown in glutamine-free IMDM medium (Specialty Media, Inc.,
Lavallette, NJ) supplemented with 4.0 mM L-glutamine (Sigma Chemical Co.), 1 U/ml penicillin
- 1 /g/ml streptomycin (Sigma), 5 mg/L transfcrrin (USB), 10 mg/L insulin (USB), 2.44 UL/L 2-
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aminoethanol, 3.5 gtL/L 2-mercaptoethanol, and 7.5 mg/L protease free bovine serum albumin
(Sigma).
3.1.2 Culture Maintenance
The cell lines were obtained from frozen stocks stored in a liquid nitrogen cell bank. The
frozen cell stocks were prepared by centrifuging cells obtained from cultures that had a viability
greater than 95% at 200g for 8 minutes and resuspending them to a concentration of 7.0*106
cells/ml in freezing medium (7.5% DMSO, 46.25% fresh medium, 46.25% conditioned
medium). Cryogenic vials (Coming Inc., Coming, NY) containing lml of the cell suspension
were placed in a cryogenic freezing container (Cole-Parmer, Niles, IL) and then placed in a
-700 C freezer. The freezing container limited the freezing rate to -10 C/min. For a culture
inoculation, the frozen cell stocks were thawed rapidly and slowly resuspended dropwise into 19
ml of fresh medium. The cells were subcultured every 2-4 days (y-CHO) or 2-3 days (CRL-1606
hybridoma) at 2.0*105 cells/ml in a 370C humidified incubator (95% relative humidity) with
either a 5% (y-CHO) or a 10% (CRL-1606 hybridoma) CO2 atmosphere. The experiments were
performed when the viability was greater than 95%.
3.2 Analytical Methods
3.2.1 Cell Enumeration
The cell concentration and viability were determined using a hemacytometer and the
trypan blue dye exclusion method. In addition, the extent of apoptotic death was determined
using an acridine orange / ethidium bromide stain as described in Mercille and Massie (Mercille
and Massie, 1994). At least 200 cells were counted in each determination of the culture viability
and cell concentration.
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3.2.2 Metabolite Assays
The steady state samples taken from the reactor were centrifuged at 200g for 8 minutes,
and the supernatent was removed and stored at -200 C for future analysis. To deproteinate the
thawed samples, 100 l of 20% m/v trichloroacetic acid was added to 340 pl of sample. After
microcentrifugation at 7,000g for 10 minutes, 200 ,l of the deproteinated sample was neutralized
with 50 ,l of 25% m/v potassium bicarbonate. The deproteinated samples were used in
performing the lactate (826-UV Sigma assay protocol, Sigma) and glucose (16-UV Sigma assay
protocol, Sigma) assays.
Amino acid analysis was conducted for samples that were deproteinated using Ultrafree-
MC 5,000 MW cutoff ultrafilters microcentrifuged at 40C for 70 minutes at 4,000g (Millipore,
Bedford, MA). The samples were diluted to ensure that the maximum expected amino acid
concentration was less than 1 mM (the upper calibration limit). The amino acids were analyzed
using the AminoQuant protocol on an HP 1090 HPLC (Hewlett Packard, Palo Alto, CA) as
described in Nyberg et al. (Nyberg et al., 1999a).
3.2.3 Protein Product Measurement
Antibody concentrations were determined using a standard ELISA procedure. First, 100
,ul of a solution containing a capture antibody (Sigma M8770) diluted to 5 g/ml in a capture
antibody solution (Sigma C3041) containing 0.1% (w/v) sodium azide was added to a 96 well
plate and incubated at 370C for 30 minutes. Then, 200 Al of a blocking solution (SuperBlockTM ,
Pierce 37515) was added and removed three times. After that, 100 Al of either samples or
standards (Sigma M9269), diluted in a solution of 1 part blocking solution to 9 parts washing
solution (PBS with 0.05% w/v Tween 20), was added and incubated for 1 hour at room
temperature. Then, 100 Al of a detection antibody solution (sample and standard diluent solution
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with detection antibody Sigma A2304) was added and incubated for 1 hour at room temperature.
After each of the previous steps, the plate was washed three times in washing solution. Finally,
200 #l1 of a substrate solution (SigmaFASTT M OPD, Sigma P9187) was added and incubated for
30 minutes in the dark. The reaction was stopped with 3 M HCl and the absorbance was read at
492 nm on a microplate reader (Molecular Devices, Palo Alto, CA).
3.2.4 FACS Analysis and Mitochondria Staining
A fluorescence activated cell sorter (FACS, Becton Dickinson, FACSCAN) was used to
analyze cells stained for mitochondria potential using Rhodamine 123 (Rh123; Molecular
Probes, Eugene, OR). Cells were diluted with the appropriate medium to a concentration of 5-
6*105 cells/ml and stained with a final concentration of 2 ,gg/ml Rh123 and incubated for ten
minutes in a 370C incubator. The cells were microcentrifuged at 200g for 6 minutes,
resuspended in PBS, and stored on ice in the dark. The stained cells were analyzed on the FACS
within 15-30 minutes. The Rh123 fluorescence values were determined to be stable for up to an
hour after this staining procedure.
3.2.5 Cell Cycle Analysis
Cell cycle analysis was performed by fixing the cells in ethanol, staining them with
propidium iodide (PI), and then analyzing them on the FACS. Cell were collected in the
exponential phase at approximately 1.0*106 cell/ml, microcentrifuged at 200g for 6 minutes, and
then resuspended in 0.3 ml of PBS. Then, 0.7 ml of cold ethanol was added dropwise to the tube
while vortexing. After leaving the tube on ice for 15-30 minutes, the cells were
microcentrifuged at 2,000 rpm at 40C for 6 minutes. The supernatent was removed, and the cell
pellet was resuspended in 0.5 ml PBS with 50 gtl of 0.5 mg/ml RNase. After letting the mixture
stand at room temperature for more than 30 minutes, 0.5 ml of PI solution (20 mg/L in PBS) was
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added. The cells were then run through a fluorescence activated cell sorter (FACS, Becton
Dickinson, FACSCAN) and the raw data was analyzed using the Modfit Lt v.2 analysis software
(Verify Software House, Topsham, ME).
3.2.6 Caspase Enzymatic Activity
Caspase-3 (DEVDase) activity was measured using an assay that measured the amount of
p-nitroaniline (pNA) chromophore cleaved from the colorimetric substrate (Ac-DEVD-pNA).
The caspase activity was also inhibited using the peptide z-VAD-fmk. The sample where
apoptosis was not induced was referred to as the positive control whereas the apoptosis induced
sample (via. staurosporin or other compounds) inhibited by z-VAD-fmk was referred to as the
negative control. The difference between the apoptosis induced sample and the negative control
was the amount of caspase activity present in the sample.
The CaspACE assay kit (Promega, Madison, WI) was used to measure the caspase-3
activity. To prepare the sample extract, cells were grown under normal conditions until reaching
mid-exponential phase. Then, the cell concentration was adjusted to 1.0*106 cells/ml and then
the apoptosis inducer was added. After incubating the cells for the proper time required to
induce apoptosis, the cells were centrifuged at 200g for 10 minutes at 40C. The cells were then
washed once with ice cold PBS and kept constantly on ice. After the washing step, the cells
were resuspended in a cell lysis buffer (Promega, CaspACE assay system - colorimetric) at a
concentration of 1.0*108 cells/mi. The cells were lysed by freezing (-200 C) and thawing them
once. The cell lysate was incubated on ice for 15 minutes and then centrifuged at 15,000g
(13,000 rpm on 24 tube microfuge, Heraeus Biofuge 15) for 20 minutes at 40C. The supematent
was collected and stored at -800 C.
69
The caspase-3 assay was performed using a 96 well plate (flat bottom, clear polystyrene).
The protein concentration of the extracts was determined using a Bradford protein assay (Bio-
Rad Protein Assay 500-0002, Bio-Rad, Hercules, CA) with a BSA reference standard. 50 pag of
extract protein was added to each well. The wells were prepared as described in Table 3-1.
Table 3-1. 100 l1 reaction preparation for the caspase-3 enzymatic activity assay
(CaspACE assay system, Promega, WI).
Blank Negative Induced Inhibited
Control Apoptosis Apoptosis
Caspase assay buffer 32 pl 32 xl1 32 pl1 32 pgl
DMSO 2 l1 2 l 2 1 2 pxl
100 mM DTT 10 l 10 10 l 10 10 l
Untreated cell extract - x l - -
Induced apoptosis cell extract - x l1
Inhibited apoptosis cell extract - - - x ll1
Add DI water to final volume 98 l 98 l.1 98 pl1 98 l
The cell extract protein concentration was identical for all reactions. The Caspase assay
buffer consisted of 315 mM HEPES (pH 7.5), 31.25% sucrose, and 0.3125% CHAPS. After the
wells were prepared, 2 al of the DEVD-pNA substrate was added to all of the wells which were
then incubated at 370 C for 3 hours. The absorbance for each well was measured at 405 nm using
a microplate reader (Molecular Devices). The pNA calibration curve was obtained using a pNA
standard that was diluted using DMSO. The pNA absorbance readings at 405 nm were linear up
to a concentration of 1 mM pNA.
The in-vitro induction of caspase-3 activity using cytochrome c was performed by
preincubating the samples with 10 aM cytochrome c (from rat heart; Sigma C7892) and 1 mM
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dATP (USB 14245) for 30 minutes at 320C. The caspase-3 enzymatic activity was then
determined according to the procedure described previously.
3.3 Continuous Culture
3.3.1 Culture Medium Conditions
The continuous culture reactor was operated under glutamine limited conditions (0.8 mM
L-glutamine) and inoculated at 2.0* 105 cells/ml.
3.3.2 Bioreactor Operation
The continuous cultures were performed in a 2.0 liter Applikon (Foster City, CA) reactor
with a 1.2 liter working volume and a heated water jacket. The temperature was maintained at
370C and the agitation was set at 200 rpm. An ML-4100 multi-loop process controller (New
Brunswick Scientific, Edison, NJ) was used to control the pH and dissolved oxygen in the
reactor using the AFS software from New Brunswick Scientific (Edison, NJ). The pH was
controlled at 7.20 + 0.05 using the addition of either 320 mM HC1 or a basic solution consisting
of 6.2 g/L NaOH and 0.4 g/L KOH (160 mM). Oxygen was supplied to the reactor through
surface aeration by adjusting an air mixture consisting of nitrogen and oxygen, and the dissolved
oxygen concentration was maintained at 50% of air saturation. The gas flow rate was controlled
using a mass flow controller set at 35 mol/day. The ML-4100 controller was also used to log
process data: time, temperature, dissolved oxygen concentration, pH, acid and base addition, and
headspace gas composition. After waiting 5 residence times at a particular dilution rate, the
reactor was assumed to be at steady state if the total cell density, viable cell density, glucose and
lactate concentrations, and oxygen uptake rate were steady within a 10% range for 48 hours.
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3.3.3 Gas Exchange Rate Measurement
Oxygen uptake rate (OUR) was calculated through a mass balance for reactor liquid
phase oxygen
OUR = kLa(C* -CR) + D(CF - CR) (3.1)
The first term accounts for the headspace aeration across the gas-liquid interface, and the second
term accounts for the net inflow of oxygen due to the liquid streams. The liquid phase oxygen
concentrations were measured using a blood gas analyzer (Ciba Coming Diagnostics, Medfield,
MA). The gas phase oxygen concentration was measured using a paramagnetic oxygen sensor
(Columbus Instruments, Columbus, OH), and the equilibrium oxygen concentration (C*) was
calculated based on the gas phase oxygen concentration at the reactor exit. The partial pressure
of oxygen was converted to a liquid concentration using Henry's Law.
Po
Co02 = 2 (3.2)Ho 2
The Henry's constant was determined using correlations for determining gas solubilities in
medium (Schumpe et al., 1982).
The CO2 evolution rate (CER) was determined through a similar method involving a
mass balance for reactor carbon dioxide
ng 
CER = (Zo 2 oR F 2)D(CL-C) (3.3)
VR
The first term accounts for the net inflow of CO2 through the gas streams, and the second term
accounts for CO2 in the liquid streams. The mole fraction of CO2 was measured with a gas
analyzer with an IR CO2 sensor (Columbus Instruments, Columbus, OH). The CO2 levels in the
liquid streams were measured using a blood gas analyzer (Ciba Coming Diagnostics, Medfield,
72
MA). Both the CO 2 and bicarbonate were determined using equilibrium relations (Nyberg et al.,
1999a).
3.4 Rhodaminel23 Sorted Subpopulations
The hybridoma cells were sorted into subpopulations based on their mitochondrial
membrane potential as measured using Rhodamine 123. A fluorescence activated cell sorter
(FACS, Becton Dickinson, FACSCAN) was used to sort the cells into high (H; top 15%) and low
(L; bottom 15%) fractions. The fractions were grown in 6 well plates and then subsequently
scaled up into T-flasks under normal growth conditions as described in the culture maintenance
section. The cells were frozen down when enough cells were grown for making five or more
stock vials (>35.0*106 cells).
3.5 Fed-Batch Cultures
The fed-batch cultures were performed in spinner flasks (250 ml total volume; 75 ml
working volume) using the stoichiometric feeding method developed by Xie and Wang (Xie and
Wang, 1994c; Xie and Wang, 1994b; Xie and Wang, 1994a)(1994). The spinners were agitated
at 70 rpm in a 370C incubator (95% relative humidity) in a 10% CO 2 atmosphere. The cells were
inoculated at 2.0* 105 cells/ml in either low glucose and glutamine IMDM medium as described
in the cell lines and media section or in the same medium with MOPS to enhance the buffering
capacity as indicated in the results section for these experiments. The medium osmolarity was
adjusted to 270 mOsm/kg using NaCI. The supplemental medium was designed as specified by
the software written by Mllborn (Mllborn, 1996). Samples and cell counts were taken
approximately every 12 hours, and then the cultures were fed according the stoichiometric
feeding protocol specified by the software developed by Xie (Xie, 1997) and Mbllborn
(Millborn, 1996).
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4. PATHWAY AND FLUX ANALYSIS OF CENTRAL CARBON METABOLISM
4.1 Central Carbon Metabolism Reaction Network
Cellular metabolism consists of a vast number of anabolic and catabolic enzymatic
reactions that produce cellular energy, reducing power, and biosynthetic precursors for cellular
growth and function. The metabolic reaction network for central carbon metabolism in
mammalian cells is shown in Figure 4-1. The main metabolic reactions are included such as
glycolysis, the tri-carboxylic acid (TCA) cycle, and glutaminolysis, and serial reactions were
lumped into single reactions. A more complete description of these reactions can be found in
Stryer (Stryer, 1988) and Zupke (Zupke, 1993). In addition, metabolite requirements for
biomass and product synthesis were considered as described in Zupke and Stephanopoulos
(Zupke and Stephanopoulos, 1995a) using the cell composition described in Xie and Wang (Xie
and Wang, 1994c) and Zupke and Stephanopoulos (Zupke and Stephanopoulos, 1995a). This
procedure is described in more detail in section 4.4. The pentose phosphate pathway was
analyzed by considering only the biosynthetic demand for ribose carbon skeletons. Although
obtaining pentose phosphate pathway metabolic fluxes could be useful, labeled substrates must
be used in order to obtain accurate flux data for this pathway. The methodology needed to obtain
this more accurate flux data is described later in this chapter, but due to the complexity involved
in these labeled substrate analysis techniques, this method was not utilized in the continuous
culture flux analysis experiments. In addition, the production of NADPH could not be used to
determine the pentose phosphate pathway recycle flux due to the uncertainty of transhydrogenase
activity in this cell line as well as the fact that the malic enzyme may use either NAD+ or NADP+
(Eigenbrodt et al., 1985). Therefore, reducing power was lumped into an NAD(P)H pool. This
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Figure 4-1. The central carbon metabolism reaction network. Serial reactions are lumped
into single reactions. In addition, biosynthetic requirements for metabolic intermediates have
been included.
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may introduce some error in distinguishing CO2 released from the pentose phosphate pathway
and the TCA cycle.
4.2 Metabolic Pathway Analysis
Cellular metabolism contains an extensive number of enzymatic reactions that are
involved in numerous cellular activities, and organizing these metabolic networks into
independent pathways and key junction points is oftentimes difficult and conducted using
arbitrary methods. Metabolism contains several key junction points termed metabolic
branchpoints or nodes, and characterizing these nodes is critical for determining their influence
on the regulation of metabolic flux. These key link metabolites can be determined through the
analysis of the junctions between various independent pathways through a given reaction
network. These independent pathways can be determined by formulating a steady state internal
metabolite matrix (N) consisting of the reaction stoichiometry and then calculating the kernel
matrix (K) using equation 4.1.
NeK =O (4.1)
Link metabolites are identified as the metabolite that is located at the point of separation between
independent pathways (Stephanopoulos and Simpson, 1997). Although several link metabolites
exist for central carbon metabolism, only pyruvate is the one common metabolite for all
independent pathways (Simpson et al., 1999). Pyruvate serves as the major link between
glycolysis, the TCA cycle, and the production of lactate and several amino acids, and enzymatic
regulation partitions the metabolic flux around this branchpoint to satisfy the catabolic and
biosynthetic needs of a cell. The flexibility of this branchpoint will ultimately determine the
extent of control this branchpoint has over metabolic flux distributions in central carbon
metabolism (Stephanopoulos and Vallino, 1991). Therefore, the flux distribution around
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pyruvate for various physiological states serves as an indicator of the flexibility of this node.
Furthermore, if this node is somewhat flexible, one could exploit this flexibility in order to
increase the culture cell concentration and viability by diverting carbon away from waste
metabolite production pathways into biomass and energy production pathways.
4.3 Metabolic Flux Analysis
The metabolic fluxes were calculated for mammalian cells growing under continuous
culture conditions. Therefore, specific growth and death rates were determined from the total
and viable cell balances around the bioreactor:
dNv
diE = ugNv - kdNv - DN
dt (4.3)
yielding at steady state:
D N T
Nv (4.4)
kd = -D (4.5)
Similarly, specific rates of metabolite production or uptake were determined from the balance:
dC
- = DCin - DCout - qcNvdt (4.6)
yielding at steady state:
D(Cin - Cout)
(4.7)
For the central carbon metabolic reaction network, the flux of each reaction i can be
represented as vi (mmole/ viable cell hr). The stoichiometric coefficient, cj, represents the
coefficient of metabolite j for reaction i. The specific consumption or production rate of
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metabolite j can be represented as qj. The resulting system of linear equations can be presented
as
qj = Y aijvi (4.8)
i
In matrix form, this equation can be written as
Av = r (4.9)
where the matrix of stoichiometric coefficients (A) times the vector of metabolic fluxes (v)
equals the vector of metabolite production and consumption rates (r). The stoichiometric
coefficient matrix is of dimension m x n, where n is the number of reactions and m is the number
of metabolites. Since the stoichiometry of the network is known along with the metabolite
production and consumption rates, one needs to invert equation 4.9 to solve for the metabolic
fluxes. Also, because the stoichiometry matrix is rarely square, a linear least squares estimate
must be calculated
v = (ATA)-lATr (4.10)
Finally, a variance-covariance matrix () can be added to weight the solution (Stephanopoulos
et al., 1998; Zupke and Stephanopoulos, 1995a; Zupke, 1993).
v = (ATT-IA)-l ATT-lr (4.11)
The sensitivity of the metabolic reaction network to changes in the metabolite production
and consumption measurements was also determined by calculating the condition number, c(A),
of the stoichiometry matrix
c(A) ||AII 9 ||A-1|| (4.12)
with II I| indicating the matrix norm. This condition number is used in order to determine the
upper bound of the potential magnification of error when solving equation 4.9. A reaction
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network is considered well posed if the value of the condition number falls below 100 whereas a
condition number that is above 1,000 indicates that the network can yield significant sensitivity
problems. For the metabolic reaction network shown in figure 4-1, the condition number was
calculated to be 69.
Redundant metabolite production and consumption measurements are necessary in order
to test the validity of the metabolic reaction network and of the measured data set. Several
methods have been proposed to elucidate whether a given data set is consistent (van der Heijden
et al., 1994a; van der Heijden et al., 1994b; Wang and Stephanopoulos, 1983) and consistency
analysis has been applied in a number of situations involving flux analysis (Nyberg et al., 1999a;
Vallino, 1991; Zupke and Stephanopoulos, 1995a). For the procedure described in Wang and
Stephanopoulos (Wang and Stephanopoulos, 1983), the redundant equations are written as
Er =0 (4.13)
in which the redundant equations matrix (E) times the vector of measurements equals the null
matrix. Since experimental data always contains some amount of error, equation 4.13 will rarely
be satisfied. Therefore, a statistical hypothesis testing method is utilized in order to determine if
the error is within the bounds expected for random error or if the error is in fact a gross error due
to inconsistent data. This hypothesis test involves the calculation of a consistency index, h,
defined as
h = T(p-IE (4.14)
where
= -Er (4.15)
p = ETTE (4.16)
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The consistency index, h, follows a 2 distribution where the number of redundant equations
determines the degrees of freedom. Therefore, h can be used to determine when the residuals of
equation 4.13 deviate from the expected distribution for a selected confidence level. When h is
greater than the X2 value, there is a certain confidence level percentage chance that the data set
contains either gross measurement errors or errors in the assumed metabolic reaction network
stoichiometry. The elimination of each measurement can be used as a method to determine
which measurement is incorrect (Wang and Stephanopoulos, 1983) although other techniques
have been developed for gross error diagnosis (van der Heijden et al., 1994a; van der Heijden et
al., 1994b).
4.4 Biomass Equation
The biomass equation involves the estimation of the amount of specific metabolites
required to produce biomass and protein product. Central carbon metabolism provides a number
of key metabolites that are used as biosynthetic precursors for the production of polysaccharides,
lipids, proteins, and nucleotides. The biomass macromolecular composition (DNA, lipids,
protein, and carbohydrate) is required in order to calculate the biomass equation. In addition, an
estimate of the amino acid composition of the cellular and product protein is required. Once
these compositions are determined, the overall amount of metabolites required to produce one
mole of biomass (carbon basis) is calculated. For metabolic flux calculations, the amino acids
required for protein production are subtracted from the metabolite production and consumption
rates. The resulting rates are only those that affect the central carbon metabolism metabolic
network. Then the biosynthetic precursor demands are factored into the flux calculations as
shown in Figure 4-1. The exact procedure used is described in more detail in Zupke (Zupke,
1993).
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4.5 Pentose Phosphate Pathway Analysis
4.5.1 Introduction
An important parameter in metabolic pathway analysis is the flux of carbon through the
pathway. Accurate determination of metabolic fluxes in-vivo is a critical step in elucidating flux
control in metabolic networks. Sensitive experimental techniques and rigorous modeling
methods are both required for the calculation of accurate flux values. Currently, the methods
used to calculate metabolic fluxes involve metabolite balancing and isotope labeled substrate
analysis techniques (Bonarius et al., 1996; Bonarius et al., 1998a; Bonarius et al., 1998b;
Mancuso et al., 1998; Mancuso et al., 1994; Marx et al., 1996; Park et al., 1999; Park et al.,
1997; Sharfstein et al., 1994; Vallino and Stephanopoulos, 1994b; Vallino and Stephanopoulos,
1994a; Vallino and Stephanopoulos, 1993; Wiechert and de Graaf, 1997a; Wiechert and de
Graaf, 1996; Wiechert et al., 1997b; Zupke et al., 1995b; Zupke and Stephanopoulos, 1995a).
Isotope labeling techniques are particularly useful due to the additional information contained in
the metabolite carbon label fractional enrichment values resulting from the scrambling of the
input substrate label. However, the models used to analyze these isotope distributions frequently
make assumptions about the reversibility of the reactions, and these assumptions can result in
errors concerning the estimated metabolic fluxes and isotope label scrambling. This section
concentrates on the development of a methodology that allows reaction reversibility to be
included in more accurate calculations of metabolic fluxes in metabolic networks by explicitly
accounting for the effect of reaction reversibility on metabolite labeling upon administration of
labeled substrates. In addition, it addresses a fundamental problem of flux analysis concerning
the uniqueness of flux estimates and the experimental measurements needed to obtain accurate
solutions. Although this analysis was not utilized in the flux calculations for the continuous
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cultures due to its complexity, it was performed in an effort to determine the data that are needed
for accurate flux calculation using isotope tracers and also the potential errors that can arise
when isotope tracer scrambling is not correctly analyzed.
Pentose phosphate pathway. The pentose phosphate pathway plays several key roles in
metabolism. It contributes to the redox potential in a cell through the maintenance of the
NADPH/NADP+ ratio and is also source of biosynthetic carbon skeletons (Stryer, 1988). Recent
research has demonstrated that the pentose phosphate pathway can carry a significant flux under
certain physiological conditions and in various cell types (Bonarius et al., 1996; Landau and
Wood, 1983). Finally, the pathway can redistribute metabolite carbon atoms leading to
difficulties in determining fluxes in other pathways using labeled substrates (Berthon et al.,
1993; Flanigan et al., 1993; Park et al., 1997). Therefore, the pentose phosphate pathway can
have a significant impact not only in the maintenance of cellular function but in the analysis of
isotope labeled substrate experiments as well.
The pentose phosphate pathway, commonly referred to as the classical pathway, was
elucidated in the late 1950's using data from labeled substrate experiments, in particular labeled
14CO2 evolution rates and metabolite conversion rates in tissue extracts (Katz and Wood, 1963;
Katz and Wood, 1960; Williams, 1980). This classical pathway is divided into two different
groups of reactions, the oxidative and nonoxidative branches. The oxidative branch begins with
the dehydrogenation of glucose 6-phosphate by glucose 6-phosphate dehydrogenase to form 6-
phosphogluconate and NADPH. An additional reaction produces another molecule of NADPH
along with ribulose 5-phosphate, which can then be isomerized to ribose 5-phosphate and used
for DNA and RNA nucleotide sugar biosynthesis. These reactions are all summarized in Figure
4-2 with vl representing the oxidative pathway and v4, v5, and v6 referring to the nonoxidative
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Figure 4-2. The classical pentose phosphate pathway reaction network. The oxidative
reactions are referred to as vl, and the nonoxidative reactions are denoted v4 , v5 , and V6. The
reactions that are part of the glycolytic pathway are vo, v2, and v3. The isomerase and epimerase
reactions (shown as E and I) between the hexose and pentose metabolites are considered to be
fast and in equilibrium.
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reactions. The isomerase and epimerase reactions between the hexose and pentose metabolites
(E and I in Figure 4-2) are fast and in equilibrium (Katz and Rognstad, 1967; Landau and Wood,
1983; Wood, 1985). Therefore, glucose and fructose 6-phosphate are treated as one hexose pool
(Hex6P), and the three pentose metabolites are treated as one pentose pool (Pen5P). Finally, the
reactions vo, v2, and v3 refer to the glycolysis reactions that are part of this network, and v7 refers
to the DNA and RNA biosynthetic pathway reactions (Stryer, 1988).
The reversible transketolase and transaldolase reactions in the nonoxidative pathway
redistribute metabolite carbon atoms in an organized manner through the enzyme transfer of two
and three carbon units to intermediate metabolites. The transfer scheme of the various
metabolite carbon atoms in these reactions is illustrated in Figure 4-3 with the circles
representing the various numbered metabolite carbon atoms. Since these reactions are all
reversible, they are split into a forward reaction (vi+) and a reverse reaction (vi-). This
reversibility can lead to further redistribution due to exchange with glycolytic intermediates, and
this redistribution must be analyzed in order to interpret pentose phosphate pathway
experimental data correctly.
Flux calculation - background. Isotopic labeling experiments have been performed and
analyzed since the late 1950's and early 1960's with the aim of verifying the biochemistry of the
classical pentose phosphate pathway (Katz and Wood, 1963; Katz and Wood, 1960). These
experiments have all been analyzed using a simplified general model which assumes recycling of
fructose 6-phosphate to glucose 6-phosphate through the isomerase reaction and also assumes
isotopic steady state. Furthermore, the model assumes no reversibility of the transketolase and
transaldolase reactions and thus no recycling of triose 3-phosphate and no label redistribution.
The overall reaction for this simplified view of the pentose phosphate pathway is given as:
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Figure 4-3. The nonoxidative pathway carbon atom redistribution scheme. The numbered
circles refer to the metabolite carbon atoms. The black carbon atoms denote either the two or
three carbon atom units that are transferred to the other metabolites in the reactions.
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7d i_
3 Hexose 3c2 > 3 Pentose - 2 Hexose + 1 Triose (4.17)
To test this model, researchers used [1-'4 C]glucose and [6-'4C]glucose labeled substrates
which allowed them to differentiate between those glucose molecules metabolized through the
pentose phosphate pathway versus those that pass exclusively through glycolysis. This strategy
was also used in order to determine label loss and scrambling due to the tricarboxylic acid cycle.
[1-14C]glucose and [6-'4C]glucose both become [3-14C]glyceraldehyde 3-phosphate after the
aldolase glycolytic reaction, and the [3-14C]glyceraldehyde 3-phosphate labeled carbon is
subsequently scrambled and lost as '4 CO2 identically after this reaction. Therefore, any
difference between radioactive carbon activities of the hexose monophosphate pool upon using
[1-'3 C]glucose and [6-13C]glucose was assumed to be due to the pentose phosphate pathway.
Observed differences between activities of the Hex6P pool for the two cases was used to
determine the fraction of input hexose that flows through the nonoxidative branch of the pentose
phosphate pathway (P) (defined as v4/vo):
-a (4.18)
a 6 (1 + 2P)
ai denotes the specific activity of the hexose 6-phosphate pool when [i-' 4C] labeled glucose was
used. The derivation of equation 4.18 (Follstad and Stephanopoulos, 1998) accounts for the
outflow of labeled carbon via the pentose phosphate pathway versus other pathways
(tricarboxylic acid cycle, etc.). This model can also be used to formulate equations to compare
triose carbon label enrichment or the amount of labeled '4CO2 released for cells fed with [1-14C],
[2-t3C], and [6-' 4 C]glucose (Katz and Wood, 1963; Katz and Wood, 1960; Landau and Katz,
1964).
Other models have been used to determine the pentose phosphate pathway flux. One
model used a black-box approach to determine a lower limit to the pathway flux by measuring
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labeled CO2 release (Larrabee, 1989). Another model employed [3- 3C]lactate labeling resulting
from [1-13C] and [6-'3 C]glucose to determine the pathway flux (Kingsley-Hickman et al., 1990;
Willis et al., 1986). However, when these models were applied to experimental data of specific
carbon activities of metabolites such as glucose 6-phosphate, glycogen, or lactate in various
tissues, they could not fully account for the observed label distributions.
Disagreement between predictions of these simplified models and experimental data led
researchers to propose alternative explanations for the observed labeling patterns.
Inconsistencies in gluconeogenic rat liver data led to the hypothesis of an alternative L-type
pentose phosphate pathway that contains several new intermediates resulting in a different
carbon redistribution scheme (Williams, 1980; Williams and Blackmore, 1983; Williams et al.,
1978). This hypothesis is still refuted in the literature by several researchers (Landau and Wood,
1983; Rognstad, 1995). Yet another hypothesis included fructose futile cycles to allow for
carbon label scrambling. Finally, although researchers have included nonoxidative reaction
reversibility in their models to account for label redistribution (Katz and Rognstad, 1967), the
calculation of the individual extents of reaction reversibility using a general model is still not
adequate. In summary, despite numerous hypotheses proposed to reconcile observed
inconsistencies between models and experimental data in the pentose phosphate pathway, a
method for the systematic quantitation and tracking of isotope labels has yet to be presented.
4.5.2 Theory
A general model utilizing mass balance equations can be formulated for any reaction
network and then be used to analyze carbon label redistribution and extents of reaction
reversibility. Other flux analysis models presented in the literature utilize similar basic concepts
of mass balances for flux determination (Wiechert and de Graaf, 1997a; Wiechert et al., 1997b).
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The model of this paper is based on the work of Park (Park, 1996) and Katz and Rognstad (Katz
and Rognstad, 1967) and is applied to the pentose phosphate pathway reaction network
illustrated in Figure 4-2. The metabolite pools are assumed to be well-mixed. Also, since the
isomerase and epimerase pentose phosphate pathway reactions (E and I in Figure 4-2) are
considered fast, they are assumed to be at equilibrium, hence the three pentose metabolites are
treated as one pentose pool (PenSP). Similarly, glucose and fructose 6-phosphate are treated as
one hexose pool (Hex6P) due to the isomerase reaction. The nonoxidative reactions are assumed
to follow the carbon redistribution scheme shown in Figure 4-3. Finally, the reaction velocity for
DNA and RNA biosynthesis reactions (v7) is assumed to be small and is neglected in this
analysis. If this assumption proves to be incorrect in some systems, the addition of this reaction
to the model equations will result in the need to calculate one additional parameter.
Mass balances. The model utilizes two types of mass balances, one of reaction network
metabolite pools, and a second of metabolite carbon atoms. The first, (equation 4.19), describes
the overall balance of network metabolite pools:
dxj
=t  10ijivi (4.19)
In the above equation, xj refers to the concentration of metabolite j (mole/cell), ji is the
stoichiometric coefficient for reaction i for metabolite j, and vi refers to the velocity of reaction i
(mole/hr/cell). For the pentose phosphate pathway depicted in Figure 4-2, the metabolite balance
equations are listed in the appendix along with the steady state solutions. The value P represents
the ratio of the nonoxidative reaction flux to the glucose uptake rate (v4/v) as defined in Katz
and Rognstad (Katz and Rognstad, 1967). For example, when P equals one, the oxidative flux is
3vo and v2 equals zero resulting in one glucose molecule being converted into three CO2
molecules and one glyceraldehyde 3-phosphate molecule. Note that rates of reactions appearing
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in the metabolite balances of equation 4.19 refer to the overall (or net) flux through the pentose
phosphate pathway; no measure of reversibility can be calculated from these rates. The
calculated flux values show that, at steady state, the net fluxes through the nonoxidative pathway
reactions are equal.
Reaction reversibility can be accounted for by recognizing a forward (vi+) and reverse
(vi-) reaction, with the extent of reaction reversibility represented by ai which is scaled by the
glucose uptake rate v0:
vi = vi - (4.20)
v i = Vi + aiv0 (4.21)
vi = aiv0 (4.22)
The extents of reaction reversibility may all vary but still result in a constant steady state net
flux. For example, Figure 4-4 shows two different cases for a metabolite pool (M). Here, the
length of the arrows refers to the relative value of the flux (a large arrow depicting a large flux).
In both cases, the net flux through the metabolite pool (vl=v2) is the same; however, reaction
extents of reversibility may be different. Case I illustrates the pool at steady state with the same
extents of reversibility for the two fluxes. Case 2 illustrates the same net flux, but the extents of
reversibility for the two reactions are different. In this case, the values for v2+ and v2- are much
greater than the values for vl+ and v although the difference between the two is the same.
Differences in extents of reversibility affect the label redistribution of the intermediate
metabolites. Therefore, assuming equal extents of reversibility for the transketolase and
transaldolase reactions of the pentose phosphate pathway could lead to errors in the data
analysis.
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Figure 4-4. The extent of reaction reversibility can vary without altering the net flux.
Here, the metabolite pool (M) has equal net input and output fluxes vl and v2 with the length of
the arrow referring to the relative value of the flux. Each net flux can be divided into a forward
and reverse flux (ex. v and v-) with the extent of reversibility denoting the relative sizes of
these two fluxes. In case 1, the extents of reversibility are equal, but the extents for case 2 are
significantly different with reaction 2 having a larger reversibility that reaction 1.
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Figure 4-5. [1-13C], [2-13C], and [3-'3C]glyceraldehyde 3-phosphate fractional enrichments
plotted as a function of a (a4=as=a6) resulting from [1- C]glucose input. The fractional
enrichments vary with reaction reversibility and approach various asymptotic values as the
reversibility becomes either small (<0.1) or large (>10).
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The introduction of reversibility is accompanied by an increase in the number of
unknown fluxes that must be determined for the complete description of the pathway. These
additional unknowns can be determined from measurements of metabolite label distributions
upon administration of labeled carbon substrates in conjunction with a second set of mass
balance equations. These equations reflect overall balances on each carbon atom in the reaction
network:
d(xy (m))_ E , iviyl(n)- yj(m)ji ivi (4.23)
dt i I i
Here yj(m) denotes the fractional enrichment (13C) or specific activity (14C) of the mth carbon
atom of metabolite j. In addition, n denotes the carbon atom of metabolite I mapped to carbon
atom m of metabolite j in reaction i (Follstad and Stephanopoulos, 1998). The above equation
applied to the carbon atoms of the pentose phosphate pathway metabolites yields the equations
given in Follstad and Stephanopoulos (Follstad and Stephanopoulos, 1998). At steady state,
unknown metabolic fluxes (vi) and nonmeasured fractional enrichments (yi(m)) can be calculated
from a sufficient number of extracellular metabolite fluxes and label fractional enrichments using
a mathematical software program such as Mathematica or Matlab.
Algorithm for solving the balance equations. The mass balance equations (4.19 and
4.23) can be cast in the following matrix form (equation 4.24):
· = I j 1 (4.24)
Ai,,(Pa,a,a) Ai,(P,a4,a5,a 6) .. bi
The matrix elements Aij represent coefficients in the metabolite carbon balance equations, yj
stands for the nonmeasured carbon atom label fractional enrichments or activities, and the bj
values refer to the fractional enrichments of the labeled input substrate. If the fraction of input
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hexose flowing through the nonoxidative pathway (P) and the three nonoxidative pathway
extents of reversibility (a4, a5, and a6) are known, the linear system of equations can be solved
easily for the fractional enrichment values. This method was used to perform the variational
studies presented in the results section. However, the determination of these variables from
experimental fractional enrichment measurements is in general a non-trivial issue, for it entails
the solution of nonlinear carbon atom balance equations. For the case of a small number of
unknown reaction reversibilities, the following iterative procedure can be used: a) formulate the
matrix A = A(P, a4, a, a6) of equation 4.24; b) guess a set of initial values for a4, as, and a6; c)
determine P from the overall metabolite balance and ensure that matrix A is invertible (detA 7 0)
for the guessed values of a4, as, and a6; d) determine y by solving Ay = b; e) adjust the values of
a4, as, and a6 by applying typical gradient methods with the ultimate goal of matching the
experimental data (yi,meas.) with the calculated values yicac. (i.e. iterate the algorithm and adjust
the values until Yicalc. equals yi,meas.).
In this paper, this iterative procedure was employed to calculate the extents of reaction
reversibility for sets of experimental data obtained from the literature. Other solution methods
can also be used to solve this nonlinear system of equations, such as the Newton-Raphson
method or nonlinear regression methods.
4.5.3 Results
The above method was applied to the classical pentose phosphate pathway reaction
network to study the effect of varying extents of reaction reversibility on label distribution and
achieve the reconciliation of published data sets.
Effect of reaction reversibility. Label enrichments of intermediate metabolites were
calculated first as a function of two parameters: the fraction of the input glucose utilized through
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the nonoxidative pathway (P), and the extent of reversibility in the transaldolase and
transketolase reactions (a). Figure 4-5 shows the labeling of [1-' 3C], [2-13.C], and [3-
'
3C]glyceraldehyde 3-phosphate resulting from [1-'3C]glucose input for varying values of the
extent of reversibility a, initially assumed to be the same for all reactions. These figures show
that the enrichment approaches different asymptotic values for very small reversibilities (<0.1)
but converges to the same value as the reversibility becomes large (>10). Figure 4-6 shows the
label enrichment of [3-13C]glyceraldehyde 3-phosphate resulting from [1-13C]glucose, as a
function of both P and a. As P increases, the fractional enrichment decreases and becomes less
sensitive to the extent of reaction reversibility. The use of [2- 3C] and [3-' 3C]glucose input
yields more complicated enrichment patterns due to more extensive label scrambling (data not
shown), while [4-'3C], [5-' 3C], and [6-'3C]glucose input results in no change in output
glyceraldehyde 3-phosphate labeling when the extent of reversibility varies. For example, the
labeling of [3-'3C]glyceraldehyde 3-phosphate resulting from [6-'3C]glucose input is shown in
Figure 4-7 as a function of P and a. The fractional labeling in this case does not depend on the
extent of reversibility but rather on the net flow through the pentose phosphate pathway due to
the loss of CO2.
The previous plots illustrate the effects of reaction reversibility when the extent of
reversibility is the same for all nonoxidative pathway reactions. Since these extents can vary
independently, their individual effects on label distribution was further investigated. There are
four adjustable parameters in this case, (P, a4, as, and a6), and pictorial representations of the
numerical variation studies are shown in Figures 4-8 through 4-11 for the case where P is fixed
and two of the extents of reversibility are identical. The data shown here are for [1-'3C]glucose
feeding with P equal to 0.50. Although varying P does affect carbon labeling (as shown
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previously in Figure 4-6), this effect is not shown in Figures 4-8 through 4-11. In general, a
lower value for P results in greater label variation.
The determination of three extents of reversibility requires that a minimum of three label
measurements be obtained. It is not a priori obvious which label enrichment measurements
would provide the most information in resolving a set of three reaction reversibilities. The
determination of the particular label enrichments that optimize the observability of reaction
reversibilities is a separate problem that is not addressed in this paper. Here we limit our
investigation to a variational study where the effect of reversibilities on different metabolite
enrichments is presented. Figure 4-8 illustrates the results for the expected labeling of [6-
'
3C]Hex6P. The curves of this plot show the resulting '3C enrichment when one extent of
reversibility is varied while the other two are held fixed at the indicated value. For example, the
leftmost curve shows the variation in [6-' 3C]Hex6P when a4 is varied from 0.0001 to 10000
while a5 and a6 both equal zero. The three sets of curves illustrate the effects that each individual
transketolase and transaldolase reaction reversibility can have on labeling. The figure also shows
some problems that could arise when one attempts to experimentally determine these
reversibilities. The relative flatness of the a6 curves suggests that the measurement of the
enrichment of this metabolite would not be particularly valuable in determining a6 accurately.
Also, the similarity between the curves for a4 and a6 points out that some difficulty could arise in
distinguishing between these two variables with this particular measurement.
Figure 4-9 shows carbon enrichment values for [1- 3C]Pen5P and Figure 4-10 shows
values for [5-'3C]Pen5P. Figure 4-9 shows that this particular carbon enrichment measurement
would lead to difficulties in differentiating a4 from a5 but might be helpful in determining a6.
Figure 4-10 illustrates that small differences result when the three extents of reaction
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Figure 4-8. [6-13C]Hex6P fractional enrichments plotted as a function of ai with P equal to
0.50 resulting from [1-' 3C]glucose feeding. For each curve, one extent of reaction reversibility
is varied while the other two are fixed at the specified values. For this case, varying a6 results in
small changes in enrichment, and differences between variations in a4 and a6 may be difficult to
resolve. Varying as, however, results in different behavior helping to resolve this reaction
reversibility.
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Figure 4-9. [1-'3C]Pen5P fractional enrichments plotted as a function of a; with P equal to
0.50 resulting from [1-13C]glucose feeding. For each curve, one extent of reaction reversibility
is varied while the other two are fixed at the specified values. For this case, variances in a4 and
a5 lead to identical or overlapping curves which leads to difficulty in resolving these
reversibilities individually. The fact that varying a6 leads to a different set of curves aids in the
determination of this reversibility.
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reversibility are varied separately. Therefore, the information content if Pen5P label
measurements is not particularly high and could lead to inaccurate reversibility estimates.
A key metabolite in this pathway is erythrose 4-phosphate (Ery4P). Although Ery4P is
difficult to isolate and analyze with NMR, the labeling of this metabolite can be determined
indirectly through aromatic amino acid analysis since Ery4P is a precursor in the biosynthesis of
these amino acids (Szyperski, 1995). Figure 4-11 illustrates the effects of varying each extent of
reversibility on [4-' 3C]Ery4P enrichment. The carbon enrichment of this metabolite shows
significant dependence on reversibility extents, with little curve overlap. This indicates that this
measurement is quite valuable in the determination of accurate extents of reaction reversibility.
The above figures illustrate the effects reversible reactions can have on metabolite carbon
label fractional enrichment. These effects become particularly important when the overall flux
through the pathway is low but the reversible reactions carry a high exchange flux. In such
cases, ignoring carbon label scrambling brought about by reaction reversibility in the pentose
phosphate pathway would affect the determination of the fluxes in other parts of the metabolic
network such as the tricarboxylic acid cycle, and lead to discrepancies between model
predictions and experimental data. The variational studies also show that the reversibility extent
and accuracy of flux determination depend on the particular choice of metabolite carbon
enrichments measured. For example, [6-'3C]Hex6P and [4-]3C]Ery4P are particularly important
measurements due to the fact that they are sensitive to variations in each of the reversible
reactions. On the other hand, [1-13C] and [5- 3 C]Pen5P are not as useful, but they could still be
used along with other metabolite carbon enrichment values, such as [3- 3C]Gra3P, to add
redundancy to the data set and help determine the three extents of reversibility with a higher
degree of accuracy.
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Figure 4-10. [5-13C]Pen5P fractional enrichments are plotted as a function of ai with P
equal to 0.50 resulting from [1-13 C]glucose feeding. For each curve, one extent of reversibility
is varied while the other two are fixed at the specified values. In this case, nearly all of the
curves are identical and overlap leading to virtually no way to determine individual
reversibilities.
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Figure 4-11. [4-1 3C]erythrose 4-phosphate fractional enrichments are plotted as a function
of ai with P equal to 0.50 resulting from [1-13C]glucose feeding. For each curve, one extent of
reversibility is varied while the other two are fixed at the specified values. For this case,
variations in each of the three reversibilities results in curves that all differ helping to resolve
these reversibilities. This demonstrates that [4- 3C]Ery4P is a key enrichment measurement and
should be included in the experimental measurement data set if one wants to calculate accurate
reversibility values.
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A similar exercise can be performed for the use of other labeled substrates in analyzing
the pentose phosphate pathway. For example, in the case for [2- 3 C]glucose feeding, large '3C
enrichments are localized in [5-13C]Hex6P, [2- 13 C]Pen5P, [4-13C]Pen5P, and [3- 3C]Ery4P. In
addition, variations in [5- 3C]Hex6P and [3-'3C]Ery4P enrichments are also valuable due to their
different response to each of the non-oxidative reaction reversibilities (data not shown) which is
a result similar to that obtained for these two metabolites with [1-'3 C]glucose feeding.
Comparison with literature data. The method presented in this paper yields theoretical
predictions that are in agreement with those of other models in the literature such as that of
Wiechert et al. (Wiechert and de Graaf, 1997a) for glyceraldehyde 3-phosphate and erythrose 4-
phosphate labeling obtained upon xylose feeding to cultures of Zymomonas mobilis (data not
shown). In addition, this method was applied to the analysis of several sets of published 4C
specific activity and 13C fractional enrichment data for Hex6P, Pen5P, Ery4P, and Gra3P
metabolite carbons. Although these data sets do not contain the ideal set of enrichment
measurements for Hex6P and Ery4P described previously, one can still obtain estimates of
reaction reversibility. These data sets covered a wide range of tissue types and cell culture
conditions. We omitted data involving the analysis of gluconeogenesis, such as that from rat
liver, due to the fact that the reversibility of reaction v2 introduced by gluconeogenesis involves
the addition of another variable in the model.
In two studies (Hostetler et al., 1966; Landau and Katz, 1964), the distribution of '4C in
glycogen from rat epididymal adipose tissue and goosefish islet cells incubated with [2-
'
4C]glucose was tabulated. Tables 4-1 and 4-2 show the specific activities of each glycogen
(Hex6P) carbon atom relative to the C-2 glycogen label. The value for P was estimated using
equation 4.18 and variations of equation 4.18 due to the limited metabolite data. Assuming no
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Table 4-1. Rat epididymal adipose tissue'
from rat epididymal adipose tissue supplied v
(Ins-) and with [2- 4C]glucose substrate.
predictions assuming no reversibility and
reactions (Landau and Katz, 1964). At lox
concentration, P = 0.23.
4 C label data. 14C label data for Hex6P (glycogen)
vith either a high (Ins+) or low insulin concentration
Experimental values are compared with model
reversibility for transketolase and transaldolase
v insulin concentration, P = 0.13; at high insulin
Method Insulin Relative 14C specific activity of Hex6P at
C-1 C-2 C-3 C-4 C-5 C-6
Experimental low 15.2 100 12.8 1.9 13.9 2.9
high 30.7 100 17.9 3.5 14.8 5.3
Model: no reversibility
(a4 =a5=a6=0.0) low 20.6 100 11.5 0.6 5.4 1.1
high 31.5 100 18.7 1.5 8.1 2.5
Model: reversibility
(a4=0.5, a5=0.2, a6=0.0) low 18.8 100 15.8 2.1 13.4 2.5
(a4=0.8, a5=0.08, a=0.0) high 30.5 100 20.9 2.7 13.1 4.0
Table 4-2. Goosefish islet cell 14C label data. '4 C label data for Hex6P (glucose
polysaccharide) from goosefish islet cells supplied with [2-I4C]glucose. Experimental values
compared with model predictions assuming no reversibility and reversibility for transketolase and
transaldolase reactions (Hostetler et al., 1966). P = 0.075.
Method Relative 14C specific activity of Hex6P at
C-1 C-2 C-3 C-4 C-5 C-6
Experimental 11.1 100 8.3 1.3 15.0 1.7
Model: no reversibility
(a4=a5 =a6=0.0) 12.0 100 7.0 1.0 3.0 1.0
Model: reversibility
(a4=0.005, as=0.5, a6=0.005) 13.0 100 7.2 1.0 15.5 2.0
101
reversibility, the model underestimates the relative specific activity at C-5 for both studies. In
the rat adipose tissue study, a moderate reaction 4 (v4) extent of reversibility (a4 = 0.5), a smaller
reaction 5 (vs) extent of reversibility (a5 = 0.2), and virtually no reaction 6 (v6) reversibility
results in closer agreement with the experimental data. Also, an insulin effect on the extents of
reversibility is revealed. The study with goosefish islet cells shows similar improvement in the
resolution of C-5 specific activity with rather low reaction 4 and 6 extents of reversibility
(a4=a6=0.005) and a higher reaction 5 extent of reversibility (as=0.5). No reversibility estimates
were presented in these papers, however, the results of Tables 4-1 and 4-2 show that the
agreement of the experimental data improved with the addition of non-zero extents of reaction
reversibility.
Another study reported 3C fractional enrichment for several metabolites from steady
state C. glutamicum chemostat cultures (Marx et al., 1996). Table 4-3 compares the
experimental fractional enrichments for erythrose 4-phosphate and glyceraldehyde 3-phosphate
with the ones predicted by the model. In this case, the value for P was calculated from the
metabolite balance data. Assuming no nonoxidative pathway reversibility, the model is unable
to determine values consistent with the experiments, particularly for the C-4 carbon of erythrose
4-phosphate. However, adding reversibility to the model improves the estimates of fractional
enrichment, lowers the C-3 value for glyceraldehyde 3-phosphate, and increases the values for
the other carbons. The relatively high value of the C-3 carbon enrichment of glyceraldehyde 3-
phosphate could be explained by adding another flux from the glyceraldehyde 3-phosphate pool
to amino acids synthesis such as serine or glycine, two reactions not covered in the reaction
network considered. Note that the extents of reversibility are all different, and that the
measurement of erythrose 4-phosphate carbon atom fractional enrichment is particularly useful
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Table 4-3. C. glutanzicum 13C label data. 13C label data for Ery4P and Gra3P intermediates
taken from C. glutamicum growing in a chemostat culture with l1-'3C]glucose substrate.
Experimental values compared with model predictions assuming no reversibility and reversibility
for transketolase and transaldolase reactions (Marx et al., 1996). The corresponding reversibility
values calculated by Marx et al. (1996) for this study were comparable to those presented here
with values of 0.23 for a5, 0.0 for a6, and 0.20 for P (scaled to the same flux basis used here)
compared to our value of 0.22. However, the value for a4 was 9.74 which deviated somewhat
from our value of 0.5, and possible sources for this deviation are discussed in Results.
Method Metabolite Metabolite carbon atom
C-I C-2 C-3 C-4
Experimental Ery4P 2.5 2.0 1.9 15.3
Gra3P 2.7 2.6 26.3 -
Model: no transketolase and transaldolase reversibility
(a4=as=a6=0.0) Ery4P 0.0 0.0 0.0 5.2
Gra3P 0.0 0.0 32.4
Model: transketolase and transaldolase reversibility
(a4=0.5, a5=0.1, a6=0.2) Ery4P 3.7 0.9 0.3 15.6
Gra3P 1.9 0.6 31.0
Table 4-4. E. coli 14 C label data at slow growth conditions. '4C label data for Hex6P and
Pen5P from E. coli at slow growth conditions supplied with [2-'4C]glucose substrate.
Experimental values compared with model predictions assuming no reversibility and reversibility
for transketolase and transaldolase reactions (Katz and Rognstad, 1967). The reversibility values
calculated by Katz and Rognstad 1967) are comparable to those presented here with a value of
0.06 for the transaldolase reaction (as), a value of 0.05 for the transketolase reactions (a4 and a6),
and an identical value of 0.02 for P.
Method Metabolite Metabolite carbon atom
C-I C-2 C-3 C-4 C-5
Experimental Hex6P 4 100 4 - 4
Pen5P 100 107 - 74 -
Model: no reversibility Hex6P 4 100 2 - 1
(a4=a5a=a6=0.0) Pen5P 100 2 - 1 -
Model: reversibility Hex6P 4 100 2 - 3
(a4=0.05, a5=0.03, a6=0.05) Pen5P 100 111 - 68 -
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due to the low fractional enrichments of C-1 and C-2 for glyceraldehyde 3-phosphate. In other
words, one could not calculate accurate reversibilities based on the low glyceraldehyde 3-
phosphate fractional enrichment values without adding the erythrose 4-phosphate measurements.
In addition, the reversibility results shown here are fairly cnsistent with those calculated by
Marx et al. (Marx et al., 1996) for this study (see Table 4-3). The approximately ten-fold
difference in the values for a is most likely due to the fact that the ribose metabolites were
treated individually by Marx et al. (Marx et al., 1996) and not as one pool, and this would affect
reversibilities involving the reactions with these metabolites, particularly for reaction a4.
Finally, the data of a study that measured polysaccharide glucose and RNA ribose
labeling in E. coli cultures incubated with [2-'4C]glucose under different growth conditions were
analyzed (Katz and Rognstad, 1967). Tables 4-4, 4-5, and 4-6 show the specific activities of
each polysaccharide glucose carbon atom relative to the C-2 label and each ribose carbon atom
relative to the C-1 label. In these cases, the value for P was determined from the metabolite
balance data. Again, these tables show that the addition of reaction reversibility dramatically
improves the agreement of the experimental data with values calculated using the model. Also,
the ribose measurements increased the redundancy of the system improving the resolution of the
data. For example, using the hexose carbon atom specific activities alone cannot resolve all
reaction reversibilities due to the low enrichment values calculated for C-1, C-3, and C-5.
However, the addition of the C-2 and C-4 specific activities from ribose 5-phosphate
measurements improved the resolution of flux determination by providing additional
measurements with high specific activities. In addition, the reversibilities calculated by Katz and
Rognstad (Katz and Rognstad, 1967) are comparable to those calculated here (see Tables 4-4, 4-
5, and 4-6).
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Table 4-5. E. coli 14C label data at log growth phase. 4C label data for Hex6P and Pen5P
from E. coli at log growth phase supplied with [2-' 4C]glucose substrate. Experimental values
compared with model predictions assuming no reversibility and reversibility for transketolase and
transaldolase reactions (Katz and Rognstad, 1967). The reversibility values calculated by Katz
and Rognstad (1967) are comparable to those presented here with a value of 0.06 for the
transaldolase reaction (a5), a value of 0.12 for the transketolase reactions (a4 and a6), and a value
of 0.08 for P, compared to our value of 0.09.
Method Metabolite Metabolite carbon atom
C-1 C-2 C-3 C-4 C-5
Experimental Hex6P 15 100 10 - 8
Pen5P 100 53 - 48 -
Model: no reversibility Hex6P 15 100 8 - 4
(a4=a5=a6=0.0) Pen5P 100 8 - 4 -
Model: reversibility Hex6P 16 100 8 - 10
(a4=O.105, a5=0.065, a6--0.11) Pen5P 100 57 - 37 -
Table 4-6. E. coli 14 C label data at stationary phase.
E. coli at stationary phase
with model predictions
supplied with [2-'4C]glucose
assuming no reversibility
14C label data for Hex6P and Pen5P from
substrate. Experimental values compared
and reversibility for transketolase and
transaldolase reactions (Katz and Rognstad, 1967). The reversibility values calculated by Katz
and Rognstad (1967) are comparable to those presented here with a value of 0.71 for the
transaldolase reaction (as), a value of 0.46 for the transketolase reactions (a4 and a6), and a value
of 0.13 for P, compared to our value of 0.16.
Method Metabolite Metabolite carbon atom
C-1 C-2 C-3 C-4 C-5
Experimental Hex6P 24 100 17 - 24
Pen5P 100 150 - 97 -
Model: no reversibility Hex6P 24 100 14 - 6
(a4=a5=a6=0.0) Pen5P 100 14 - 6 -
Model: reversibility Hex6P 26 100 25 - 25
(a 4=0.6, a 5=0.8, a6=0.6) Pen5P 100 147 - 82
105
4.5.4 Conclusions
A variety of methods have been employed in the past to determine pentose phosphate
pathway fluxes. One method assumed that pentose phosphate pathway flux equals that required
for ribose carbon skeletons for DNA and RNA biosynthesis (Xie and Wang, 1994c; Zupke and
Stephanopoulos, 1995a). Another method used the ratio of specific activities of metabolite
carbons resulting from the addition of [1-'4C] and [6- 4C]glucose to calculate pentose phosphate
pathway activity (Katz and Wood, 1963; Katz and Wood, 1960; Kingsley-Hickman et al., 1990;
Larrabee, 1989; Willis et ai., 1986). A third method used 13C labeling to determine the amount
of pentose phosphate pathway flux in cells under low growth conditions and assumed that the
flux equaled the amount needed for biosynthesis with no scrambling due to this pathway
(Mancuso et al., 1994; Sharfstein et al., 1994). All of these methods may be accurate under
certain conditions (such as low growth rates) but in general, they only represent the net fluxes
through the corresponding pathways. These approaches are not general and do not take into
account the resulting label redistribution caused by reaction reversibility which could lead one to
calculate incorrect fluxes in other parts of the metabolic network.
The general metabolic reaction network model presented here includes not only overall
carbon redistribution balances but also accounts for varying extents of reaction reversibilities.
This general approach applied to the pentose phosphate pathway illustrated that varying extents
of reaction reversibility can have a dramatic influence on fractional enrichment data. In addition,
the accuracy of reversibility calculation depends on the choice(s) of specific metabolite carbon
enrichment measurement as illustrated with the [6-'3C]Hex6P and [4-'3 C]Ery4P enrichment
values in the variational study for [1- 3C]glucose feeding.
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Fractional enrichment measurements of intermediate metabolites present at small
concentrations may be difficult to obtain due to low sensitivity of NMR spectroscopic
measurements. A compound usually produced in larger amounts in cultured cells is lactate
which could be used to obtain an analyzable NMR spectrum. Lactate carbon atoms are all
derived from the pyruvate pool which is usually formed from glycolysis and thus glyceraldehyde
3-phosphate. However, it is also possible that a fraction of the lactate production is the result of
glucose carbon cycling from pyruvate via anapleurotic reactions into the tricarboxylic acid cycle
and then back into pyruvate via the malic enzyme. Therefore, in order to properly account for
lactate labeling, one needs to account for the tricarboxylic acid cycle recycle labeling effect
added to the lactate carbons. This analysis can be done using [4-'3 C], [5-'3 C], and [6-
13C]glucose, since the pentose phosphate pathway does not scramble these labeled carbon atoms
in a particular metabolite, although fractional enrichment values for the labeled carbon atoms
may vary (data not shown). In other words, each metabolite would have one labeled carbon
atom with a variable fractional enrichment. Using the carbon enrichment labeling of the [1-13C],
[2-13C], and [3-' 3C]lactate carbon atoms, the tricarboxylic acid recycle effect can be calculated
using a procedure described in (Klapa et al., 1999; Park, 1996; Park et al., 1999; Park et al.,
1997).
When applied to literature data sets, the modeling approach was successful in explaining
the appearance of label on several metabolite carbon atoms. This was demonstrated with data
sets for the rat adipose tissue and goosefish islet cells in which the high experimental specific
activity at the C-5 carbon in the analyzed glycogen was explained by introducing reaction
reversibility to the model. The need for reaction reversibility was also clearly shown in the
analysis of the C. glutamicum and E. coli data sets. Finally, the variability in the extents for all
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of these data sets suggested that each transketoiase and transaldolase reaction may have a
different extent of reversibility depending on the cell type, medium environment, or culture
growth conditions.
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5. METABOLIC FLUX IN CHINESE HAMSTER OVARY CONTINUOUS CULTURE
5.1 Introduction
Two of the most important parameters in metabolic pathway analysis are the flux through
various biochemical reactions and the distribution of this flux at key nodes within a biochemical
reaction network. The accurate calculation of these fluxes is required in order to elucidate
relations between metabolic fluxes and physiological states. Metabolic flux analysis was applied
to elucidate these relations for Chinese hamster ovary cells at different growth rates for several
continuous culture steady states. These various steady states are representative of the bioreactor
environments and cellular physiological states encountered under batch and fed-batch culture
conditions. A low residence time (high growth rate) correlates with the initial time points of a
batch or fed-batch culture, whereas a high residence time (low growth rate) correlates with the
later stages of batch or fed-batch culture. In addition, the low growth rates correlate with the
higher cellular death rates observed during the late stages of a batch or fed-batch culture.
Theilc;ore, the analysis of the cellular physiology encountered in continuous culture steady states
can yield a significant amount of information concerning the cellular control of metabolic flux
distribution occurring in various bioreactor environments. Furthermore, this information could
be applied in not only process design but also in the modeling of batch or fed-batch processes.
The cellular and environmental conditions that result in metabolic flux and flux
distribution variations as well as those that trigger apoptosis were analyzed under steady state
conditions. In addition, protein product glycosylation was investigated, and these results are
discussed elsewhere in Nyberg et al. (Nyberg et al., 1999b). Specifically, the cellular
physiological state was characterized not only through measurements of viability but also
through the calculation of metabolic fluxes and variations of flux distribution around the
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pyruvate branchpoint. This metabolite was chosen due to the fact that it is the most important
branchpoint in metabolism as demonstrated through theoretical analysis of the central carbon
metabolism network (Simpson et al., 1999). The results indicated that metabolic flux
distribution around pyruvate fluctuates as a function of the cellular growth rate with a higher
TCA cycle and respiration activity occurring at the lower growth rates. At these low growth
rates, the onset of lactate consumption coincided with the rapid rise in the cellular death rate.
These results correlate with the metabolic changes that occur over the course of a fed-batch and
illustrate the metabolic regulation occurring as cells attempt to satisfy energetic and biosynthetic
requirements as well as the flexibility of the pyruvate branchpoint. In addition, these results
indicate that an operating window of growth rates exists for this cell line where cell death can be
minimized, and this result could be utilized in the design of a batch or fed-batch culture process.
5.2 Results
The continuous culture runs for the Chinese hamster ovary cell line involved four steady
states operated under glucose limiting conditions and one glutamine limited steady state. These
reactor runs were initially operated in batch mode and then switched to continuous mode. The
culture was determined to be at steady state when the cell density, viability, and key metabolite
production rates did not vary for more than 10% for 48 hours. The specific cell growth rates and
death rates were calculated using equations 4.4 and 4.5, and the results for the four glucose
limited steady states and one glutamine limited steady state are shown in Figure 5-1. As the
residence time increased (dilution rate decreased), the specific growth rate decreased while the
specific death rate increased. Furthermore, at high dilution rates, large changes in the growth
rate resulted in only minor changes in the death rate. This contrasts with the lower dilution rates
110
0.025
=- 0.020
: 0.015
cam
o 0.010
0 0.0050
0.0
0 0.005 0.01 0.015 0.02 0.025
Dilution Rate (hr-1)
Figure 5-1. Specific growth and death rates versus dilution rate. The specific growth and
death rates for the Chinese hamster ovary cell continuous cultures were determined using
equations 4.4 and 4.5. As the dilution rate decreased, the death rate increased resulting in lower
viabilities at these higher residence times.
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which showed large increases in the death rates with only minor changes in the growth rates.
This phenomenon has been described in the literature before (Hayter et al., 1993; Lee et al.,
1995). Metabolite production and consumption rates were calculated using equation 4.7 and are
summarized in Table 5-1 along with the calculated biomass demands. A significant amount of
cell aggregation was observed, particularly at the low dilution rates, and the dry cell weight was
measured in an effort to obtain accurate biomass concentrations. The errors presented in the
table are the propagated errors that include not only metabolite measurement errors but biomass
concentration and dilution rate errors as well. The cellular consumption of peptides was
measured due to the presence of 2.5 g/L of peptide hydrolysate in the medium (Nyberg et al.,
1999a). In addition, the biosynthesis demands for each amino acid were considered in the
calculation of each of these values. Therefore, the final values are the metabolite production and
consumption rates directly affecting the metabolic network shown in Figure 4-1.
The consistency of the data was evaluated by calculating the consistency index values (h)
listed in Table 5-2 as described previously (Nyberg et al., 1999a; Zupke and Stephanopoulos,
1995a). The first and third glucose limited steady states as well as the glutanmine limited steady
state initially failed the consistency check. However, these data sets became consistent upon the
elimination of specific measurements. In particular, the glucose limited steady state became
consistent after the elimination of the oxygen measurement. Furthermore, the third glucose
limited and the glutamine limited steady states became consistent upon the elimination of the
leucine consumption rate. The error in the leucine consumption rate was connected to the OUR
and CER measurements and TCA cycle flux as described in Nyberg et al. (Nyberg et al., 1999a).
The final calculated metabolic fluxes were obtained for these data sets after the elimination of
each of these inconsistent measurements.
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Table 5-1. Measured metabolite production and consumption rates (mmole/gDcw d). Tlse
values were calculated taking into consideration the biosynthesis demand for amino acids .d
other metabolites. Positive values indicate metabolite production whereas negative values
indicate metabolite consumption.
Metabolite Steady State Steady State Steady State Steady State Steady State
Glc-limited 1 Glc-limited 2 Glc-limited 3 Glc-limited 4 Gn-limited
Glucose
Lactate
CO 2
02
Ala
Asn
Asp
Gln
Glu
Gly
Ile
Leu
Lys
Pro
Ser
Thr
Val
Biomass
AcetylCoA
a-KG
CO 2
G6P
GAP
NADH
OAA
R5P
-2.71_-0.15
0.87±0.35
15.89+1.37
-20.54±1.46
0.52+0.04
-0.25+0.02
0.00±0.02
-2.31+0.14
0.05_0.02
0.09±0.04
-0.06+0.02
-0.15+0.03
0.01l0.11
0.27±0.03
0.36+0.03
0.05±0.02
-0.01+0.04
4.296
-0.354
-0.035
0.248
0.226
-0.346
0.094
0.188
-1.71-+0.10
0.22-0.09
17.23±1.30
-15.52±1.30
-0.17-+0.02
-0.23-0.03
-0.06_+0.02
-1.67±0. 10
-0.02-+0.01
0.06+0.03
-0.11+0.02
-0.29±0.02
0.06±0.05
0.09±0.03
0.19±0.02
0.04±0.01
-0.12_0.02
4.296
-0.354
-0.035
0.248
0.226
-0.346
0.094
0.188
-1.28-+0.04
0.04±0.11
14.15+0.77
-13.76+0.76
-0.16_-0.02
-0.21+0.02
0.00±0.02
-1.25+0.06
0.08+0.02
0.17+0.03
-0.07+0.01
-0.21-+0.01
-0.01+0.05
0.04+0.02
0.15+0.02
0.06+0.02
-0.07+±0.02
4.296
-0.354
-0.035
0.248
0.226
-0.346
0.094
0.188
-1.27±0.06
-0.08_-.02
12.82+0.85
-12.70±1.04
-0.22+0.02
-0.19+0.02
-0.01+0.02
-1.18_-0.07
0.10±0.01
0.22±0.05
-0.07-0.01
-0.22+0.02
0.010.14
0.04_0.07
0.15±0.02
0.08±0.01
-0.07-0.02
4.296
-0.354
-0.035
0.248
0.226
-0.346
0.094
0.188
-8.14-+035
9.19±0.49
i8.68±1.15
.16.02±1.09
0.07+0.03
-0.26-0.03
-0.19-+0.03
-0.04+0.03
-0.27+0.03
-0.05+0.04
-0.13+0.02
-0.34+0.03
-0.04+0.05
0.02+0.06
0.06+0.04
0.04±0.02
-0.13+0.02
4.296
-0.354
-0.035
0.248
0.226
-0.346
0.094
0.188
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Table 5-2. Calculated consistency index values. Consistency index (h) values were calculated
to determine the consistency of the metabolite production and consumption rate data sets.
Values lower than the 2 distribution value (90% confidence interval, 2 degrees of freedom)
indicate that the data set was consistent. The three data sets that were inconsistent were modified
through the elimination of the specified measurements resulting in consistent data sets (90%
confidence interval, 1 degree of freedom).
Steady State h Z2 Pass / Fail
Glc-limited 1 22.04 4.60 Fail
-OUR 0.60 2.71 Pass
Glc-limited 2 0.02 4.60 Pass
Glc-limited 3 13.84 4.60 Fail
-leucine 0.03 2.71 Pass
Glc-limited 4 1.31 4.60 Pass
Gin-limited 1 6.53 4.60 Fail
-leucine 0.08 2.71 Pass
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Metabolic fluxes for the network in Figure 4-1 are listed in Table 5-3 for each of the five
steady states. The four glucose limited steady states demonstrated that as the specific growth
rate was decreased, several key metabolic fluxes varied uniquely as shown in Figure 5-2. The
flux of pyruvate into the TCA cycle via pyruvate dehydrogenase (PDH) decreased, but at a rate
lower than that for the influx of pyruvate from glycolysis. This variation in the slopes of the
best-fit lines in Figure 5-2 indicates that the flux distribution around pyruvate changes as a
function of growth rate with the TCA recycle flux showing the least amount of variation with the
growth rate. Figure 5-3 illustrates these flux distribution changes more clearly, and figure 5-3b
shows values for the ratios of several calculated metabolic fluxes around the pyruvate
branchpoint. As mentioned previously, pyruvate is a key branchpoint in central carbon
metabolism linking glycolysis with the TCA cycle, overflow metabolism, and transamination
reactions. As mentioned in chapter four, it has been shown through theoretical analysis to be the
main link metabolite in this biochemical reaction network (Simpson et al., 1999). Plotted in
figure 5-3b are the ratios of the sum of the glycolytic flux (reaction 3) plus the TCA recycle flux
(reaction 12) divided by the TCA cycle inlet flux (reaction 6) as a function of specific growth
rate. For this ratio, deviations from the value of unity are indicative of waste metabolite
production (lactate and alanine). Therefore, high values of the ratio correspond to a large
amount of carbon influx, secretion of large amounts of lactate and alanine, and a small carbon
flux entering the TCA cycle. Lower values, however, correspond to more efficient utilization of
pyruvate for energy generation in the TCA cycle. As the dilution and specific growth rates
decreased for the four glucose limited steady states, the pyruvate ratio decreased indicating a flux
distribution shift around pyruvate. This shift involves the shuttling of more pyruvate carbon into
the TCA cycle as opposed to being converted to lactate. The two lowest steady states were
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Table 5-3. Calculated metabolic fluxes (mmole/g viable DCW). The metabolic fluxes were
calculated using equation 4.11 and the data listed in Table 5-1.
Reaction Steady Steady Steady Steady Steady
State State State State State
Glc-lim 1 Glc-lim 2 Glc-lim 3 Glc-lim 4 Gln-lim
1 Glc -- G6P 4.96 4.05 3.80 4.26 13.67
2 G6P - 2 GAP 4.52 3.62 3.37 3.82 13.24
3 GAP --> Pyr 7.98 6.42 5.56 6.23 26.22
4 Pyr ---> Lac 1.89 0.51 0.11 -0.27 15.44
5 G6P -> BiomassRsp + CO2 0.19 0.19 0.19 0.19 0.19
6 Pyr -> AcCoA + C0 2 9.53 11.50 10.37 11.95 12.55
7 Pyr + Glu --> ocKG + Ala 0.95 -0.41 -0.47 -0.75 0.12
8 OAA + AcCoA - - 6.03 9.24 8.17 10.68 10.33
ocKG + CO 2
9 aKG -> SuCoA + CO2 10.02 13.40 11.88 14.58 11.18
10 SuCoA --> Fum 10.05 13.85 12.08 14.79 11.55
11 Fum ---> OAA 10.05 13.85 12.08 14.79 11.55
12 OAA --> Pyr + CO 2 4.38 5.18 4.44 4.70 1.89
13 Gln --> Glu 4.67 4.51 4.33 4.60 0.50
14 Glu -- ocKG 2.31 4.29 3.50 3.78 1.12
15 GAP + Glu - Ser + cKG 0.66 0.45 0.46 0.49 0.11
16 GAP + Glu - Gly + KG 0.17 0.15 0.49 0.70 -0.09
17 Lys -4 2 AcCoA + 2 CO2 -0.05 -0.14 0.04 0.30 0.07
18 Ile -- AcCoA + SuCoA 0.11 0.25 0.19 0.23 0.22
19 Leu --> 3 AcCoA 0.27 0.69 0.61 0.73 0.57
20 Glu --> Pro 0.49 0.20 0.12 0.08 0.03
21 Thr ---> SuCoA -0.09 -0.10 -0.19 -0.26 -0.06
22 Val ---> SuCoA + CO2 0.01 0.29 0.20 0.24 0.21
23 OAA + Gin --> Asn + cKG -0.45 -0.54 -0.62 -0.65 -0.44
24 OAA + Glu -> Asp + caKG 0.00 -0.13 0.00 -0.03 -0.32
25 G6P --> BiomassG6p 0.25 0.25 0.25 0.25 0.25
26 GAP -> BiomassGAp 0.23 0.23 0.23 0.23 0.23
27 AcCoA - BiomassAccA 4.31 4.29 4.30 4.28 4.30
28 BiomassKGO -- ccKG 0.35 0.35 0.35 0.35 0.35
29 OAA ---> BiomassoAA 0.09 0.09 0.09 0.09 0.09
30 CO2 -> Biomassco2 -0.22 -0.22 -0.22 -0.22 -0.22
31 NADH --> BiomassNADH 5.38 5.38 5.38 5.37 5.38
32 0.5 02 + 3 ADP + NADH - 40.40 56.32 50.43 63.56 55.09
3 ATP + NAD+
33 0.5 02 + 2 ADP + FADH 2 - 10.39 14.94 13.12 16.29 12.63
2 ATP + FAD
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Figure 5-2. Calculated metabolic fluxes (mmole/gDcw hr) versus growth rate. Metabolic
fluxes decrease as the growth rate decreases. However, these fluxes decrease at different rates,
and the glycolytic metabolic flux drops faster than the TCA cycle flux.
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Figure 5-3a,b. Metabolic flux distribution around the pyruvate branchpoint. The values
plotted in (5-3b) are the ratio of the sum of glycolytic flux (reaction 3) and the TCA recycle flux
(reaction 12) divided by the TCA cycle inlet flux (reaction 6), (reactions shown in 5-3a).
Deviations from unity represent waste metabolite (lactate and alanine) production. High values
of the ratio indicate a condition of high waste metabolite production, whereas lower values
indicate more efficient utilization of pyruvate carbon. The metabolic flux distribution around
pyruvate shifted with a higher fraction of pyruvate flowing into the TCA cycle as the growth rate
decreased. The condition of lactate consumption (ratio less than 1.0) coincided with a noticeable
increase in the death rate and decrease in culture viability.
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also situations in which the medium lactate was consumed with a significant increase in the
cellular death rate (pyruvate flux ratio less than unity; Figure 5-3b). This net lactate
consumption was a result of the fact that the peptide hydrolysate present in the medium
contained a small amount of lactate.
The glutamine limited steady state resulted in a higher glucose consumption and lactate
production with a higher glycolytic activity as demonstrated by the inefficient metabolism as
measured using the technique described in Figure 5-3. The ratio described in Figure 5-3 was
calculated to be 2.23 or almost twice the value for the high growth rate steady state under
glucose limited conditions. Glucose limitation clearly has a stronger effect on the flux
redistribution around pyruvate.
5.3 Discussion
The data presented in this chapter demonstrate that cells underwent changes in their
metabolic flux distribution and physiological state in response to progressively lower dilution
and growth rates until reaching a point of high cellular death. At the progressively lower growth
rates, the utilization of pyruvate carbon became more efficient with more pyruvate flowing into
the TCA cycle for respiration and biomass production. This adaptation enabled the cells to
maintain energy production as well as meet the requirements for cell biosynthesis.
These results match the behavior observed in batch and fed-batch cultures. At high
growth rates, a significant amount of lactate is produced indicating that the TCA cycle is not
extremely active and does not demand much pyruvate carbon for energy production. However,
over the course of a culture, the lactate to glucose ratio decreases indicating that metabolism is
becoming more efficient with more pyruvate carbon flowing into the TCA cycle (Glacken et al.,
1986; Hansen and Emborg, 1994; Hassell et al., 1991; Lanks and Li, 1988; Xie, 1997). Feeding
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low amounts of glucose and glutamine substrate also results in a lowered lactate to glucose ratio
indicating that TCA cycle demand for carbon is a major determinant for byproduct production as
demonstrated in the comparison between the glucose and glutamine limited steady states
(Glacken et al., 1986; Ljunggren and Higgstr6m, 1994; Xie, 1997). In addition, lactate
consumption correlates with the time in a culture at which the cell death rate becomes significant
(Xie, 1997).
These results reveal an operating window one should maintain when growing this cell
line. Cells should be maintained at a growth rate that is not too high which results in inefficient
metabolism but also not too low resulting in cell death. In addition, the fact that flux distribution
can change significantly around pyruvate as a function of both the growth rate and the culture
limiting substrate indicates the flexibility of this metabolic node. However, the pyruvate node is
not completely flexible due to the extensive regulation of the pyruvate dehydrogenase complex
(PDH) (Behal et al., 1993). Therefore, this node could be classified as a weakly rigid node that
is dominated by PDH activity (Stephanopoulos and Vallino, 1991). PDH is one of the most
complex enzymes known, and the PDH enzyme complex consists of sixty subunits, three
different enzyme groups, and several separate regulatory proteins and requires five different
coenzymes (Lodish et al., 1995). PDH is regulated through separate enzymes involving both a
kinase (inactivates PDH) and a phosphatase (activates PDH) that are in turn regulated by NADH,
ATP, pyruvate, and acetyl CoA. Figure 5-4 illustrates the enzymes around the pyruvate
branchpoint. Lactate dehydrogenase, malic enzyme, pyruvate kinase, and transaminase are not
nearly as regulated as pyruvate dehydrogenase. The flux distribution around pyruvate in cultured
mammalian cells appears to be dominated by the activity of PDH. Typically, only a minimal
amount of pyruvate is allowed through PDH resulting in excess pyruvate flowing through lactate
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Figure 5-4. Pyruvate branchpoint flexibility. The pyruvate branchpoint is a weakly rigid
branchpoint. A significant amount of the regulation around pyruvate occurs at the pyruvate
dehydrogenase complex, and this enzyme dominates the partitioning of metabolic flux.
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dehydrogenase. However, since the TCA cycle generates a significant amount of energy due to
the more efficient respiration process, enhancing the metabolic flux to the TCA cycle in the
pyruvate branchpoint could result in increased cellular energy and biomass production.
Engineering the metabolic flux distribution around this branchpoint would be a difficult if
not impossible task. Even with enzymes that are easy to transfect and overexpress within a cell
line, metabolic engineering oftentimes results in little enhancement of the desired metabolic flux
(Bailey, 1999). An easier solution would be to define cell culture operating conditions that
would cause the cells to increase their PDH activity while continuing to grow at a high rate. This
form of inverse metabolic engineering involves the identification of environments that result in a
desired phenotype, and this strategy has proven to be an effective method to enhance desired
traits in cultured cell lines (Bailey et al., 1996).
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6. STEADY STATE MULTIPLICITY IN HYBRIDOMA CONTINUOUS CULTURE
6.1 Introduction
The previous chapter demonstrated the importance of the pyruvate branchpoint in the
identification of cellular phenotypes associated with efficient metabolic patterns. The PDH
enzyme was identified as a potential site for metabolic engineering techniques. However,
inverse metabolic engineering could provide a more useful method for enhancing this cellular
flux by identifying operating conditions that lead to enhanced PDH activity.
Metabolic flux analysis was applied to elucidate the physiological state of hybridoma
cells at different continuous culture steady states. Of particular interest is the observed steady
state multiplicity, whereby drastically different cell concentrations were observed under the same
dilution rate. The specific steady state obtained depended on the operating path that was
followed in reaching the steady state. Metabolic flux analysis applied to these multiple steady
states provided a framework for the rational integration of a multitude of metabolic rate data and
also showed that cell concentration multiplicity was the result of physiological state multiplicity,
as measured by the fraction of carbon flux shuttled into the TCA cycle for energy generation.
Elucidation of cellular physiological states provided the basis for designing operating and cell
strain selection strategies to reproduce the high efficiency physiological states in industrial cell
applications.
6.2 Results
The total and viable cell concentrations, as well as the dilution rate for the continuous
culture run are presented in Figure 6-1. Cell physiology of each of the five steady states was
characterized by analyzing the last few data points in each of the sections marked as A, B, C, D
and E on Figure 6-1. After the reactor run was initiated, the dilution rate was set at 0.04 hr-'. At
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Figure 6-1. Cell concentration and dilution rate versus time. Viable (open circles) and total
(closed circles) cell concentrations for the hybridoma continuous culture run as well as the
dilution rate for each time period. The five sections marked A, B, C, D, and E represent the five
time periods with different dilution rates. Flux analysis was carried out for the last few data
points in each time period.
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Figure 6-2. Cell viability versus time for each time period. The five sections marked A, B,
C, D, and E represent the five time periods with different dilution rates. Flux analysis was
carried out for the last few data points in each time period.
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each dilution rate, the reactor was determined to be at steady state after five residence times as it
satisfied the steady state criteria previously mel:ioned. The dilution rate was decreased in
increments of 0.01 hr' for each of the next three steady states after a steady state had been
reached. At the end of the period corresponding to a dilution rate of 0.01 hr', the dilution rate
was stepped back up to 0.04 hr '1 over a period of approximately 100 hours. The viable cell
density ranged from 5*105 to 9*105 cells!ml in the first four steady states (A, B, C, and D) and
increased further to 1.3*106 cells/ml upon return to a dilution rate of 0.04 hr'1 in the last steady
state (E). Even though the dilution rates for steady states A and E were the same, the viable cell
concentrations for steady state E were approximately two-fold higher compared to steady state
A. Therefore, the culture can reach different viable cell concentrations at the same operating
conditions, indicating steady state multiplicity. Figure 6-2 shows the cell viabilities for the
various steady states. As the dilution rate decreases, the viability drops, ranging from 95% to
approximately 42% at the lowest dilution rate examined. Upon stepping the dilution rate back up
to 0.04 hr-', the viability returned to 95% similar to that obtained at the first steady state (A).
The specific cell growth rates and death rates calculated from equations 4.4 and 4.5 for
the five steady states are shown in Figure 6-3. As the dilution rate decreased, the specific growth
rate decreased while the specific death rate increased. At a hybridoma steady state, a condition
of abortive proliferation eventually is reached where cell growth is exactly balanced by cell death
and cell dilution at steady state as described previously by Chung et al. (Chung et al., 1998) for
this cell line. Most of the death occurring at the low dilution rates was by apoptosis as shown in
Figure 6-4. Most of the apoptotic cells were found to be in the late apoptotic phase (data not
shown) which explains the agreement between the fraction of apoptotic cells measured by
acridine orange / ethidium bromide with the fraction of dead cells determined by trypan blue.
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Figure 6-3. Specific growth and death rates versus dilution rate. The specific growth and
death rates were determined using equations 4.4 and 4.5. As the dilution rate decreased, the
death rate increased resulting in lower viabilities at these higher residence times.
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Figure 6-4. Acridine orange / ethidium bromide stain for each steady state. Nearly identical
death characteristics were observed for steady states A and E. Also, apoptosis was the
predominant type of death for the low growth rate steady states.
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The specific productivity of IgG is shown in Figure 6-5. An intermediate dilution rate
(steady state B) yielded the largest specific productivity compared to the other steady states. As
the dilution rate was reduced to 0.02 and further to 0.01 hr-', the specific productivity also
decreased and remained low, even after the dilution rate had been increased back to 0.04 hr'
(steady state E). Even though the specific productivity was lower compared to steady state A,
the final product concentration was higher for steady state E due to the higher cell concentration
at this steady state (data not shown). The observation of an increasing specific productivity at
lower dilution rates has been recorded (Linardos et al., 1991). However, in the case of CRL-
1606 cells, a maximum specific productivity is obtained at an intermediate growth rate. One
possible explanation may be that previous work did not investigate dilution rates and cell
viabilities as low as the one presented here. However, the maintenance of the low specific
productivity upon return to the high dilution rate steady state of 0.04 hr- was never observed in
previous continuous culture experiments. The fact that in the experiment reported here the
specific productivity was not found to be a function of the specific growth rate suggests that
metabolism and other factors may play a role in IgG productivity.
Metabolite production and consumption rates calculated using equation 4.7, as well as
calculated biomass demands are summarized in Table 6-1. The errors presented in the table are
the propagated errors that include not only metabolite measurement errors but cell concentration
and dilution rate errors as well. In addition, the biosynthesis demands for each amino acid were
considered in the calculation of each of these values. Therefore, the final values are the
metabolite production and consumption rates directly affecting the metabolic network shown in
Figure 4-1.
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Figure 6-5. Specific productivity of the IgG product for each steady state. A maximum
specific productivity was achieved at the intermediate growth rate in steady state B. The
subsequent reduction in specific productivity observed at the lower growth rates was maintained
at the last steady state (E). However, the final product concentration was higher in steady state E
as compared to steady state A due to the differences in cell density (data not shown).
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Table 6-1. Measured metabolite production and consumption rates (*10-10 mmole/viable
cel/hr). These values were calculated taking into consideration the biosynthesis demand for
amino acids and other metabolites. Positive values indicate metabolite production whereas
negative values indicate metabolite consumption.
Metabolite Steady State Steady State Steady State Steady State Steady State
A B C D E
-3.54_-0.32
6.71+0.61
2.28±0.21
-2.69+0.24
0.13+0.01
-0.04+0.03
0.00±0.00
-0.38+0.10
0.01±0.01
0.07+0.00
-0.13+0.04
-0.12-+0.04
-0.09-+0.10
-0.02+0.11
-0.02±0.03
-0.03+0.03
-0.10-+0.03
0.66±0.05
-0.12+0.01
0.01-0.00
0.05+0.00
0.06+0.00
0.83-0.06
0.04+0.00
0.07_0.01
-3.62+0.52
7.23+0.79
3.57±0.41
-3.41-0.39
0.12+0.01
-0.04+0.03
-0.01+0.02
-0.35+0.09
-0.05+0.02
0.05±0.01
-0.14+0.03
-0.13+0.04
-0.16_0.09
-0.03-0.10
-0.02+0.02
-0.05+-0.02
-0.11+-0.02
0.55+0.06
-0.10_0.01
0.01+0.00
0.04_0.00
0.05±0.01
0.69+0.07
0.04_0.00
0.06-0.01
-1.81_0.20
2.70+0.31
3.40_+0.41
-3.92±+0.47
0.03_0.00
-0.02+0.01
0.01±0.00
-0.12-+0.03
0.03_0.00
0.02±0.00
-0.08_0.01
-0.08_0.02
-0.05_0.03
-0.03+0.03
-0.02_0.01
-0.01±0.01
-0.05+0.01
0.39_0.04
-0.07_0.01
0.01_0.00
0.03_0.00
0.03_0.00
0.49_0.05
0.03_+0.00
0.04_0.00
-1.21_+0.15
1.63-0.14
3.02+-0.24
-3.54+0.28
0.01±+0.00
-0.01_+0.01
0.00±0.00
-0.06+0.02
0.01+-0.00
0.01_0.00
-0.05-0.01
-0.05±+0.01
-0.03+0.02
-0.02+0.02
-0.02_0.01
-0.02_+0.01
-0.04_0.01
0.36±0.02
-0.07+0.00
0.01+0.00
0.03+0.00
0.03_0.00
0.45_0.03
0.02+0.00
0.04_0.00
-3.89+0.37
5.71_0.54
3.10±+0.31
-3.53_0.36
0.06±0.01
-0.03±_0.02
-0.02+-0.01
-0.21_0.05
-0.04-0.01
0.00±+0.00
-0.11_-0.02
-0.10_0.02
-0.10±0.05
-0.04_0.05
-0.08_+0.02
-0.02_0.01
-0.08_0.02
0.64±0.06
-0.12_0.01
0.01_+0.00
0.05_0.00
0.05_0.00
0.80±0.07
0.04+0.00
0.07-0.01
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Glucose
Lactate
CO2
02
Ala
Asn
Asp
Gin
Glu
Gly
Ile
Leu
Lys
Pro
Ser
Thr
Val
Biomass
AcetylCoA
a-KG
CO2
G6P
GAP
NADH
OAA
R5P
The consistency of the data was evaluated by calculating the consistency index values (h)
listed in Table 6-2 as described previously (Nyberg et al., 1999a; Zupke and Stephanopoulos,
1995a). All of the consistency indexes passed the X2 distribution test with a 90% confidence
interval indicating that all data sets are consistent and unlikely to contain gross measurement
errors.
Metabolic fluxes for the network in Figure 4-1 are listed in Table 6-3 for each of the five
steady states. At the first four steady states (A, B, C, and D), as the specific growth rate was
decreased, the glycolytic flux decreased. Additionally, the flux of pyruvate into the TCA cycle
increased, but the flux of glutamine was reduced. The consumption of branched chain amino
acids (lysine, isoleucine, and leucine) was reduced as well at the lower growth rates.
Flux distributions varied for the different steady states, and Figure 6-6 shows values for
the ratios of several calculated metabolic fluxes around the pyruvate branchpoint. Plotted in
Figure 6-6 are the ratios of the sum of the glycolytic flux (reaction 3) plus the TCA recycle flux
(reaction 12) divided by the TCA cycle inlet flux (reaction 6) as a function of specific growth
rate. High values of this ratio represent a large amount of carbon influx with the secretion of
large amounts of lactate and alanine. Only a small amount of carbon flux enters the TCA cycle.
Conversely, lower values represent the more efficient metabolic states with high TCA cycle
activity. As the dilution and specific growth rates decreased at the first four steady states, the
pyruvate ratio decreased indicating a flux distribution shift around pyruvate shuttling more
pyruvate carbon into the TCA cycle as opposed to being converted to lactate. Upon return to a
high dilution rate at the fifth steady state (E), cells maintained this efficient utilization of
pyruvate in contrast to the physiology observed at steady state A. The fact that more pyruvate
was shuttled into the TCA cycle for steady state E as opposed to being converted to lactate as in
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Table 6-2. Calculated consistency index values. Consistency index (h) values were calculated
to determine the consistency of the metabolite production and consumption rate data sets.
Values lower than the X2 distribution value (90% confidence interval) indicate that the data set
was consistent.
h Z2 Pass / Fail
Steady State A 0.68 4.60 Pass
Steady State B 0.74 4.60 Pass
Steady State C 0.43 4.60 Pass
Steady State D 2.10 4.60 Pass
Steady State E 3.93 4.60 Pass
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Table 6-3. Calculated metabolic fluxes (*10'10 mmole/viable cell/hr). Metabolic fluxes
calculated using equation 4.11 and the data listed in Table 6-1.
Reaction Steady Steady Steady Steady Steady
State State State State State
A B C D E
I Glc - G6P 3.53 3.63 1.81 1.21 3.84
2 G6P 2 GAP 3.38 3.52 1.73 1.16 3.56
3 GAP -- Pyr 6.64 6.98 3.42 2.29 7.03
4 Pyr -- Lac 6.72 7.24 2.70 1.62 5.74
5 G6P --- BiomassRsP + CO2 0.08 0.06 0.04 0.03 0.12
6 Pyr - AcCoA + C0 2 0.36 0.59 0.89 0.81 1.15
7 Pyr + Glu -- aKG + Ala 0.13 0.12 0.03 0.01 0.09
8 OAA + AcCoA -- 0.42 0.66 1.06 0.96 0.91
cKG + CO2
9 KG --- SuCoA + CO 2 0.86 1.25 1.21 1.06 1.06
10 SuCoA Fum 1.11 1.50 1.37 1.23 1.12
11 Fum - OAA 1.09 1.52 1.36 1.21 1.07
12 OAA - Pyr + CO2 0.59 0.97 0.21 0.16 -0.02
13 Gln --) Glu 0.38 G.42 0.12 0.05 0.14
14 Glu - cKG 0.16 0.40 0.04 0.03 0.03
15 GAP + Glu - Ser + aKG -0.01 -0.02 -0.01 -0.01 -0.05
16 GAP + Glu - Gly + aKG 0.08 0.04 0.03 0.02 0.03
17 Lys -> 2 AcCoA + 2 CO, 0.12 0.10 0.09 0.09 0.09
18 Ile -- AcCoA + SuCoA 0.13 0.11 0.10 0.08 0.07
19 Leu --- 3 AcCoA 0.12 0.10 0.09 0.08 0.06
20 Glu - Pro -0.01 -0.03 -0.03 -0.02 0.00
21 Thr -- SuCoA 0.03 0.05 0.01 0.02 -0.01
22 Val - SuCoA + CO2 0.10 0.09 0.07 0.07 0.05
23 OAA + Gln -- Asn + aKG -0.03 -0.06 -0.01 0.01 0.02
24 OAA + Glu -- Asp + aKG 0.02 -0.03 0.02 0.02 0.02
25 G6P --> BiomassG6p 0.06 0.04 0.03 0.02 0.10
26 GAP -- BiomassGAp 0.06 0.05 0.03 0.03 0.08
27 AcCoA --> BiomassAcCoA 0.67 0.55 0.39 0.36 0.66
28 BiomassaKG -> cXKG 0.10 0.12 0.06 0.05 0.06
29 OAA -- BiomassoAA 0.07 0.01 0.05 0.05 0.09
30 CO 2 -- Biomassco2 0.03 -0.01 0.02 0.03 0.03
31 NADH -- BiomassNADH 0.83 0.70 0.48 0.44 0.80
32 0.5 02 + 3 ADP + NADH -- 3.79 4.97 6.08 5.49 5.64
3 ATP + NAD+
33 0.5 02 + 2 ADP + FADH 2 - 1.58 1.90 1.73 1.55 1.39
2 ATP + FAD
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Figure 6-6. Metabolic flux distribution around the pyruvate branchpoint. The values
plotted in (6-6) are the ratio of the sum of glycolytic flux (reaction 3) and the TCA recycle flux
(reaction 12) divided by the TCA cycle inlet flux (reaction 6). Deviations from unity represent
waste metabolite (lactate and alanine) production. High values of the ratio indicate a condition
of high waste metabolite production, whereas lower values indicate more efficient utilization of
pyruvate carbon. For the first four steady states when the growth rate was progressively reduced,
the metabolic flux around pyruvate was redistributed in favor of more efficient metabolism. This
efficient metabolism was maintained during the subsequent increase in growth rate to the final
steady state (E).
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steady state A, explains the nearly two-fold increase in cell concentration for steady state E. In
addition, less branched chain amino acids and glutamine were metabolized in the TCA cycle for
steady state E as compared to steady state A. In short, flux analysis reveals a more efficient
utilization of substrate carbon associated with steady state E which was reached after the cells
were first adapted to lower growth rate conditions.
6.3 Discussion
The data presented in this chapter demonstrate that two steady states can be obtained for
the same dilution rate, exhibiting similar specific growth rates and cell viabilities but drastically
different cell densities and metabolic flux distributions. After the first high dilution steady state
(A), cells underwent changes in their metabolic flux distribution in response to progressively
lower dilution and growth rates until reaching a point of near abortive proliferation (D). At the
progressively lower growth rates, the utilization of pyruvate carbon became more efficient with
more pyruvate flowing into the TCA cycle. This adaptation enabled the cells to maintain energy
production as well as meet the requirements for cell biosynthesis at the last high dilution steady
state (E). This efficient metabolic pattern was maintained resulting in a higher cell density.
The observation of multiple steady states with different metabolic flux distributions was
observed previously by Hayter et al. (Hayter et al., 1992a). This glucose limited continuous
culture of Chinese hamster ovary (CHO) cells was grown under varying glucose concentrations.
The first and last steady state sections of the run were performed at a glucose concentration of
2.75mM. Although the glucose uptake rates for these two sections were similar, the specific
lactate production rates differed by nearly a factor of two. This demonstrates that this cell line
also underwent a metabolic shift to a metabolically more efficient state where less glucose
substrate carbon was released as lactate. Although the cell densities in these two cases did not
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vary by a significant amount, this may have been due to the low growth rate and the fact that
these cultures were glucose limited and unable to consume higher amounts of this substrate for
biomass production.
The metabolic shifts observed in the reported continuous culture run could be due to a
favorable genetic mutation, a change in the genetic expression of particular metabolic enzymes,
or a change in the regulation of these enzymes. A favorable genetic mutation causing the higher
cell concentration and metabolic flux redistribution is highly unlikely due to the rather long time
period it would take for a favorably mutated cell to become a noticeable fraction of the reactor
cell population. For example, if an identically favorable mutation occurred in one of every 107
cells (a high mutation rate) that resulted in a growth rate advantage of 20% over the wild-type
cell line, 100 cell doublings would be required in order for the cell population to reach a
contamination level of 10%. This value increases to 199 doublings for a 10% growth rate
advantage. For the continuous run reported, doubling times ranged from 16 hours to 30 hours
yielding a total of approximately 70 cell doublings before reaching steady state E. In addition,
since selection in chemostats typically results after cells have grown for several hundred
generations (Dykhuizen and Hartl, 1983), the hypothesis that the cells in this study underwent a
favorable random mutation around the pyruvate branchpoint is unlikely.
The metabolic shift could also be due to a phenomena connected to asymmetric cell
division. At the low viability steady state (D), for every cell that divides, approximately one of
the two daughter cells must die before it can divide. One could hypothesize that the dividing cell
does not equally distribute its cellular resources to the two daughter cells but rather it favors one
over the other following a stochastic process. An unequal distribution of mitochondria could aid
in the maintenance of the culture cell population at the expense of the culture viability under the
136
more stressful environmental conditions. This increase in population heterogeneity could be
used as a way for cell populations to increase their chances for survival at the expense of
individual cell survival by attaching critical cell survival parameters to a stochastic genetic
regulatory mechanism that is induced under stressful conditions. Unequal mitochondrial
inheritance has been observed for a variety of cell types (McConnell et al., 1990; Rappaport et
al., 1998; Smirnova et al., 1998). This would also explain the increase in mitochondrial or TCA
cycle activity at the lower dilution rates. At the second high growth rate steady state (E), a cell
subpopulation with this history of adaptation to higher mitochondrial activity could maintain this
physiology as a result of the population now expressing a new genetic regulatory state
(McAdams and Arkin, 1999).
The operation pathway followed to reach steady state E suggests potential feeding
strategies and fed-batch reactor operations to achieve high cell densities. Typically, fed-batch
cultures are run under glucose and/or glutamine limitation in order to reduce the production of
toxic byproducts such as lactate and ammonia. This nutrient limitation results in lower growth
rates but more efficient substrate utilization with lower conversion of glucose into lactate (Xie
and Wang, 1994c). Alternatively, the results from this paper suggest that an initial adaptation
phase in a fed-batch could be used as a means of shifting cells to a more efficient state of
pyruvate utilization. After this adaptation is achieved, the cells could then be grown under
conditions of higher nutrient concentrations at a higher growth rate resulting in the maintenance
of the lower lactate production but with a higher viable cell concentration. This new approach
toward fed-batch operations may prove to enhance not only industrial cell culture performance
but fundamental knowledge concerning cell behavior and metabolism as well.
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The utilization of bioreactor operating conditions to induce the appearance of a desired
phenotype differs from the typical approach used in metabolic engineering to achieve modified
flux distributions. In this case, the cell concentration was doubled and flux distribution was
altered dramatically without the transfection of any enzyme involved in the altered metabolic
branchpoint. The success of this type of inverse metabolic engineering could be applied in other
situations where knowledge about the metabolic network regulatory architecture could allow for
the perturbation and adaptation of cells that express more desirable phenotypes without using
transfection techniques. In addition, knowledge concerning the physiological characteristics of
desirable phenotypes could also be used in the isolation of subpopulations that express these
desirable traits, and this strategy was employed in the experimental work covered in the next
chapter.
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7. MITOCHONDRIAL MEMBRANE POTENTIAL SORTED SUBPOPULATIONS
7.1 Introduction
The continuous culture steady state multiplicity results indicate that the enhancement of
TCA cycle activity and the flux through PDH could be beneficial for cultured mammalian cells
resulting in increased culture viable cell concentrations and viabilities. The observed changes in
metabolic flux distribution that involved a higher production of energy generated through the
oxidative phosphorylation pathway and a higher production of biomass were hypothesized to be
reproducible under either batch or fed-batch culture conditions. The oxidative phosphorylation
respiratory chain located in the inner mitochondrial membrane is a significant contributor to
cellular energy production, and therefore, the characterization of mitochondrial activity was
hypothesized to be a strategic cellular target for the development of novel strategies aimed at
improving viable cell concentration and culture viability.
The characterization of oxidative phosphorylation and TCA activity along with the
metabolic flux distribution around the pyruvate branchpoint requires metabolic flux analysis
calculations that need accurate gas exchange measurements (OUR and CER). These flux
analysis techniques, however, require extensive amounts of experimental and computational
effort. In addition, obtaining accurate redundant gas exchange measurements under transient
culture conditions is extremely difficult (Bonarius et al., 1995; Stephanopoulos et al., 1998;
Zupke and Stephanopoulos, 1995a). Therefore, a quicker technique was developed in order to
obtain data that characterize the physiological state of mitochondria in-vivo. Since oxidative
phosphorylation is driven by the proton-motive force across the inner mitochondrial membrane,
the mitochondrial membrane potential (MMP; A'm) was used as a measure of the mitochondrial
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physiological state. This membrane potential was experimentally determined using the
commonly used lipophilic cationic dye, Rhodamine 123 (Rh123). FACS techniques provided a
quick and simple method for obtaining membrane potential values for a significant number of
cells in culture resulting in a statistically significant measure of mitochondrial physiology.
Fluorescent dye characterization of ATm has been used extensively in a large number of cell
lines for mitochondrial membrane potential measurement and mitochondrial physiology analysis
(Bereiter-Hahn and Vth, 1994; Chen, 1988; Petit et al., 1990). Unlike other dyes that stain
mitochondrial membrane potential such as JC-1 and DiOC6 (see Literature Review), Rh123 has a
low toxicity at low concentrations, enabling one to stain cells and then perform long-term
experiments on these stained cells (Bereiter-Hahn and Voth, 1994; Chen, 1988).
Cells with different mitochondrial physiologies, as determined through the measurement
of ATPm, were hypothesized to have different cellular physiologies. The experimental strategy
designed to test this hypothesis consisted of several stages. The first stage involved the
development of a staining procedure using Rhodamine 123 and then checking the dye specificity
by subjecting stained cells to mitochondrial membrane uncouplers. The second stage involved
the separation of a population of stained cells using FACS techniques in order to obtain several
subpopulations of cells that varied in their mean mitochondrial membrane potential as
determined using Rh123. The third stage involved the development of methods for killing cells
through apoptosis induced through specific mechanisms. The mitochondrial membrane potential
sorted subpopulations were subjected to these apoptosis inducers, and the apoptotic death was
characterized both morphologically through the measurement of apoptosis related chromatin
condensation and also biochemically through the measurement of caspase-3 enzymatic activity.
In addition, cytochrome c was added to cytosolic extracts obtained from these apoptotic cells in
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order to obtain more insight concerning the differences between the mechanisms of apoptosis for
the various mitochondrial membrane potential sorted subpopulations.
The results from these experiments demonstrated that a population of wild-type cells
contains subpopulations that vary in their resistance to apoptosis. Furthermore, these apoptosis
resistant subpopulations could be separated based on their mitochondrial membrane potential
with significant differences between the measured membrane potentials being maintained even
after numerous generations. The differences in apoptosis resistance involved not only
morphological variances as demonstrated by their different chromatin condensation kinetics but
also biochemical variances as shown by their different caspase-3 enzymatic activities.
7.2 Results
7.2.1 Staining for Mitochondrial Membrane Potential
The hybridoma cells were stained with a final concentration of 2 gg/ml Rhodanline 123
for 10 minutes, washed with PBS, and analyzed on a FACS machine according to the procedure
described in Materials and Methods. An example histogram of the resulting cellular
fluorescence is shown in Figure 7-1. The histogram of an unstained control showed a
distribution of fluorescence values between 1 and 10 (mean fluorescence of approximately 3 to
4) whereas the stained cells resulted in a distribution of values centered above 1,000 (Figure 7-
1). In cultures with a high dead cell fraction, as measured using the trypan blue dye exclusion
method, a smaller peak was observed that had a fluorescence value distribution lower than the
viable fraction (Figure 7-1). The appearance of this lower dead cell peak has been observed
previously (Ferlini et al., 1995). The mitochondrial membrane potential was the driving force
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Figure 7-1. Rhodamine 123 staining of mitochondrial membrane potential. The hybridoma
cells were incubated with Rh123, washed, and then analyzed on a FACS. The resulting
histogram of fluorescence values is shown. A dead cell peak is observed in cultures with a low
viability as measured using the trypan blue dye exclusion method.
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Figure 7-2. Rhodamine staining of mitochondria subjected to a membrane potential
uncoupler (CCCP). The hybridoma cells were subjected to CCCP for 10 minutes and then
stained with Rh123. The resulting histograms of fluorescence values showed a dramatic drop in
Rh123 uptake indicating the specificity of Rh123 for mitochondrial membrane potential.
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behind the cellular uptake of Rhodamine 123 as demonstrated in Figure 7-2. A dramatic loss of
Rh123 uptake was observed when the cultured cells were incubated with a specific
mitochondrial membrane uncoupler, carbonyl cyanide m-chlorophenylhydrazone (CCCP), for 10
minutes at a working concentration of 2 ptg/ml. This result has been repeatedly shown in the
literature for this uncoupler as well as for a variety of other mitochondria specific depolarizing
agents (Chen, 1988; Emaus et al., 1986; Juan et al., 1994). Furthermore, researchers have
analyzed compounds that collapse the mitochondrial proton gradient (Ap) and hyperpolarize the
electrochemical potential (ATm) which result in an increased uptake of Rh123. This result
demonstrates that this stain serves primarily as an indicator of the mitochondrial membrane
potential (Am) component of the proton motive force (Emaus et al., 1986).
Although Rh123 can be used to determine the overall cellular mitochondrial activity and
membrane potential, it can not effectively distinguish between an increase in either the specific
mitochondrial activity or the overall mitochondrial mass. Other stains such as 10-n-nonyl
acridine orange are not incorporated according to the electrochemical potential but rather through
interactions with specific mitochondrial membrane proteins and lipids. Although not used in this
research, these stains could be used to determine these other mitochondrial parameters in order to
obtain more detailed data describing mitochondrial physiology (Benel et al., 1989).
7.2.2 Sorting Cells Based on Mitochondrial Membrane Potential
The low toxicity of Rh123 enables one to separate and then grow cells stained with this
dye. The Rh123 stained hybridoma cells were separated into various subpopulations using a
FACS (FACSCAN, Becton Dickinson) based on their individual fluorescence values (Figure 7-
3). These sorted mixed-culture cell subpopulations were passaged for several generations until
enough cells were grown to permit the freezing of several vials for cell bank storage. These
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Figure 7-3. FACS sorting of cells separated based on mitochondrial membrane potential.
The hybridoma cells were stained for mitochondrial membrane potential using Rh123 and then
separated into subpopulations using FACS. Here, the low (L) and high (H) fractions each
represent approximately 15% of the total population. These sorted cells were passaged for
numerous (10-20) generations and then restained with Rh123. The resulting histogram of
fluorescence values showed a distinct difference between the two subpopulations with respect to
mitochondrial membrane potential.
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passaged cells maintained a significant mitochondrial membrane potential fluorescent staining
differential, as measured by restaining with Rh123, even after passaging for approximately 10-20
generations. The sorted cell populations were named high (H) and low (L) with respect to their
mean fluorescent values when stained with Rh123. Additional enrichment was also performed
on these high and low populations in an effort to increase their mean Rh123 fluorescence
staining differential by resorting them in a FACS. In other words, the high fraction from the
high subpopulation (H) was separated and passaged, and this resulted in even higher mean
Rh123 fluorescence values and mitochondrial membrane potential differentials.
The cell populations were analyzed not only for their mean Rh123 fluorescence values
but also for their cell cycle and DNA content properties as well. Table 7-1 lists the results for
cells that were stained with propidium iodide and then analyzed using FACS to determine the
cell cycle properties for both the high (H) and low (L) populations. These cells were all taken
from cultures that were growing at mid-exponential phase. Although the two subpopulations
listed in Table 7-1 had Rh123 mean fluorescence values that differed by over one third, the cell
cycle values were virtually identical. In addition, no differences in DNA content were observed
(data not shown) indicating that the observed differences in Rh123 staining could not be
attributed to cell cycle variances or the appearance of multiple chromosomes.
7.2.3 Apoptosis Induction
Apoptosis is the primary cause of death for cultured mammalian cells (Goswami et al.,
1999; Mercille and Massie, 1994; Mosser and Massie, 1994; Simpson et al., 1998). Therefore,
the Rh123 sorted subpopulations were characterized for their differences in resistance to
apoptosis as determined by their responses to incubation with specific apoptosis inducers. A
mitochondria specific apoptosis inducer, rotenone, and another more commonly used apoptosis
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Table 7-1. Comparison of cell cycle data for MMP sorted subpopulations. Cells stained
with propidium iodide were examined using FACS. The high (H) and low (L) staining
subpopulations had similar cell cycle characteristics indicating that these cells do not vary
significantly in their DNA content or cell cycle. The relative fluorescence (mean signal to noise
ratio) for the high subpopulation was 39% higher than that for the low subpopulation.
Cell Cycle Phase Low (L) High (H)
Go/Gl 24.5 -+ 0.5 24.5 + 0.9
G2/M 13.6 + 0.6 12.5 + 0.3
S 61.9 + 1.1 63.1 ±+ 1.1
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inducer, staurosporin, were both utilized in these experiments. Numerous electron transport
chain inhibitors have been implicated in apoptosis induction (Kroemer et al., 1995; Susin et al.,
1998; Wertz and Hanley, 1996)], and rotenone specifically inhibits the NADH dehydrogenase
complex (Krippner et al., 1996; Stryer, 1988; Wertz and Hanley, 1996). Staurosporin is another
potent apoptosis inducer that is believed to inhibit protein serine / threonine kinases that affect
protein phosphorylation and survival factor signaling (Wertz and Hanley, 1996). The wild-type
unsorted hybridoma cells were subjected to each of these inducers, and the resulting kill curves
are shown in Figure 7-4 along with their point of action in the mitochondria related apoptosis
pathway. The viable and apoptotic fractions were differentiated by determining the degree of
chromatin condensation shown using the acridine orange and ethidium bromide stain described
in Materials and Methods. Since these compounds induce apoptosis within a few hours, they can
be used in experiments that are aimed at determining specific differences between apoptotic
death mechanisms and kinetics in various cell populations. This method contrasts with long-
term experiments which are subject to variable culture conditions in which additional inducers of
apoptotic death exist such as glucose and amino acid nutrient limitation or growth factor
depletion. Since the cells for these apoptosis induction experiments were taken from mid-
exponential growth cultures, these additional apoptosis inducing factors can be ruled out as
significant sources of apoptosis, leaving the apoptosis inducers as the primary source of the
observed apoptotic cell death. This was supported by the fact that virtually no apoptotic death
was observed in the uninduced control cultures.
Figure 7-5 illustrates a more specific quantitation of the effect of rotenone on viable cells
(determined using the trypan blue exclusion method). 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl
tetrazolium bromide (MTT) measures mitochondria dehydrogenase activity and has been
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Figure 7-4. Apoptosis induction using staurosporin and rotenone. The hybridoma cells were
subjected to th2se two apoptosis inducers in order to characterize the responses of the Rh123
sorted subpopulations to defined apoptotic stimuli. The specific point of action of each apoptosis
inducer within the overall apoptotic pathway is shown in the figure along with the corresponding
kill curves.
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Figure 7-5. MTT measurement of cells undergoing rotenone induced apoptosis. Cells taken
from the same culture were incubated either with or without 30 lM rotenone for two hours. The
resulting MTT assay measurement of mitochondrial dehydrogenase activity is shown for each of
the viable cells concentrations (viability was measured using trypan blue).
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used extensively to measure surviving and proliferating cells (Mosmann, 1983; Slater et al.,
1963). These results indicate that rotenone caused a dramatic loss of mitochondrial
dehydrogenase activity after the cells were incubated with rotenone for only two hours. These
results show that mitochondrial dehydrogenase activity was affected by apoptotic death and that
the trypan dye exclusion method does not necessarily correlate with the MTT method for cells
undergoing apoptosis (Knorr, 1999; Mosmann, 1983).
7.2.4 Characterizing Apoptosis for Mitochondrial Membrane Potential Sorted Cells
The Rh123 sorted hybridoma cell subpopulations were characterized for both key
morphological and biochemical features of apoptosis resulting from the apoptotic death inducers.
The cell subpopulations were all taken from frozen cell stocks and cultured until they reached
mid-exponential phase. The subpopulations were stained for mitochondrial membrane potential
using Rh123 and FACS. Then, the apoptosis inducers were added to the cultures (30 M
rotenone and 1 laM staurosporin). Dimethyl sulfoxide (DMSO) was added to the control cultures
to account for the DMSO present in the apoptosis inducer stock solutions. The apoptosis related
chromatin condensation was assessed at various time points using the acridine orange and
ethidium bromide stain. Figure 7-6 shows the compiled results from three separate experiments
for the rotenone induced apoptosis with the percentage of viable cells containing intact
chromatin plotted versus the mean Rh123 fluorescence signal to noise ratio (S/N) for the various
inoculum subpopulations. All of these mean Rh123 fluorescence values refer to the values for
the inoculum; no time course of Rh123 uptake was taken for these experiments. Initially, the
cultures all started out with a viability of approximately 95%. Even after two hours, no
significant differences between the subpopulations were observed. Beginning at four hours,
however, a significant deviation between the various subpopulations was observed. After eight
150
I rl'
I I IIt
80-
U
- 60-
fm 40-
20-
v . . . . . . . . . . . . . . . . . . . . I . . . .
500 600 700 800 900 1000
Rh 123 Relative Fluorescence of Inoculun
(Mean Signal / Mean Noise)
Figure 7-6. Apoptotic death kinetics for Rhodamine 123 sorted subpopulations subjected
to 30 lM rotenone. The hybridoma cell subpopulations were stained with Rh123 and then
analyzed on a FACS. Then, they were given either rotenone (30 AM) or DMSO (the rotenone
stock contained DMSO). The chromatin condensation apoptotic morphology was measured at
the indicated time intervals using the acridine orange and ethidium bromide stain. The Rh123
fluorescence values refer to only the initial values taken for the inoculum; no Rh123 fluorescence
value time course data was taken. This plot is a compilation of data taken from three separate
experiments.
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hours, the highest Rh123 staining subpopulation was still 70% viable as compared to the lowest
Rh123 staining subpopulation that was only 25% viable. This indicates that subpopulations with
a higher mean mitochondrial membrane potential as measured using Rh123 have an enhanced
ability to resist apoptotic death. Furthermore, these results were reproducible as demonstrated
with the cells subjected to staurosporin induced apoptosis (Figure 7-7). This result indicates that
these subpopulations vary in their resistance to multiple apoptosis inducers, and a feature of the
apoptotic pathway related to mitochondria physiology may be the source of this resistance.
Effector caspase activity causes the apoptosis related chromatin condensation
morphology. Caspase-3 has been shown to be a potent effector caspase that targets a number of
specific cellular proteins, causing a significant number of changes associated with apoptotic
death. Therefore, biochemical differences between the Rh123 sorted subpopulations were
determined by measuring the caspase-3 enzymatic activity. For this experiment, the cells were
again taken from the frozen cell stock and cultured until they reached mid-exponential phase.
The mean Rh123 fluorescence values were determined using FACS, and then the subpopulations
were subjected to each of the apoptosis inducers described previously (30 gM rotenone and 1
,gM staurosporin). After several hours (3 hours for staurosporin and 4 hours for rotenone), the
cellular apoptotic morphology was determined using acridine orange and ethidium bromide
measurement of apoptosis related chromatin condensation, and the results are shown in Table 7-2
for rotenone and Table 7-3 for staurosporin. Then, cytosolic extractions were performed for each
set of apoptosis inducers as described in Materials and Methods. The protein content of the
extracts was measured using the Bradford assay with a BSA standard. The caspase-3 enzymatic
activity was then determined colorimetrically by incubating 50 ptg of extract protein with DEVD-
pNA and then by measuring the amount of free pNA (cleaved DEVD-pNA substrate). Figure 7-
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Figure 7-7. Apoptotic death kinetics for Rhodamine 123 sorted subpopulations subjected
to 1 iM staurosporin. The hybridoma cell subpopulations were stained with Rh123 and then
analyzed on a FACS. Then, they were given either staurosporin (1 M) or DMSO (the
staurosporin stock contained DMSO). The chromatin condensation apoptotic morphology was
measured at the indicated time intervals using the acridine orange and ethidium bromide stain.
The Rh123 fluorescence values refer to only the initial values taken for the inoculum; no Rh123
fluorescence value time course data was taken. The constant value data points refer to the
controls that were not subjected to staurosporin.
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Table 7-2. Data for rotenone induced caspase-3 enzymatic activity. Cytosolic extracts were
taken from cells subjected to 30 tM rotenone for 4 hours and assayed for caspase-3 activity
using DEVD-pNA.
Low (L) High (H)
Percent Viable 76.5 92.5
(AO / EB)
Rh123 (S/N) 562 886
(Relative Fluorescence of inoculum)
Caspase-3 Activity 3.17 1.10
(gmonle / hr gprotein)
Table 7-3. Data for staurosporin induced caspase-3
were taken from cells subjected to 1 tM staurosporin
activity using DEVD-pNA.
enzymatic activity. Cytosolic extracts
for 3 hours and assayed for caspase-3
Low (L) High (H)
Percent Viable 64.5 83.5
(AO / EB)
Rh123 (S/N) 562 886
(Relative Fluorescence of inoculum)
Caspase-3 Activity 5.38 1.92
(gmole / hr Jgprotein)
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8 shows the caspase-3 enzymatic activity results for rotenone induced apoptosis and these data
demonstrate a significant difference in the enzymatic activity for this critical caspase. The fact
that the z-VAD-fmk inhibited caspase-3 activity matched the activity for the uninduced control
indicates that the extraction procedure did not inadvertently cause the activation of any caspase-3
activity. These results were also repeated in the staurosporin induced apoptosis cell extracts, and
the caspase-3 enzymatic activity is shown in Figure 7-9. Again, a significant difference in
caspase-3 activity is shown for the two Rh123 sorted subpopulations. The specific caspase-3
enzymatic activities are tabulated in Tables 7-2 and 7-3. The specific caspase-3 enzymatic
activities differ by nearly three-fold between the two subpopulations. This supports the
morphological differences observed previously and provides a more fundamental biochemical
basis for these observations.
Additional experiments were also conducted in an effort to determine more fundamental
aspects of the observed variance in apoptotic resistance for these Rh123 sorted subpopulations.
Since cytochrome c has been implicated in the activation of apoptosis and caspase activity
(Bossy-Wetzel et al., 1998; Green and Reed, 1998; Krippner et al., 1996), cytochrome c (10OM)
was added along with dATP (mM) in order to activate the apoptosome in-vitro. Figure 7-10
shows the results for cytochrome c induction of capsase-3 activity for various experimental
cases. These results indicate that caspase-3 activity was inducible in the control cells, but again
this activity was different for each of the Rh123 sorted subpopulations. In addition, extracts
taken from the Rh123 sorted cells subjected to rotenone and incubated with cytochrome c and
dATP did not yield a significant increase in caspase-3 activity.
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Figure 7-8. Caspase-3 enzymatic activity for Rhodamine 123 sorted subpopulations
subjected to 30 ptM rotenone. Cytosolic extracts were collected from cells subjected to
rotenone. The caspase-3 enzymatic activity was measured using DEVD-pNA substrate
incubated with 50 pgg of extract protein. The caspase inhibitor, z-VAD-fmk was also added to
the apoptosis induced extracts in order to demonstrate the absence of caspase activity in the
control.
156
O =k
1 c.-W0 C)"t
----------
it
n 'I
Control Induced Induced
z-VAD-fmk
Figure 7-9. Caspase-3 enzymatic activity for Rhodamine 123 sorted subpopulations
subjected to 1 M staurosporin. Cytosolic extracts were collected from cells subjected to
staurosporin. The caspase-3 enzymatic activity was measured using DEVD-pNA substrate
incubated with 50 jtg of extract protein. The caspase inhibitor, z-VAD-fmk was also added to
the apoptosis induced extracts in order to demonstrate the absence of caspase activity in the
control.
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Figure 7-10. Caspase-3 enzymatic activity for Rhodamine 123 sorted subpopulations
subjected to 30 p.M rotenone, cytochrome c, and dATP. Cytosolic extracts were collected
from cells subjected to rotenone. Cytochrome c (10 p.M) and dATP (1 mM) were preincubated
with the control and induced extracts before incubation with the DEVD-pNA substrate. Then,
the caspase-3 enzymatic activity was measured using DEVD-pNA substrate incubated with 50
glg of extract protein.
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7.3 Discussion
Apoptosis is a significant problem for mammalian cell culture (Goswami et al., 1999;
Mercille and Massie, 1994; Mosser and Massie, 1994; Simpson et al., 1998). Nutrient
limitations, death receptor activation, as well a vast number of other factors Jl1 trigger apoptotic
cell death (Simpson et al., 1998; Wertz and Hanley, 1996). Previous strategies aimed at
preventing apoptotic cell death have involved either eliminating the apoptosis triggers from the
culture environment or creating more robust cell lines through the over-expression of
antiapoptosis genes. The results from this research suggest an additional strategy. Selecting for
subpopulations present within the wild-type subpopulation that are resistant to apoptosis could
provide an additional means of reducing apoptosis in culture. As demonstrated in the research
presented in this thesis, this selection process could be based on mitochondrial properties. The
link between mitochondria and apoptosis has been established in the past several years by a
number of researchers (Green and Reed, 1998; Susin et al., 1998). The release of numerous
mitochondrial factors, such as cytochrome c, procaspases, and AIF, upon stimulation of the
apoptosis pathway in addition to the presence of Bcl-2 family members residing in mitochondrial
membranes all support the hypothesis that mitochondria play a key role in orchestrating
apoptotic death.
The results from this research support the hypothesis concerning the importance of
mitochondria in apoptotic death. Cell populations sorted based on mitochondrial membrane
potential result in subpopulations that vary in their resistance to apoptosis as determined using
both morphological and biochemical measures of apoptosis. The molecular biology behind the
differences between these subpopulations was investigated in an effort to determine the exact
molecular differences between these subpopulations through cytochrome c induction of caspase-
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3 activity. The results showed that caspase-3 activity differed even in the uninduced control
cells, suggesting an endogenous heterogeneity with respect to base cytosolic levels of
procaspase-3 . Mitochondria have been shown to contain a number of procaspases, including
procaspase-3, and one hypothesis could be that the increased level of inducible caspase-3 activity
in the control extracts was caused by mitochondria with lower membrane potential resulting in
the release of procaspase-3. Since the subpopulations originated from a single wild-type culture
and were sorted based only on their mitochondrial membrane potential, these variances are likely
related to some basic mitochondrial properties. The collapse of the mitochondrial membrane
potential and the opening of the nmitochondrial permeability transition pore may play a role in the
observed differences between these sorted subpopulations (Green and Reed, 1998). Research
has shown that the voltage-dependant anion channel (VDAC) switches between an open and
closed state when subjected to a 30 mV potential difference (Martinou, 1999). Using equation
2.1, one can approximate the potential differences measured between the mitochondrial
membrane potential sorted subpopulations by assuming that the concentration difference is the
same as the Rh123 fluorescence signal to noise ratio. For these subpopulations, these values
differ by approximately 20 mV, and this suggests that mitochondrial channels could be operating
differently for these two subpopulations.
Virtually all cell culture researchers have observed cell death heterogeneity in which
certain subpopulations of cells assume the morphological and biochemical features associated
with either necrotic or apoptotic death sooner than other subpopulations. Why do these cell
subpopulations die faster than others? This question concerning population heterogeneity is not
trivial and unimportant. Physiological heterogeneity can result from asymmetric cell division in
which membrane proteins and RNA associate with specific cellular regions before cellular
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division (Horvitz and Herskowitz, 1992; Jan and Jan, 1998). Furthermore, cells characterized by
specific morphological features can vary significantly in their functionality as demonstrated in P-
cell responsiveness to glucose levels in-vitro (Pipeleers, 1992). Additionally, organisms can
create physiological heterogeneous populations even when they are genetically identical and
grown in identical environments (Spudich and Koshland, 1976). Theoretical deterministic
models have been successfully utilized to explain population heterogeneity in a number of
biological systems (Chung and Stephanopoulos, 1996).
Heterogeneity also occurs intracellularly with respect to organelle function. For example,
within the same mitochondrial population, various subpopulations with different membrane
potentials exist. Under membrane depolarizing conditions, subpopulations of mitochondria have
been observed to maintain a high membrane potential despite the appearance of a significant
number of depolarized mitochondria. Furthermore, the physiological environment contributes to
the appearance of various classes of mitochondria that differ in mitochondrial membrane
potential even when size and density changes are considered (Cossarizza et al., 1996; Diaz et al.,
1999; Petit et al., 1990).
As was previously shown, the appearance of steady state multiplicity in continuous
culture in which drastically different cell concentrations were observed to occur at virtually
identical growth rates was attributed to physiological multiplicity as measured through the
determination of the metabolic flux distribution occurring around the pyruvate branchpoint. In
this section, sorting based on mitochondrial membrane potential led to correlations between
physiological heterogeneity, measured using Rh123, and differences in both morphological and
biochemical features associated with apoptosis. Heterogeneity clearly plays a significant role in
mammalian cell culture and could be utilized in the formulation of novel culture strategies.
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8. APPLICATIONS TO FED-BATCH CULTURE
8.1 Introduction
Industrial mammalian cell culture has typically been conducted in batch mode. However,
fed-batch cultivation has proven to be a more effective method for increasing the culture cell and
product concentrations. This bioreactor operational mode prevents nutrient depletion that
oftentimes occurs late in a batch culture. The maintenance of proper nutrient levels allows cells
to continue to grow which could result in a higher product concentration. High product titers are
desirable not just because of the obvious increase in the amount of product that can be sold but
also due to the fact that high product concentrations improve downstream separation process
efficiency. This contrasts with other operational modes, such as continuous or perfusion mode,
which produce large amounts of product but typically at low concentrations (Hu and Peshwa,
1991; Xie and Wang, 1994c).
Novel strategies have been developed as modifications of the basic fed-batch cultivation
mode. Feeding medium concentrates, utilizing stoichiometric feeding protocols, and designing
feeding strategies based on cell culture models have all been applied to fed-batch culture
processes (Glacken et al., 1989b; Hu and Peshwa, 1991; POrtner and Schafer, 1996; Xie and
Wang, 1994c). The results from the previous chapters suggest two additional novel strategies for
fed-batch culture operation. The multiple steady state continuous culture results dramatically
illustrate the potential for mammalian cells to operate at a high growth rate with an increase in
efficiency in their utilization of nutrients as demonstrated by the lower lactate production and
higher respiration. Therefore, one hypothesis would be that fed-batches that are initially put
through an adaptation phase of low nutrient feeding would increase the cellular metabolic
efficiency. Then the culture could be switched to a higher feeding rate to increase the growth
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rate while maintaining the higher metabolic efficiency. This strategy was tested using a
modification of the stoichiometric feeding strategy developed by Xie and Wang (Xie, 1997; Xie
and Wang, 1994c). The results clearly show that this new strategy resulted in a higher viable cell
concentration, culture viability, specific productivity, and culture product concentration when
compared to the conventional stoichiometric feeding method.
The second new fed-batch operational strategy involved using the mitochondrial
membrane potential sorted subpopulations in order to increase the culture viable cell
concentration. The previous results concerning the Rh123 sorted subpopulations indicate that
higher mitochondrial membrane potential subpopulations are able to resist apoptosis when
induced by specific factors under short-term conditions. Therefore, these sorted subpopulations
were hypothesized to be able to resist the other various apoptosis inducing influences present in a
typical cell culture. This strategy was implemented, and the results demonstrated that the cell
populations with a higher mitochondrial membrane potential were able to resist the general
apoptosis inducing conditions encountered during fed-batch culture. Consequently, these more
resistant cell populations reached higher viable cell concentrations and maintained culture
viabilities for an extended period of time. These results could provide for a new approach
toward culture operation in which inoculums and cultures are analyzed using FACS techniques
to determine cellular physiological states that would in-turn dictate the feeding strategy. In
addition, this method may also result in culture processes becoming more predictable in terms of
knowing relations between cellular death kinetics and cellular physiology.
8.2 Feeding Strategy and Design of Fed-batch Cultures
The first variation of fed-batch operation involved adjusting the feeding during a culture
in order to account for altered metabolic behavior with the goal of increasing the culture viable
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cell concentration and viability. The fed-batches were labeled X, X-2X, and 2X in reference
to the feeding protocol used for each culture. The X fed-batch refers to the control culture that
was fed the regular stoichiometric amount as prescribed by Xie (Xie and Wang, 1994c) and
Mo11born (Mijllborn, 1996). The 2X fed-batch refers to the second control culture that was fed
twice the stoichiometric amount. The 1X-2X fed batch refers to the experimental culture that
was initially fed the low stoichiometric amount and then later on overfed with twice the
stoichiometric amount after the mitochondrial activity was determined to be different for the two
IX and 2X control cultures. The fed batches were all inoculated with cells taken from a common
stock and suspended in IMDM medium containing low concentrations of glucose and glutamine:
glucose (IX: 1 g/L; 1X-2X: 1 g/L; 2X: 2 g/L) and glutamine (1X: 0.5 mM; lX-2X: 0.5 mM; 2X:
1.0 mM). In addition to the stoichiometric feeding of nutrients, growth factors were also fed
everyday (10 mg/L insulin and 5 mg/L transferrin) in order to prevent the possible degradation of
these medium proteins, particularly insulin, as demonstrated by Goswami (Goswami, 1998).
The viable cell concentrations and percent viabilities for these three cultures are shown in
Figures 8-1 and 8-2. In addition, the lactate/glucose ratio is shown for time points up to the point
at which the feeding rate was switched for the experimental lX-2X fed-batch. The vertical lines
on these two figures refer to the time at which the mitochondrial membrane potential was
determined (dashed line) along with the time at which the feeding rate was switched for the 1X-
2X fed-batch (solid line). The 2X culture reached the highest viable cell concentration, but this
concentration dropped rapidly after reaching this peak. The culture viability was maintained the
longest in the X-2X fed-batch with a higher viability ranging from 10 to over 40 percent over
the 2X culture. The 2X culture also had a higher lactate/glucose ratio as compared to the 1X fed
cultures which indicates that these cells growing under low nutrient levels had a more efficient
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Figures 8-1 and 8-2. Viable cell concentration and percent viability versus time for the
feeding strategy test fed-batch. The fed-batch experiment involved two control cultures (1X
and 2X) and one experimental (X-2X) culture. The term "X" refers to the fed-batch feeding
amount prescribed in the stoichiometric feeding protocol (Xie, 1997). The dashed and solid lines
refer to the times at which the MMP was measured and the time at which the feeding was
switched respectively.
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utilization of glucose as compared to the 2X culture. The IX cultures also had a 20% higher
mean Rh123 fluorescent value for the mitochondrial membrane potential as compared to the 2X
culture. The Rh123' fluorescence values along with the lactate/glucose ratios suggest that the 2X
fed-batch culture had a lower level of mitochondrial activity. The medium used in these fed-
batches was relatively rich as compared to other fed-batches, and these differences would most
likely increase under leaner medium conditions in the 1X fed-batch culture.
The glucose consumption and lactate production profiles are shown in Figure 8-3. In this
figure, the integrated viable cell density is used in order to enable one to visualize the specific
consumption and production rates (slopes in the plot). The specific lactate production rate is the
highest in the 2X fed-batch at the initial stages of the culture. As the culture progresses, the
lactate production profiles all level off, indicating that the cells have all shifted their metabolism.
The 1X-2X fed-batch, however, did continue to produce some additional lactate when the
feeding rate was switched to the 2X feeding schedule. This indicates that the metabolism of the
pre-adapted cells could still switch to a somewhat more inefficient metabolic state for a short
period of time. The lactate concentrations for the 1X and 2X all appear to drop indicating lactate
consumption. However, the 1X-2X fed-batch does not show a noticeable amount of lactate
consumption. The 2X and X-2X cultures appear to end with a similar overall yield
(lactate/glucose). However, this is misleading due to the fact that lactate was consumed in the
2X culture. The glucose consumption profiles show that the 2X fed-batch consumed the most
lactate, but the specific glucose consumption rates all appeared to be similar. The main
observation for Figure 8-3 is that the initial behavior of the metabolism for 1X fed-batches
differs from the behavior for the 2X fed-batches
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Figure 8-3. Glucose consumption and lactate production versus the integrated viable cell
concentration. The fed-batch experiment involved two control cultures (1X and 2X) and one
experimental (1X-2X) culture. The term "IX" refers to the fed-batch feeding amount prescribed
in the stoichiometric feeding protocol (Xie, 1997).
o
7:$
0
0
"-.
0-
A
ff
. V.4
a.)!:0
0
U
0 1 10 2 10" 3 10"
Integrated Viable Cell Concentration
(cells hr / ml)
Figure 8-4. Monoclonal antibody concentration versus the integrated viable cell density for
the feeding strategy test fed-batch. The fed-batch experiment involved two control cultures
(1X and 2X) and one experimental (X-2X) culture. The term "1X" refers to the fed-batch
feeding amount prescribed in the stoichiometric feeding protocol (Xie, 1997).
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The monoclonal antibody concentrations versus the integrated viable cell concentrations
for the three cultures are shown in Figure 8-4. The antibody concentration reached the highest
value of approximately 350 mg/L for both the 2X and IX-2X cultures as compared to less than
200 mg/L for the X culture. In addition, the highest specific antibody productivity occurred in
the 2X and 1X-2X fed-batches. The plots are more linear for the X and 2X fed-batches when
compared to the X-2X fed-batch, and this suggests that the switch in feeding rate had a direst
influence on the cellular specific productivity.
8.3 Rhodamine 123 Sorted Subpopulations in Fed-batch Culture
In chapter 7, subpopulations with a higher mitochondrial membrane potential, as
measured using Rh123, were demonstrated to have a higher resistance to apoptosis induced with
various compounds. This enhanced apoptosis resistance was hypothesized to be applicable in
fed-batch cell cultivation. The fed-batches were inoculated with cells that had been previously
sorted according to their Rh123 fluorescence as described in chapter 7 and Materials and
Methods. The initial and supplemental medium for these fed-batches was identical. The initial
medium was IMDM with low glucose (2mM) and glutamine (0.5mM) with 8.36 g/L of MOPS to
increase the medium buffer capacity (osmolarity adjusted accordingly). The conditioned
medium was also identical because it was prepared by mixing the conditioned medium obtained
from each of the two Rh123 sorted subpopulation inoculums. The fed-batches were fed
according to the stoichiometric feeding protocol. The 1X, 2X, and 1X-2X feeding strategies
described previously were all used to determine differences between the behavior for the Rh 123
sorted subpopulations.
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8.3.1 1X-2X Fed-batches With Rh123 Sorted Subpopulations
The results for the viable cell concentrations and culture viabilities for the X-2X fed-
batch are shown in Figures 8-5 and 8-6. The cultures labeled L and H refer to the cell
populations that have either a low or high mean Rh123 fluorescence value respectively. The fed-
batch culture with the higher mitochondrial membrane potential maintained a higher percent
viability and reached a higher viable cell concentration as compared to the low membrane
potential culture. This viability difference ranged from 10 to 20% and was maintained for a
period of almost 70 hours. The error bars on the plots refer not to the measurement error but to
the error between duplicate fed-batch cultures containing each subpopulation.
Figure 8-7 shows the mean Rh123 fluorescence values for the fed-batch cultures. The
mitochondrial membrane potential difference was maintained between the two cultures for the
entire length of the experiment. Also, the membrane potential increased at 90 hours in both sets
of cultures. This increase could potentially be attributed to a number of phenomena. However,
since this increase occurred after the onset of cell death in the culture, it could be due to the
higher death rate of subpopulations that have a lower mitochondrial membrane potential as
shown previously in the apoptosis induced death experiments. In other words, over the course of
the culture, the cell population was enriched with the higher membrane potential cells that had
the lower death rate.
The glucose consumption and lactate production profiles are shown in Figure 8-8. The
metabolic behavior for these different fed-batches does not differ significantly from one another.
This suggests that the differences in Rh123 staining indicate the ability for a cell population to
survive when apoptosis begins. In the fed-batches with different feeding strategies, differences
in Rh123 staining were observed, but this data indicates that the reverse may not be true.
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Figures 8-5 and 8-6. Viable cell concentration and percent viability versus time for
Rhodamine 123 sorted subpopulations (high (H) and low (L) MMP). The fed-batches were
fed according to the 1X-2X feeding protocol.
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Figure 8-7. Rhodamine 123 relative fluorescence values versus time for Rhodamine 123
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remained separate over the course of the experiment. In addition, the values increased when the
cells began to die.
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Figure 8-9. Monoclonal antibody concentration versus integrated viable cell density for
Rhodamine 123 sorted subpopulations (high (H) and low (L) MMP). The fed-batches were
fed according to the 1X-2X feeding protocol. The subpopulation with the higher MMP had a
lower productivity.
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Although metabolic changes involving mitochondria cause changes in Rh123 staining, these data
suggest that even without metabolic changes, the mitochondrial membrane potential could
indicate additional physiological properties of the mitochondria that are related to the cell
population's response to apoptotic stimuli.
The monoclonal antibody concentrations versus the integrated viable cell concentrations
for the 1X-2X fed-batches are shown in Figure 8-9. The specific productivity was higher for the
culture containing the low mitochondrial membrane potential subpopulation. This phenomena
has been observed previously for this same hybridoma cell line. Chang (Chang, 1994)
demonstrated that cultures subjected to sodium butyrate, a known apoptosis inducer, increased
their specific productivity despite causing lower viable cell concentrations. A lower growth rate
sometimes correlates with an increase in specific productivity. The IgG product from this
hybridoma cell is oftentimes approximately 15% of the total protein produced by the cell. One
hypothesis could be that these cells shift their protein production away from product protein and
into biomass protein in the higher Rh123 staining subpopulations.
8.3.2 1X and 2X Fed-batches With Rh123 Sorted Subpopulations
Additional data were collected for fed-batches conducted using the two control feeding
strategies that were described previously in the Feeding Strategy section (8.2). The results for
the X and 2X fed-batch culture viable cell concentrations and viabilities are shown in Figures 8-
10 and 8-12 respectfully. These figures all demonstraLe the fact that the culture inoculums with
the higher mitochondrial membrane potential subpopulations result in higher culture viable cell
concentrations and viabilities as was the case in the X-2X fed-batch cultures. Furthermore, the
drop in specific monoclonal antibody production was also observed for each fed-batch culture as
shown in Figures 8-11 and 8-13.
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Figures 8-10 and 8-11. Viable cell concentration and percent viability versus time for
Rhodamine 123 sorted subpopulations (high (H) and low (L) MMP) along with the
monoclonal antibody concentration versus the integrated viable cell density. The fed-
batches were fed according to the X feeding protocol.
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Figures 8-12 and 8-13. Viable cell concentration and percent viability versus time for
Rhodamine 123 sorted subpopulations (high (H) and low (L) MMP) along with the
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In addition, the low mitochondrial membrane potential subpopulations always consumed
lactate at the end of cultures unlike the high mitochondrial membrane potential subpopulations.
This occurred even when the viability for both subpopulations dropped to approximately the
same value. This phenomena was most dramatic in the 2X fed-batch as shown in Figure 8-14.
From 80 hours to the end of the culture, the lactate concentration dropped from 20 to 16 mM for
the L subpopulation whereas the lactate levels for the H subpopulation remained relatively
constant. Lactate consumption has been observed in a number of mammalian cell cultures, and
is generally attributed to the onset of cell death in the culture (Bibila et al., 1994; Xie and Wang,
1994c). This observation combined with the observation that cells with a higher mitochondrial
membrane potential can resist apoptosis suggest that the mitochondrial integrity changes that
occur during apoptosis may be associated with lactate consumption.
8.4 Discussion
A vast number of fed-batch feeding strategies have been proposed for mammalian cell
culture over the past twenty years. Controlling fed-batches at low glutamine and glucose levels
in order to reduce the build up of lactate and toxic ammonium has been one of the most
commons strategies proposed and applied in cell culture (Glacken et al., 1986; Ljunggren and
Haggstr/im, 1994). Medium concentrates have also been fed to cultures to improve culture
performance (Bibila et al., 1994; Zhou et al., 1995). The stoichiometric feeding protocol
developed by Xie and Wang (Xie and Wang, 1994c) and utilized in this work involved reducing
the glucose and glutamine concentrations while feeding just the amount of supplemental
nutrients required to produce biomass and protein product.
This work presents two new strategies for fed-batch operation. The first strategy involves
the optimization of the stoichiometric feeding process by taking into account the changes in
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metabolic behavior that occur over the course of a typical fed-batch. The increase in feeding rate
resulted in higher viable cell concentrations, viabilities, and productivities, and this indicates that
the stoichiometric feeding strategy may in fact lead to cell starvation and suboptimal culture
performance. Later in the culture when the metabolic behavior of the cells changes to a more
efficient utilization of glucose, cells respond positively to slight overfeeding. In addition, the
maintenance of a healthy nutrient level to avoid starvation has a higher priority over the
prevention of supposed toxic by-product build-up. Although ammonium is a definite threat to
cell survival, researchers should focus on the cellular nutrient needs and not necessarily on
lactate build-up.
The second strategy was an extension of the mitochondrial membrane potential sorted
cell population results that demonstrated increased resistance to apoptosis. The high Rh123
sorted subpopulations were able to resist the various bioreactor stimuli that cause apoptosis.
This adds yet another method one can use to prevent apoptosis in culture. The observations that
a wild-type subpopulation contains cells that vary in their resistance to apoptosis may suggest a
number of new novel views towards mammalian cell cultures. Heterogeneity will almost
inevitably occur in a culture with respect to any number of cellular properties. Physiological
heterogeneity could provide a basis for survival in which individual cell survival is not optimized
but rather the survival of the cell population is key. A cell population that has a robust ability to
survive would demonstrate heterogeneity toward a variety of death inducers with the surviving
cells determining the new population's adaptation to new environments. Understanding these
variances in responses to various bioreactor environments could be a dramatic step forward in
understanding heterogeneity with respect to bioreactor performance. Furthermore,
understanding the death kinetics for a given subpopulation may enable researchers to predict the
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death rate for a mammalian cell culture. An inoculum with a high mitochondrial membrane
potential would be preferred over one with a lower potential, and this physiological parameter
could be used as a way to screen for optimal inoculum cultures.
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9. CONCLUSIONS AND RECOMMENDATIONS
9.1 Conclusions
The goals outlined in the introduction of this thesis included the desire to contribute to
the continual development of quantitative methodologies that analyze complex biological
systems and illustrate relations between cellular physiology and behavior. Analyzing metabolic
fluxes are not enough for metabolic engineering to become an effective tool for mammalian cell
culture analysis, but rather, fluxes must be combined with observations of cellular physiology.
Furthermore, all biological systems must be analyzed with the thought that heterogeneity almost
undoubtedly exists within these systems. The analysis of multivariable and nonlinear dynamic
biological systems must be done within a mathematical framework and not the "mental model"
framework that currently dominates much of the biology literature (Bailey, 1999). This thesis
employed mathematical techniques to analyze experimental data that was then, most importantly,
used to formulate hypothesis concerning relations between mitochondria and cell death.
The findings from this research helped strengthen the field of metabolic flux analysis by
showing how this analysis technique can be employed in the quantitation of cellular physiology.
The analysis of metabolic pathways formed the basis for much of the work described in this
thesis. The theoretical analysis of central carbon metabolism led to the confirmation that
pyruvate is the most important flux distribution point within this biochemical reaction network,
enabling one to focus efforts on this branchpoint and direct research efforts toward the analysis
of factors that affect this branchpoint. Redundant data, collected in the continuous culture
experiments from the gas exchange rate measurements, resulted in the ability to not only
determine errors within data sets but also to generate confidence in the relevance of these
calculated metabolic fluxes to the true physiological and metabolic state of cultured cells. The
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mathematical analysis of the pentose phosphate pathway improved upon over forty years of
research in which experimental data could be resolved through the recognition that the previous
"mental models" and simplified mathematical models could not completely describe this small
yet complex part of central carbon metabolism. Furthermore, it demonstrates how a seemingly
complex reaction pathway could be simplified through the use of metabolic flux analysis
techniques.
Metabolic flux analysis applied to continuous culture experiments using both Chinese
hamster ovary and hybridoma cells resulted in numerous conclusions concerning the metabolic
and physiological behavior of these cells lines. The ability to use flux analysis to determine the
actual flux distribution around pyruvate resulted in the determination of the flux distribution as
related to cellular physiology parameters such as the death rate and metabolite production or
consumption rates. Factors related to respiration that appeared to correlate with physiology were
the common thread throughout this flux analysis research, leading to the hypothesis that
respiration, oxidative phosphorylation, and other factors related to mitochondria are critical
parameters that contribute to mammalian cell culture physiology.
This conclusion was further supported by the result concerning steady state multiplicity
in which cells that were pre-adapted to a high respiratory physiological state were able to
maintain this high respiratory flux leading to a dramatic increase in cell density. Since most
mammalian cultures are inefficient with respect to their ability to convert glucose into carbon
dioxide through the respiratory chain, this finding that cells can become more efficient even
when at high growth rates indicates the definite potential for cell cultures to reach more efficient
physiological states. In other words, this result shows the potential for cell cultures to
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dramatically increase their respiratory capacity. The question now is, how can one reach these
efficient metabolic states consistently?
The hypothesis concerning the important role of mitochondria in mammalian cell culture
was also supported through the research involving the cell populations sorted based on
mitochondrial membrane potential. The fact that cell populations with a higher mean
mitochondrial membrane potential resist apoptosis was demonstrated through measurements of
both the morphological and biochemical characteristics associated with cells undergoing
apoptosis. This result is reasonable since mitochondria have proven to be one of the key players
involved in orchestrating the apoptosis mechanism.
Finally, these results were applied in the development of two new strategies for fed-batch
operation and design. The first strategy showed that overfeeding cells later in a culture leads to
an increase in culture viable cell concentration, viability, and productivity. The second strategy
showed that cell populations with a higher mean mitochondrial membrane potential are able to
resist apoptosis stimuli encountered in typical bioreactor fed-batch conditions. These results
indicate that mitochondrial physiology plays a significant role in cell culture performance.
9.2 Recommendations
Mammalian cell culture modeling and flux analysis should continue to play a significant
role not only in he development of bioreactor operations such as for feeding strategy
formulation, but also as a means of obtaining a fundamental understanding of biological
mechanisms related to cell death and productivity. Previous work using metabolic fluxes has
resulted in several novel hypothesis concerning these biological mechanisms. Peptide
hydrolysate metabolism and product glycosylation have been two areas of research covered in
other work, and the role of mitochondria in mammalian cell culture was covered in this work.
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Future work should continue to examine central carbon metabolism flux distribution when cells
are subjected to changes in controlled environmental conditions. Typical biological research
does not adequately provide an experimental framework through which one can examine the
complex multivariate dynamical systems present in biological systems. For example, the effects
of a growth factor are almost always conducted in experiments that measure only a few
parameters such as gene expression or cell growth. This contrasts dramatically with a
continuous culture experiment in which the withdrawal or supplementation of a key medium
component provides information concerning the overall physiological effects of these
compounds and their relations with central carbon metabolism and enzyme and gene regulatory
networks.
Population heterogeneity is also another significant area of research in biochemical
engineering that has not been adequately explored. Issues such as genetic instability and
bioreactor performance heterogeneity are considered a significant problem in the field of
biochemical engineering, and effort should be directed toward solving these issues. FACS is an
excellent tool for population heterogeneity hypothesis testing, and it will most likely become a
standard piece of equipment for all biotechnology labs. For example, a therapeutic drug
undergoing testing may result in little overall stimulation of a target cell population. Through
ordinary, whole-population analysis such as gel electrophoresis, true effects that influence a
small subpopulation of cells would be masked. FACS could detect these subpopulations, allow
one to isolate them, and then allow one to perform additional testing on this cell subpopulation
which could lead to the development of a more potent therapeutic. The laser scanning
cytometer, the gene chip, and other technologies would also play a major role in this analysis of
population heterogeneity leading to more effective therapeutics aimed at a more select cell or
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patient subpopulation. The downside to this research will be the now unavoidable truth that
heterogeneity exists in places where it was previously either unknown or ignored. Commonly
used cell lines will likely show considerable population heterogeneity and this will add another
dimension to biological research by requiring not only the specification of the cell line being
used but also the exact experimental background of that cell line.
Apoptosis research has made considerable progress in the last few years. The future
work in this area, though, is still limitless due to the fact that research in this field is still in the
basic discovery stage. The recent understanding that mitochondria play a fundamental role in the
apoptotic mechanism still leaves scientists without a basic understanding of the translocation
process of mitochondrial based apoptosis inducing factors to the cytosol for activation of the
effector caspases.
Mitochondria research has not been given as much attention as it deserves during the last
thirty years. In the past, the Mitchell hypothesis was the major driving force behind research on
mitochondria. Only recently through apoptosis research has the behavior of these critical
organelles been appreciated. Research demonstrating their ability the move, change shape, and
respond to cellular physiological changes illustrate how these "organisms within an organism"
operate. Inverse metabolic engineering strategies that focus on the development of cell lines
with desirable mitochondrial physiology should play a definite role in future biochemical
engineering research.
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NOMENCLATURE
A Matrix of biochemical reaction network stoichiometry
ai Extent of reaction reversibility
bj Fractional enrichment of labeled input substrate
Ci Metabolite or nutrient concentration (mmole/L)
D Dilution rate (hr l')
E Matrix of redundant equations
Hi Henry's law coefficient for species i (Pa/mole L)
h Consistency index
K Kernal matrix for N
kd Death rate (hr' l)
kLa Mass transfer coefficient
m Number of metabolites in a reaction network
N Steady state internal metabolite matrix
NT, Nv Total and viable cell density (cells/ml)
n Number of reactions in a reaction network
P Pentose phosphate pathway non-oxidative reaction flux
Pi Partial pressure of species i
Ap Proton motive force (mV)
qc Metabolite or nutrient uptake rate (mmole/cell/hr)
r Vector of metabolite production and consumption rates
vi Reaction velocity or metabolic flux for reaction i (mmole/cell hr)
v Vector of reaction fluxes
VR Reactor volume (L)
xi Concentration of metabolite i (mmole/cell)
yi Jsotope fractional enrichment of metabolite i
zi Gas phase mole fraction of species i
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Greek Letters
aCij, ij Stoichiometric coefficient for metabolite j and reaction i
E Defined in equation 4.15
(P Defined in equation 4.16
A'm Mitochondrial membrane potential (mV)
fT Variance-covariance matrix for the measurement vector, r
At Growth rate (hr' l)
Abbreviations
CER Carbon dioxide evolution rate
Ery4P Erythrose 4-phosphate
Gra3P Glyceraldehyde 3-phosphate
Hex6P Hexose pool consisting of glucose 6-phosphate and fructose 6-phosphate
MMP Mitochondrial membrane potential
MTT 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide
OUR Oxygen uptake rate
Pen5P Pentose pool consisting of ribulose 5-phosphate, ribose 5-phosphate, and
xylulose 5-phosphate
Sed7P Sedoheptulose 7-phosphate.
Rh123 Rhodamine 123
RQ Respiratory quotient
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